Protection against severe malaria by hemoglobin S and C: A quantitative understanding of the cytoadhesion behavior of Plasmodium falciparum infected erythrocytes by Lansche, Christine
  
 
 
DISSERTATION 
 
 
Protection against severe malaria by hemoglobin S and C: A 
quantitative understanding of the cytoadhesion behavior of 
Plasmodium falciparum infected erythrocytes  
 
 
submitted to the  
Combined Faculties for the Natural Sciences and for Mathematics 
 of the Ruperto-Carola University of Heidelberg, Germany  
for the degree of Doctor of Natural Sciences  
 
 
 
presented by 
Christine Lansche (M. Sc.) 
Heidelberg 2018 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Dissertation  
 
 
 
submitted to the  
Combined Faculties for the Natural Sciences and for Mathematics 
 of the Ruperto-Carola University of Heidelberg, Germany  
for the degree of  
Doctor of Natural Sciences  
 
 
 
 
 
 
 
 
presented by  
Christine Lansche (M. Sc.) 
born in Heredia, Costa Rica 
 
 
 
 Date of oral examination: _______________ 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Protection against severe malaria by hemoglobin S and C: A 
quantitative understanding of the cytoadhesion behavior of 
Plasmodium falciparum infected erythrocytes  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Referees:  Prof. Dr. Michael Lanzer 
  Dr. Ann-Kristin Müller 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Hiermit erkläre ich, dass ich die vorliegende Arbeit von May 2014 bis May 2018 unter 
Anleitung von Prof. Dr. Michael Lanzer selbst durchgeführt habe und schriftlich 
ausgearbeitet habe. Ich habe mich keiner anderen Hilfsmittel und Quellen bedient als 
den hier ausdrücklich erwähnten 
 
 
 
 
……………………………… ……………………………………………. 
Datum Christine Lansche 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
TABLE OF CONTENTS  
 
 
Table of Contents 
List of Abbreviations ................................................................................................. I 
List of Figures and Tables ....................................................................................... V 
Summary ................................................................................................................. VII 
Zusammenfassung ................................................................................................ VIII 
1. Introduction ....................................................................................................... 1 
1.1. Blood rheology and hemodynamics .................................................................. 1 
1.2. Background about malaria ................................................................................ 2 
1.3. Plasmodium falciparum biology and pathogenesis ........................................... 3 
1.4. Plasmodium falciparum-infected erythrocytes cytoadherence and antigenic 
variation ...................................................................................................................... 6 
1.5. Molecular mechanism of infected erythrocytes adherence to host receptors ... 8 
1.6. Knob formation and its role in cytoadherence ................................................. 10 
1.7. Dynamic adherence: a multi-step process ...................................................... 13 
1.8. Endothelial cells response to infected erythrocytes adherence ...................... 15 
1.9. The impact of host genetic on red blood cells and protection against       
malaria ...................................................................................................................... 19 
1.10. Aims of the study ......................................................................................... 23 
2. Materials and Methods .................................................................................... 24 
2.1. Materials ...................................................................................................... 24 
2.1.1. Equipment ............................................................................................. 24 
2.1.2. Disposables .......................................................................................... 27 
2.1.3. Kits ........................................................................................................ 29 
2.1.4. Chemicals ............................................................................................. 29 
2.1.5. Biological materials ............................................................................... 30 
2.1.6. Buffers and solutions ............................................................................ 32 
2.1.7. Computer software and databases ....................................................... 33 
2.2. Methods .......................................................................................................... 34 
TABLE OF CONTENTS  
 
 
2.2.1. Ethical clearance ......................................................................................... 34 
2.2.2. Blood collection and genotyping .................................................................. 34 
2.2.3. Cell culture methods .................................................................................... 34 
2.2.3.1. Endothelial cell culture and handling ..................................................... 34 
2.2.3.2. Plasmodium falciparum in vitro culture and handling ............................ 35 
2.2.4. Binding assays ............................................................................................ 40 
2.2.4.1. Static adhesion assay (wash assay technique)..................................... 40 
2.2.4.2. Flow chamber adhesion assay.............................................................. 41 
2.2.4.3. Tracking analysis of single infected erythrocytes .................................. 42 
2.2.4.4. Quantification of infected erythrocytes cytoadhesive behavior ............. 42 
2.2.5. Assessment of endothelial cell activation .................................................... 44 
2.2.6. Immunofluorescent methods ....................................................................... 45 
2.2.6.1. Enzyme-linked immunosorbent assay for IL-6 quantification ................ 45 
2.2.6.2. ICAM-1 cell surface levels measured by flow cytometry ....................... 45 
2.2.6.3. NF-ҡB immunolocalization .................................................................... 46 
2.2.7. Microscopy techniques ................................................................................ 47 
2.2.7.1. Confocal imaging acquisition and analysis ........................................... 47 
2.2.7.2. Scanning electron microscopy (SEM) ................................................... 47 
2.2.7.3. Atomic force microscopy (AFM) ............................................................ 48 
2.2.7.3.1. Sample preparation for knob imaging by scanning AFM ................ 48 
2.2.7.3.2. AFM-Single cell force spectroscopy (AFM-SCFS) .......................... 49 
2.2.8. Molecular biology methods .......................................................................... 49 
2.2.8.1. P. falciparum RNA isolation for var gene transcriptional profiling .......... 49 
2.2.8.2. P. falciparum gDNA isolation ................................................................ 51 
2.2.9. Spectrophotometric assays ......................................................................... 52 
2.2.9.1. Quantification of hemoglobin content by spectroscopy (new    
permeation pathways activation) ........................................................................... 52 
3. Results ............................................................................................................. 53 
TABLE OF CONTENTS  
 
 
3.1. Selection and characterization of a P. falciparum FCR3 binding population to 
HDMEC .................................................................................................................... 53 
3.1.1. Selection of Plasmodium falciparum (FCR3) binding to HDMEC ................... 53 
3.1.2. Characterization of FCR3HDMEC receptor binding preference .......................... 55 
3.1.3. Parasite multiplication rate, multiple infectivity and development ................... 57 
3.2. Characterization of infected hemoglobinopathic erythrocytes adherence          
to HDMEC ................................................................................................................ 61 
3.2.1. Adherence of FCR3HDMEC P. falciparum-infected hemoglobinopathic 
erythrocytes under static conditions ......................................................................... 61 
3.2.2. Adherence of FCR3HDMEC P. falciparum-infected hemoglobinopathic 
erythrocytes under physiological flow conditions ...................................................... 62 
3.2.3. Quantification of FCR3HDMEC P. falciparum-infected erythrocytes    
cytoadhesive behavior on resting HDMEC ............................................................... 65 
3.2.4. Differential motion behavior for P. falciparum-infected erythrocytes at 
trophozoite and schizont stage on resting HDMEC .................................................. 69 
3.2.5. Differential adhesion behavior for infected hemoglobinopathic erythrocytes    
on HDMEC ............................................................................................................... 73 
3.2.6. Delayed activation of new permeation pathways in infected   
hemoglobinopathic erythrocytes ............................................................................... 82 
3.2.7. Knob characterization of hemoglobinopathic P. falciparum-infected 
erythrocytes .............................................................................................................. 84 
3.3. Endothelial cell activation by P. falciparum infected erythrocytes ................... 90 
3.3.1. NF-ĸB nuclear translocation induced by infected erythrocytes binding ....... 90 
3.3.2. Endothelial ICAM-1 surface expression and IL-6 secretion upon infected 
erythrocytes binding .............................................................................................. 91 
3.3.3. Reduced endothelial cell activation by infected HbAS erythrocytes ............ 93 
3.4. Quantification of P. falciparum-infected erythrocytes binding strength at    
single cell level by atomic force microscopy-single cell force spectroscopy ............. 95 
4. Discussion ....................................................................................................... 98 
4.1. Reduced cytoadherence of FCR3HDMEC infected hemoglobinopathic 
erythrocytes to HDMEC under flow conditions ...................................................... 98 
TABLE OF CONTENTS  
 
 
4.2. Differential cytoadhesion behavior for infected HbAS erythrocytes on  
HDMEC at trophozoite and schizont-stages ....................................................... 100 
4.3. Strong binding population of infected HbAS erythrocytes .......................... 103 
4.4. Reduced endothelial cell activation by infected HbAS erythrocytes .......... 105 
5. Conclusions and Outlook ............................................................................. 108 
References ............................................................................................................... IX 
Publications and Conference Presentations ................................................... XXVII 
Acknowledgements ............................................................................................ XXIX 
 
 
 
 
 
LIST OF ABBREVIATIONS 
 
 
I 
List of Abbreviations 
Abbreviations 
AFM Atomic force microscopy 
AP Alkaline phosphatase  
ATS Acidic terminal segment  
BSA Bovine serum albumin 
BSS Balanced salt solution 
CD Cluster of differentiation 
cDNA Complementary DNA 
CIDR Cysteine-rich interdomain region   
CO2 Carbon dioxide  
CR1 Complement receptor 1 
CSA Chondroitin-4-Sulfat A 
C-terminal Carboxy terminal 
DBL Duffy-binding like  
ddH2O Double distilled water 
DIC Differential interference contrast  
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP Deoxyribonucleoside triphosphate 
dsDNA Double stranded DNA 
DV Digestive vacuole 
EC Endothelial cell 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme linked immunosorbent assay 
Em Emission 
EPCR Endothelial protein C receptor 
EPM Erythrocyte plasma membrane 
Ex Excitation 
FACS Fluorescence activated cell sorter 
FCR3 P. falciparum adapted Lab strain 
FCS Fetal calf serum 
gDNA Genomic DNA 
LIST OF ABBREVIATIONS 
 
 
II 
HA Hyaluronic acid  
Hb Hemoglobin 
HBSS Hank's Balanced Salt Solution 
HDMEC Human dermal microvascular endothelial cells 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl] ethanesulfonic acid 
hpi Hours post invasion 
HRP  Horseradish peroxidase 
HUVEC Human umbilical vein endothelial cells 
ICAM Intercellular adhesion molecule  
IF Immunofluorescence 
IFN Interferon  
Ig Immunoglobulin 
IL Interleukin 
iRBC Infected red blood cell 
KAHRP  Knob Associated Histidine Rich Protein  
KO Knock out 
LFA-1 Lymphocyte-associated function antigen -1 
Mac-1 Macrophage antigen-1  
MACS Magnetic activated cell sorter 
MHC Major histocompatibility complex 
mRNA Messenger RNA 
NF-κB Nuclear factor kappa B 
NLI Nuclear labeling index 
NO Nitric oxide 
NPP New permeation pathways  
N-terminus  Amino-terminus  
NTS N-terminal sequence 
O2 Oxygen 
OD Optical density 
P. Plasmodium 
PBS Phosphate buffered saline 
PCA Principal component analysis 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PECAM Platelet endothelial cell adhesion molecule 
LIST OF ABBREVIATIONS 
 
 
III 
PFA Paraformaldehyde 
PfEMP Plasmodium falciparum erythrocyte membrane protein 
pH Power of hydrogen 
PSGL-1 P-selectin glycoprotein ligand-1 
PV Parasitophorous vacuole 
PVM Parasitophorous vacuolar membrane 
RBC Red blood cell 
RNA Ribonucleic acid 
rpm  Revolutions per minute 
RPMI Roswell Park Memorial Institute 
RT Room temperature 
SCFS Single cell force spectroscopy 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
SEM Standard error of the mean or scanning electron microscopy 
TAE Tris-acetate-EDTA 
Taq Thermus aquaticus 
TM Transmembrane  
TNF-α Tumor necrosis factor alpha 
Tris Tris(hydroxymethyl)-aminomethan 
Ups Upstream promoter sequence 
uRBC Uninfected red blood cell 
UV Ultra violet 
v/v Volume-volume 
VCAM-1 Vascular cell adhesion molecule 1 
w/v Weight-volume 
WBC White blood cells 
WHO World Health Organization 
 
Measuring units and symbols 
% Percent 
°C  Degree Celsius 
∞ Infinite 
LIST OF ABBREVIATIONS 
 
 
IV 
A Ampere or Absorbance 
au Arbitrary units 
cm Centimeter 
Da Dalton  
g Gramm 
hr Hour 
k  Kilo  
Kb Kilobasepare  
l Liter 
M Molar  
m Meter or milli  
min Minute 
mol Mol 
n  Nano  
N Newton  
p Pico  
Pa Pascal  
s Second 
U Unit(s) 
V Volt 
x g Times gravitational force 
α Alpha - anti 
β Beta 
Δ Delta, difference, change 
κ kappa 
μ  Micro 
τ Tau, shear stress 
LIST OF FIGURES AND TABLES 
 
 
V 
List of Figures and Tables 
Figure 1 | Life cycle of Plasmodium falciparum. ......................................................... 4 
Figure 2 | Var gene structure and protein diagram ..................................................... 8 
Figure 3 | Schematic representation of the P. falciparum-infected erythrocytes knob 
structure.. .................................................................................................................. 12 
Figure 4 | Schematic illustration of leukocytes and P. falciparum-infected  
erythrocytes dynamic and firm adhesion process. .................................................... 15 
Figure 5 | Summary figure showing the endothelial cell responses to infected 
erythrocytes biding ................................................................................................... 18 
Figure 6 | Aberrant protein trafficking system observed in infected HbS and HbC 
erythrocytes .............................................................................................................. 22 
Figure 7 | Surface expression levels of ICAM-1 and CD36 on HDMEC .................... 54 
Figure 8 | Selection of P. falciparum FCR3 strain for binding to HDMEC ................. 55 
Figure 9 | Effect of blocking antibodies on FCR3HDMEC binding to HDMEC .............. 56 
Figure 10 | Characterization of FCR3HDMEC var gene transcription ........................... 57 
Figure 11 | Characterization of Plasmodium falciparum FCR3HDMEC growing in 
hemoglobinopathic erythrocytes. .............................................................................. 60 
Figure 12 | Comparative adherence of infected HbAA, HbAC and HbAS   
erythrocytes to HDMEC under static conditions. ...................................................... 61 
Figure 13 | Adherence of P. falciparum-infected erythrocytes under low   
physiological flow conditions. .................................................................................... 63 
Figure 14 | Detachment assay for P. falciparum-infected erythrocytes bound under 
physiological flow conditions.. ................................................................................... 64 
Figure 15 | Effect of SYBR Green staining on cytoadherence of FCR3HDMEC to 
microvascular endothelial cells ................................................................................. 66 
Figure 16 | Schematic of flow experiment setup ....................................................... 68 
Figure 17 | Differential motion behavior of P. falciparum-infected erythrocytes   
flowing at low flow conditions .................................................................................... 69 
Figure 18 | Effect of the parasite developmental stage on the dynamic adhesion 
behavior .................................................................................................................... 71 
Figure 19 | Dynamic adhesion behavior observed for P. falciparum-infected 
erythrocytes at different developmental stages.. ...................................................... 72 
LIST OF FIGURES AND TABLES 
 
 
VI 
Figure 20 | Quantification of P. falciparum-infected erythrocytes dynamic adhesion   
to HDMEC under low physiological flow conditions .................................................. 74 
Figure 21 | Differential cytoadhesive behavior of P. falciparum-infected     
erythrocytes under low physiological flow conditions. ............................................... 75 
Figure 22 | Quantification of P. falciparum-infected erythrocytes cytoadhesive 
behavior at 0.03 Pa .................................................................................................. 78 
Figure 23 | Quantification of P. falciparum-infected erythrocytes cytoadhesive 
behavior at 0.05 Pa .................................................................................................. 79 
Figure 24 | Quantification of P. falciparum-infected erythrocytes cytoadhesive 
behavior on TNF-α activated endothelium at 0.05 Pa. .............................................. 81 
Figure 25 | Differential cytoadhesive behavior of P. falciparum-infected HbAC 
erythrocytes under low physiological flow conditions ................................................ 82 
Figure 26 | New permeation pathways activation for parasitized HbAA, HbAC and 
HbAS erythrocytes .................................................................................................... 84 
Figure 27 | Knob characterization for hemoglobinopathic infected erythrocytes. ...... 86 
Figure 28 | Principal component analysis. ................................................................ 88 
Figure 29 | Adhesion foot prints patterns for infected erythrocytes. .......................... 89 
Figure 30 | P. falciparum-infected erythrocytes induce nuclear translocation of       
NF-ĸB in a dose dependent manner ......................................................................... 91 
Figure 31 | P. falciparum-infected erythrocytes directly activate HDMEC ................. 92 
Figure 32 | Reduced endothelial cell activation by HbAS infected erythrocytes ....... 94 
Figure 33 | Force measurements between P. falciparum-infected erythrocytes and 
HDEMCs at a single cell level ................................................................................... 96 
 
 
Table 1. Correspondent flow rates used to generate the different shear stresses in 
the µ-slide VI0.4 chamber. ......................................................................................... 42 
Table 2. Knob characterization of infected HbAA and HbAS erythrocytes at the 
trophozoite and schizont stage by AFM. ................................................................... 87 
 
 
SUMMARY 
 
 
VII 
Summary 
 To avoid clearance by the spleen, P. falciparum-infected erythrocytes adhere 
to the microvascular endothelial cells lining the blood vessels and sequester in the 
microvasculature of vital organs. Cytoadhesion results in reduced blood perfusion 
and inflammatory endothelial cell activation. While the parasite matures during the 
intraerythrocytic cycle, the infected erythrocyte undergoes a series of modifications 
including altered morphology, reduced deformability and increased adhesiveness. 
These properties govern the cytoadherence process and determine the dynamic 
adhesion behavior under physiological flow conditions. Several red blood cell 
polymorphisms, including sickle hemoglobin and hemoglobin C, have been 
associated with protection against severe malaria and malaria-related death. The 
mechanisms underlying this protection are poorly understood but it might be 
conferred, in part, by the reduced binding capability of infected erythrocytes to 
microvascular endothelial cells. Here, we quantitatively compared the adhesion 
dynamics of infected wild-type and sickle cell trait erythrocytes, at different parasite 
developmental stages, using flow chamber assays. Differences in the dynamic 
adhesion behavior were observed for trophozoite and schizont-stages. While a 
discoid shape in early stage caused flipping of the infected cell, an almost spherical 
cell at the late stage of the intraerythrocytic cycle results in a regular rolling motion. 
We further showed that changes in mechanical and adhesive properties of infected 
sickle cell trait erythrocytes resulted in substantial differences in the flipping and 
rolling dynamics, relative to infected wild-type erythrocytes, which led to a reduced 
contact time and predicted contact area to the endothelial cells as well as a reduced 
firm adherence. As a consequence of the differential firm and dynamic adhesion 
behavior, infected sickle trait-erythrocytes were less likely to activate microvascular 
endothelial cells, which in turn, might reduce the pathology observed in sickle cell 
trait individuals infected with P. falciparum. Overall, our findings improve the 
understanding of the protection mechanism against severe malaria conferred by 
sickle hemoglobin. 
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Zusammenfassung 
P. falciparum infizierte Erythrozyten adhärieren an mikrovaskuläre Endothelzellen an 
der Innenseite von Blutgefäßen und sequestrieren in die Kapillarsysteme 
lebenswichtiger Organe, um ihrer Aussonderung in der Milz zu entgehen. Die 
Zytoadhärenz reduziert die Blut Perfusion und ruft inflammatorische 
Endothelzellaktivierung hervor. Das intraerythrozytische Reifen des Parasiten führt 
zu einer Reihe von Veränderung des infizierten Erythrozyten dazu zählen eine 
veränderte Morphologie, eine reduzierte Verformbarkeit und verstärkte Zelladhärenz. 
Diese  Eigenschaften bestimmen den Prozess der Zelladhäsion und das dynamische 
Adhäsionsverhalten unter physiologischen Flussbedingungen. Mehrere 
Polymorphismen roter Blutkörperchen, wie das Sichelzellhämoglobin oder 
Hämoglobin C, werden mit dem Schutz vor schweren bis tödlichen 
Krankheitsverläufen einer Malaria Infektion assoziiert. Der zugrundeliegende 
Schutzmechanismus ist nur unzureichend verstanden, basiert aber vermutlich auf 
der verminderten Fähigkeit von infizierten Erythrozyten an mikrovaskuläre 
Endothelzellen zu binden. In dieser Arbeit wurde das dynamische 
Adhäsionsverhalten von infizierten Wildtyp-Erythrozyten und Erythrozyten mit 
heterozygoter Sicherzellanämie mit Hilfe von Durchflusskammer Experimenten für 
verschiedene Entwicklungsstadien quantifiziert. Dabei konnten für alle 
intraerythrozytische Entwicklungsstadien Unterschiede im dynamischen 
Adhäsionsverhalten beobachtet werden. Infizierte Blutzellen führen zu Beginn des 
Reifezyklus aufgrund der biokonkaven Zell Form eine taumelnde Bewegung aus, 
was sich in späteren Stadien und der typischen fast sphärische Form zu einer 
regelmäßigen Rollbewegung wandelt. Änderungen in mechanischen und adhäsiven 
Eigenschaften infizierter HbAS Erythrozyten resultierten in substanziellen 
Unterschieden bezüglich der taumelden und rollenden Bewegungsmuster, was zu 
einer Reduktion der Kontaktzeit, der zu erwartenden Kontaktfläche und der 
dauerhaften Adhäsion auf Endothelzellen führte. Als Konsequenz aus dem 
unterschiedlichen dynamischen und beständigen Adhäsionsverhalten haben infizierte 
Erythrozyten mit heterozygoter Sicherzellanämie eine geringere Wahrscheinlichkeit 
eine Aktivierung mikrovaskulärer Endothelzellen hervorzurufen, was im Gegenzug 
den Krankheitsverlauf abmildert, wie es für Patienten mit Sichelzellanämie 
beobachtet wird. Insgesamt verbessern die Ergebnisse dieser Arbeit das Verständnis 
des Schutzmechanismus von Sichelzellhämoglobin gegen schwere Formen der 
Malaria. 
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1. Introduction 
1.1. Blood rheology and hemodynamics 
Blood is a biological two-phase suspension composed of red blood cells (RBCs, 
erythrocytes), white blood cells (WBCs, leukocytes) and platelets suspended in 
plasma. The cell component comprises about 35-50% of the whole blood volume, 
where approximately 99% correspond to erythrocytes [1]. Blood is responsible for the 
transportation of oxygen and nutrients to the cells of the body and for carrying away 
metabolic waste products [2]. Blood is considered a non-Newtonian fluid as its 
viscosity changes with varying shear stresses. The non-Newtonian behavior 
becomes more evident at low shear stresses, when the erythrocytes spontaneously 
aggregate into linear arranges called rouleaux [2]. The size of the erythrocyte 
aggregate is inversely proportional to the magnitude of the shear forces [3]. Low 
shear stresses promote cell to cell encounter, supporting erythrocyte aggregation. As 
a consequence, the blood viscosity increases. On the contrary, high shear stresses 
causes the disruption of these aggregates up to single cells, leading to a decrease in 
viscosity [3]. The shear forces encountered in arterioles and capillaries are too high 
to promote RBCs aggregates, however, their formation is facilitated in axial regions of 
large vessels and under low shear stress in small vessels [4].  
 
Erythrocytes are highly specialized cells, responsible for transporting oxygen from 
lungs to the tissue and carbon dioxide from the tissue to the lungs. To perform this 
function, erythrocytes must be highly deformable in order to squeeze and pass 
through very narrow capillaries (about 2-3 µm diameter) without damage [5]. The 
deformability is determined by the red blood cell geometry, viscosity and membrane 
elasticity [2].  
 
Erythrocytes have a biconcave-discoid shape with an approximate diameter of 6-8 
µm and a thickness of 2-3 µm [5][6]. With a mean cell volume of about 90 µm3 and an 
approximate mean surface area of 135 µm2, erythrocytes possess a high surface 
area to volume ratio, which enables cell shape changes [2][7]. Furthermore, mature 
mammalian erythrocytes lack a nucleus and other organelles, ensuring full flexibility, 
as well as providing more space for hemoglobin storage [8]. Consequently, about 
95% of the erythrocyte cytosolic protein content corresponds to hemoglobin [9], 
INTRODUCTION 
 
 
2 
giving a low cytoplasmic viscosity [2][7]. The extent of the erythrocyte deformation 
however, is mainly determined by the membrane elasticity. The erythrocyte 
membrane consists of a carbohydrate rich glycocalyx on the outer surface, a 4-5 nm 
tick phospholipid bilayer and the underlying two-dimensional membrane skeleton. 
The latter, is responsible for the maintenance of the biconcave-discoid shape and is 
composed of a protein network, where spectrin and actin are the main components 
[2].  
  
Several genetic or acquired pathological conditions like sickle cell disease [10] or 
malaria [11], can drastically affect the erythrocytes deformability and fluidity, leading 
to impairments of the blood flow and significantly affecting tissue perfusion. During an 
episode of Plasmodium falciparum-malaria, two major rheological abnormalities 
impair the infected red blood cells (iRBCs) ability to circulate. Firstly, the cell rigidity 
increases due to the presence of a large and rigid intracellular parasite and the 
erythrocyte membrane elasticity decreases as consequence of extensive erythrocyte 
modifications induced by the parasite [12]. Secondly, P. falciparum-infected 
erythrocytes become adhesive and bind to several host receptors expressed on the 
microvasculature [12]. These modifications prevent infected erythrocytes from flowing 
through small vessels and, at the same time, they cause infected erythrocytes to 
sequester in the deep microvasculature, leading to vascular obstruction, vascular 
inflammation, ischemia and organ failure [11].  
 
1.2. Background about malaria  
Malaria is an infectious disease caused by a protozoan parasite of the genus 
Plasmodium. It is transmitted to the human host through a female anopheles 
mosquito during blood feeding. Among all Plasmodium species P. falciparum, P. 
vivax, P. ovale (P. ovale curtisi and P. ovale wallikeri), P. malariae and P. knowlesi  
infect humans [13][14][15]. Infection with malaria parasites causes a range of clinical 
manifestations including fever, headache and chills. If not treated in time, infection 
can progress to severe disease often leading to death, especially in the case of P. 
falciparum malaria [16]. P. vivax, on the other hand, is responsible for a significant 
world-wide morbidity, being the major cause of illness in most parts of the world, 
nevertheless it is rarely life-threatening [16]. In 2017, the World Health Organization 
(WHO) reported approximately 216 million clinical cases of malaria and 445 000 
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deaths [16]. To date, P. falciparum is responsible for most malaria-related deaths, 
especially among non-immune children under the age of five in sub-Saharan Africa 
[16]. Other groups with high risk of mortality include pregnant women and non-
immune travelers [16]. The morbidity and mortality caused by P. falciparum is mainly 
attributed to the resistance of mosquito vector to insecticide, socio-economic factors, 
resistance of P. falciparum to antimalarial drugs and the absence of a vaccine which 
provides full protection [17].  
 
1.3. Plasmodium falciparum biology and pathogenesis 
P. falciparum has a complex life cycle involving a human host and a mosquito vector 
(Figure 1). During a blood meal, an infected mosquito inoculates < 25 sporozoites 
(motile form) into the host skin [13]. Some will reach the blood stream and travel to 
the liver, cross the sinusoidal barrier (endothelial cells and Kupffer cells) and invade 
the hepatocytes. There, parasites multiply asexually to produce approximately 40000 
infective daughter cells called merozoites in a period of about 10 days [18][19]. The 
merozoites are released into the blood circulation and invade erythrocytes in a very 
fast manner (~2 min).  
 
Once the intraerythrocytic infection is established, the 48 h replicative cycle starts 
[18]. The parasite develops subsequently from ring stage (up to 16 h post invasion 
(hpi)) to trophozoite (20 to 36 hpi) and finally to schizont (40 to 48 hpi) [20]. Each 
schizont divides asexually to produce 16-32 merozoites [19]. Following erythrocyte 
rupture, merozoites are released and able to infect new red blood cells. Intracellular 
parasite growth and replication prevents direct parasite exposure to immune cells 
[21]. Additionally, erythrocytes surface lack MHC class I molecules, preventing the 
recognition of the infected erythrocytes by CD+8 T cells [22][23].  
 
The rupture of schizont infected erythrocytes and the release of their contents is 
characterized by episodes of fever [24]. The fever is caused by systemic release of 
pyrogenic cytokines such as tumor necrosis factor alpha (TNF-α), produced by 
macrophages in response to parasite derived products such as 
glycosylphosphatidylinositol (GPI) [25][26][27][28]. 
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Figure 1 | Life cycle of Plasmodium falciparum (adapted from L. Bannister and 
W. Sherman (2009) [29]). (A) Asexual intra-erythrocytic cycle. 
 
Approximately 10% of intraerythrocytic parasites commit to sexual development and 
produce sexual forms called gametocytes [30]. Circulating gametocytes can be 
ingested by a female mosquito, were the parasite sexual replication occurs. Once in 
the mosquito midgut, the microgametes exflagellate from the male gametocyte and 
can then swim and fertilize the female gametocyte called macrogamete, to form the 
zygote [19]. The latest transforms into a motile form called ookinete, which migrates 
through the mosquito midgut epithelium and encyst to form the oocyst. Through 
asexual multiplication, thousands of sporozoites are produced and released into the 
mosquito hemocoel after ~17 days. Resultant sporozoites find their way to the 
salivary glands, from where they can be transmitted to the human host by a 
subsequent mosquito bite and initiate a new cycle [19][18]. 
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The intra-erythrocytic stage of infection is responsible for the clinical manifestations 
of malaria. Malaria disease can range from asymptomatic parasitemia or mild 
symptomatic malaria (fever) to severe illness and death [31]. The clinical outcome 
depends on several factors including parasite virulence and drug resistance, host 
immunity and genetics, mosquito transmission intensity and access to treatment [26]. 
About 1 to 2% of the malaria cases progress to life-threatening illness [32][33]. The 
clinical manifestations of severe P. falciparum malaria are variable and thus difficult 
to define. The WHO criteria to define severe malaria include the manifestation of one 
or various of the following symptoms: (1) cerebral malaria (CM) (coma and seizures), 
(2) respiratory distress as consequence of lactic acidosis (plasma bicarbonate <15 
mmol/l), (3) pulmonary edema (radiologically confirmed), (4) jaundice (plasma 
bilirubin >3 mg/dl), (5) severe anemia (hemoglobin <5 g/dl), (6) hypoglycemia (blood 
glucose <40 mg/dl), (7) renal failure (plasma creatinine >3 mg/dl) and (8) 
hyperparasitaemia (>10%) [16]. CM, is the most common severe complication in 
children, causing up to 30% of deaths [34][35][36][37] and neurological sequelae in 
about 9 to 12% of the survivors [34][37]. 
 
The most prominent and early observed pathological feature in severe P. falciparum-
malaria cases is the presence of late stage-infected erythrocytes in capillaries and 
post-capillary venules of several organs including brain, placenta, heart, eyes, liver, 
kidneys, intestines and adipose tissue [38][39][33][40][41]. The ability of P. falciparum 
infected erythrocytes to adhere to endothelial cells (EC) and sequester from the 
circulation, ensures the parasite survival by avoiding passage to the spleen. There, 
parasitized erythrocytes would be eliminated by splenic clearance mechanisms, 
which remove old and damaged erythrocytes [42][43][44].  
 
Sequestration not only facilitates dissemination of the parasite in the human host, but 
also causes severe disease by obstructing the vascular lumen which can lead to low 
blood perfusion, ischemia, acidosis and organ damage [45]. Increased rigidity of 
uninfected erythrocytes, possibly as a consequence of membrane oxidation by 
parasite derived products such as hemozoin (β-haematin) [46][47][47], may act 
synergistically with sequestered infected erythrocytes in compromising the blood 
tissue perfusion [48][47]. Oxygen delivery to the affected tissue might be further 
compromised by anemia, induced as a consequence of elevated hemolysis of 
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parasitized erythrocytes,  accelerated elimination of rigid uninfected erythrocytes and 
impaired erythropoiesis due to excessive release of proinflammatory cytokines such 
as TNF-α and IFN-γ [25].  
 
Anemia as well as lactic acid production from the parasite anaerobic glycolysis, 
contribute to the observed lactic acidosis during severe malaria [49]. However, the 
main cause of this syndrome is the increase of anaerobic glucose metabolism 
caused by the generalized microvascular sequestration of infected erythrocytes and 
the resultant decreased blood flow perfusion into the tissues [50][41]. As result of 
lactic acidosis, the body will experience respiratory distress when it tries to equilibrate 
the blood pH by excreting larger amounts of carbon dioxide. At the same time, 
hypoglycemia might also develop as a consequence of high glucose consumption by 
the intra-erythrocytic parasite and by the hypermetabolic peripheral tissue [51]. 
 
1.4. Plasmodium falciparum-infected erythrocytes cytoadherence 
and antigenic variation 
Sequestration of infected erythrocytes on the microvasculature coincides with the 
erythrocyte surface expression of the major P. falciparum adhesin termed P. 
falciparum erythrocyte membrane protein 1 (PfEMP-1) at approximately 16 hpi 
[52][53], matching with the time of transition from ring to trophozoite. PfEMP-1 
proteins are encoded by the var gene family and mediate both cytoadherence and 
antigenic variation [54]. About 60 different copies of var genes exist per haploid 
genome and they are distributed along the parasite 14 chromosomes, predominantly 
located in clusters at the subtelomeric regions [55][56]. The localization at the 
subtelomeric regions makes them more susceptible to recombination and likely to 
undergo frequent sequence alterations, thus diversifying the antigenic repertoire [57]. 
Var genes are not only diverse in sequence polymorphism but also in size, ranging 
from  3.9 to 13 kb and generating PfEMP-1 proteins with sizes between 200 and 350 
kDa [57].  
 
All var genes possess conserved features in their structure, consisting of a 
5´upstream promoter sequence (Ups) followed by the first exon, an intron and the 
second exon (Figure 2). The first exon is highly variable in sequence and size 
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(between 3.5 to 9 kb) and it encodes the extracellular exposed portion of the protein, 
as well as the transmembrane domain (TM) [13]. The TM anchors the PfEMP-1 to the 
erythrocyte plasma membrane. Following a relatively conserved intron, the second 
exon, shorter in sequence (1 to 1.5 kb) and highly conserved. It encodes the 
cytoplasmic tail which contains the acidic terminal segment (ATS) that anchors 
PfEMP-1 molecules to the host cell cytoskeleton [13][58].  
 
The extracellular portion of PfEMP-1 is composed of a variable N-terminal segment 
(NTS), several Duffy-binding like domains (DBL, five distinct sequence classes α-ε) 
and cysteine-rich interdomain regions (CIDR, three distinct sequence classes α-γ) 
[59]. The number and types of DBL and CIDR in the polymorphic interdomain region 
controls the parasite binding phenotype. This determines the infected erythrocytes 
tissue tropism, thus contributing to the parasite survival, transmission and clinical 
outcome [59]. PfEMP-1 mediates binding of infected erythrocytes to several host 
receptors including CD36, intercellular adhesion molecule-1 (ICAM-1/CD54), 
endothelial protein c receptor (EPCR), thrombospondin (TSP), complement receptor 
1 (CR1)/CD35, chondroitin sulphate A (CSA), hyaluronic acid (HA), E-
selectin/CD62E, vascular cell adhesion protein 1 (VCAM-1), platelet endothelial cell 
adhesion molecule (PECAM/CD31) and P-selectin/CD62P [60][61][62][63][64]. The 
ability of PfEMP-1 molecules to target different host receptors, expressed differently 
in diverse vascular beds, leads to organ-specific syndrome, such as cerebral malaria 
or placental malaria [26][40]. 
 
Only a single PfEMP-1 variant is exclusively expressed on each infected erythrocyte 
at a time, while the other members of the family remain silenced [65][66]. This 
prevents unnecessary exposure of the parasite antigenic repertoire. Successful 
immune evasion through antigenic variation thus requires the mutual expression of a 
single var gene at the time and slow switching to another variant. In vitro the var gene 
switching occurs in a rate of 2% per generation [67]. Antigenic variation is 
advantageous for the parasite because it prolongs the length of infection within the 
host and thus increases the chances of transmission to new hosts [68]. The infection 
would be cleared once the host immune response detects and controls all variants 
present [69].  
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Figure 2 | Var gene structure and protein diagram (adapted from I. W. Sherman 
(2005) [13]). The features of PfEMP-1 structure include the extracellular exposed N-
terminal composed of the NTS followed by a variable number of polymorphic DBL 
domains and CIDR domains, and the TM region, encoded by the highly variable exon 
I. Adhesion of some DBL and CIDR domains to host receptors such as CD36 by 
CIDR1α domain [70][71][72][73], ICAM-1 by DBLβC2 [74], CSA by DBLγ [75][76] 
have been reported. The intron flanked between exon I and II is noncoding. Exon II 
encodes the semi-conserved ATS.  
 
1.5. Molecular mechanism of infected erythrocytes adherence to 
host receptors 
Three major forms of P. falciparum infected erythrocytes adhesion to host receptors 
have been described. (1) Cytoadhesion to endothelial cells [77] (also includes 
adhesion to syncytiotrophoblasts in placenta [78]), (2) rosetting to uninfected 
erythrocytes [79] and (3) auto-agglutination of infected erythrocytes due to binding 
interactions with platelets (platelet-mediated clumping) [80].  
 
Cytoadhesion via CD36  
CD36 is an 88 kDa transmembrane glycoprotein that belongs to the B class 
scavenger receptor. It is involved in fatty acid metabolism, angiogenesis and 
phagocytosis [81]. It is expressed on various cells such as vascular endothelial, 
macrophages, monocytes, dendritic cells, platelets and adipocytes [82][45] and is 
most abundant in the liver, kidney, lungs and muscle [55]. The CD36 binding pocket 
of PfEMP-1 resides in amino acids 139-184 [83]. Binding to this receptor is a feature 
of almost all clinical parasites isolates [84][85]. Several studies associate CD36 
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binding to severe disease in Asia [85][86] and polymorphisms in this receptor confer 
protection against severe malaria in Africa [87] and Asia [88].  
 
Cytoadhesion via ICAM-1 
ICAM-1, a 80-115 kDa membrane glycoprotein from the immunoglobulin superfamily, 
is expressed on the surface of endothelial cells and leukocytes [89][45]. It is found in 
different vascular beds including lungs [90] and brain [91]. Its natural function is to 
enable adhesion of leukocytes to vascular endothelial cells during immune and 
inflammatory responses [92]. It contains five immunoglobulin like-domains (D1 to D5) 
and the binding site for P. falciparum infected erythrocytes is localized in the first 
domain [93]. Adhesion to ICAM-1 has been linked to cerebral malaria (CM) 
[94][84][95]. The sequestration of infected erythrocytes in the brain of CM post-
mortem samples co-localize with ICAM-1 expression [96] and parasitized 
erythrocytes isolated from CM patients highly bind to ICAM-1 in vitro [84].  
 
Cytoadhesion via CSA and HA 
CSA and HA are glycosaminoglycan highly expressed on the syncytiotrophoblasts of 
the placenta intervillous space. CSA serves as major receptor for P. falciparum 
adhesion during pregnancy causing pregnancy-associated malaria (PAM) [40][97]. 
PAM often leads to premature birth, low-birth weight, stillbirth, maternal anemia and 
increased maternal and neonatal mortality [98]. Binding to CSA is mediated by a 
single PfEMP-1 encoded by the distinct highly conserved var2csa gene [99][100]. 
PAM syndrome affects primarily women in their first pregnancy [101]. After first 
exposure, effective humoral responses against placental binding parasites develop, 
since antibodies recognize the highly conserved regions of the var2csa on different 
parasite isolates [102]. Some parasitized erythrocytes isolated from infected 
placentas show binding to HA [103]. Thus, binding to HA might contribute to 
placental malaria [103]. 
 
Other receptors mediating cytoadhesion 
Binding of infected erythrocytes to EPCR in the brain has recently been associated 
with cerebral malaria [63]. Other endothelial cell receptors like P-selectin, E-selectin 
and VCAM-1, all important for leukocyte trafficking, mediate cytoadhesion of infected 
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erythrocytes via PfEMP-1 [64][104][105] but no correlation with severity has been 
found [73][84].  
 
Rosetting  
Infected erythrocytes can bind via PfEMP-1 to complement-receptor 1 (CR1) 
expressed on uninfected erythrocytes [106].  This interaction promotes the binding of 
uninfected erythrocytes to infected erythrocytes, forming cell clusters termed rosettes 
[79]. Rosetting contributes to disease severity by increasing vascular obstruction, 
shielding infected erythrocytes from immune recognition and by facilitating new 
erythrocytes reinvasion [107]. A common African polymorphism on CR1, which leads 
to CDR1 deficiency, is associated with reduced rosettes formation [106] and with 
protection against severe malaria [108].  
 
Platelet-mediated clumping 
Adhesion of infected erythrocytes to other infected erythrocytes via platelets can also 
occur [80]. Infected erythrocytes can bind to the CD36 expressed on activated 
platelets and auto-agglutinate. This phenomenon strongly correlates with malaria 
severity [80][109]. Similarly, infected erythrocytes can bind and sequester in the brain 
via platelets that are simultaneously bound to von Willebrand factor (vWF) strings 
exposed on the activated endothelium [110].  
 
1.6. Knob formation and its role in cytoadherence 
Effective cytoadherence of infected erythrocytes requires the display of PfEMP-1 
molecules on the parasite derived knob-like nanoscale protrusions that are located 
on the erythrocyte plasma membrane [111]. The display and concentration of PfEMP-
1 molecules in the knobs is necessary to ensure adherence under physiological flow 
conditions [111]. Knobs are positively charged, whereas the remaining infected 
erythrocyte membrane is negatively charged [112]. Concentrating PfEMP-1 
molecules at the knobs might be necessary to elevate the positive charged structure 
for proper adherence to the negatively charged endothelial cell surfaces [113][114]. A 
mature infected erythrocyte can express as many as 10000 knobs on its surface with 
height and diameter varying between 2-20 nm and 50-120 nm, respectively 
[115][116][117].  
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The transport of PfEMP-1 molecules to the knobs on the erythrocytes plasma 
membrane is mediated via Maurer´s cleft [118]. These structures are uni-lamellar 
membrane profiles that function as an intermediate compartment for trafficking of 
parasite-encoded proteins [119]. It was proposed that the parasite remodels the 
erythrocyte membrane skeleton to build its own actin network that connects the 
Maurer’s cleft to the knobs at the plasma membrane, where cargo vesicles, carrying 
e.g. PfEMP-1, move towards the knobs [120][121][122][123]. 
 
Knobs are formed by interaction of parasite derived proteins such as knob-associated 
histidine rich protein (KAHRP), PfEMP-1 and Plasmodium helical interspersed 
subtelomeric proteins (PHIST) with host membrane skeletal proteins such as 
spectrin, actin, ankyrin R and protein band 4.1 (4.1 R) [124] (Figure 3). KAHRP, the 
major constituent of knobs [125], is a 85-105 kDa protein expressed during late 
stages of the intraerythrocytic cycle [126]. Its essential role in knob formation has 
been demonstrated in several studies [111][114][127], where erythrocytes infected 
with kahrp-deficient P. falciparum were unable to produce knobs and to cytoadhere to 
several host receptors under physiological flow conditions [111][114][127]. PfEMP-1 
proteins however, remain at the erythrocyte surface [114][111][128] suggesting that 
PfEMP-1 display on the knobs is critical for proper cytoadhesive interactions.  
 
KAHRP contains several protein binding domains which distinctly interact with 
several host and parasite-derived proteins (Figure 3). It binds to both α- and β- 
spectrin, but preferentially to the β-spectrin. The latest is mediated by electrostatic 
interactions and partly by sequence specificity [129][130]. Additionally, KAHRP self-
associate into clusters and bind to spectrin-actin-protein 4.1 complexes [58]. At the 
same time, KAHRP binds to ankyrin R, which seems to be essential for KAHRP 
attachment to the erythrocyte plasma membrane (EPM) [131]. In turn, ankyrin R 
binds to the cytoplasmic domain of the transmembrane protein band 3, which is 
found to be attached to the spectrin tetramers [132][133].  
 
The PfEMP-1 cytoplasmic domain binds to spectrin-actin junction and to self-
associated KAHRP via a conserved cytoplasmic segment [58][134]. At the same 
time, PfEMP-1 binds to PHIST [135], which interacts with junctional complexes such 
as band 3 and α-/β- spectrin [136]. Furthermore, P. falciparum histidine rich protein 1 
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(PfHRP-1) mediate anchoring of the parasite PfEMP-1 to ankyrin R [137]. All these 
interactions provide the required mechanical support for binding of PfEMP-1 to host 
receptors under physiological flow conditions [124]. Additional mechanical support 
could be provided by the conical spiral structure (spiral scaffold) of unknown nature, 
underlying the knobs [138]. 
Figure 3 | Schematic representation of the P. falciparum-infected erythrocytes 
knob structure (adapted from Helms et al., (2016) [124]). The different P. 
falciparum and host erythrocyte proteins involved in knob formation at the infected 
erythrocyte surface are shown. PFE1605w is a member of the PHIST family which 
links the cytoplasmic tail of the PfEMP-1 molecule to spectrin and band 3 [135].  
 
The role of knobs in the increased rigidity of infected erythrocytes 
Theoretical predictions and experimental tests provide fundamental understanding of 
the stiffening mechanism of P. falciparum-infected erythrocytes and indicate that 
knobs are the main cause of membrane stiffening [139][140][114][141]. Micropipette 
aspiration measurements show an increase in rigidity of the infected erythrocytes 
from several knobby parasite lines compared to knobless parasite lines [140]. 
Additionally, KAHRP, responsible for knob formation, accounts for the 51% of the 
increased erythrocyte rigidity [114][141]. Other parasite-derived cytoskeleton binding 
proteins such as PfEMP-3 [141][142] and ring parasite-infected erythrocytes surface 
antigen (RESA) [143], as well as the spiral scaffold [138], can contribute to the 
increased cell membrane rigidity observed for infected erythrocytes [144][145].  
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Rigidity of P. falciparum parasitized erythrocytes might be further amplified by 
oxidative damage of the erythrocyte plasma membrane due to parasite derived 
products [47]. Moreover, an important contributor to the increased cell rigidity is the 
presence of a large and stiff intracellular parasite, as well an unfavorable increase in 
cell sphericity (increase surface area/volume ratio)[146][20]. 
 
1.7. Dynamic adherence: a multi-step process 
Less deformable and spherical cells such as activated leukocytes are marginated as 
soon as they enter post-capillary venules, by being pushed away from the 
aggregated erythrocytes at the center of the blood vessel. This passive rheological 
mechanism is known as margination [147][148][149]. The overall increase in cell 
stiffness and change in morphology (biconcave to spherical) of P. falciparum-infected 
erythrocytes causes the infected cell to behave similarly to leukocytes and show 
margination towards the endothelium [150]. For both, leukocytes and P. falciparum-
infected erythrocytes, margination is the initial step in the adhesion process to 
endothelial cells lining the vessels. 
 
Adhesion dynamics of Leukocytes 
The dynamic adhesion of leukocytes is a multistep process, where cells are initially 
captured from flow (tether) and roll on the endothelial cell surface, forming weak 
interactions that strengthen following leukocyte activation [151]. In detail (Figure 4), 
leukocytes express at high density L-selectins and P-selectin glycoprotein ligand-1 
(PSGL-1) near the tips of microvillus cell surface protrusions [152][124]. At the same 
time, endothelial cells express P- and E-selectins upon activation by cytokines and 
other proinflammatory agents. PSGL-1 expressed on leukocytes can weakly bind to 
endothelial P- and E-selectin, causing the cell to capture from flow and to roll, 
reducing its velocity [153]. Binding interactions between selectins and their 
endothelial ligands occur with very fast association and dissociation rates, which 
allows the fast-flowing leukocytes to initially engage from the blood stream to the 
endothelium [153]. Further rolling adhesion is provided by L-selectin on leukocyte 
with endothelial peripheral-node addressin (PNAd) [154][124]. 
 
INTRODUCTION 
 
 
14 
Slow rolling velocities promote the leukocytes to encounter chemokines, such as IL-
8, presented on the luminal surface of the inflamed endothelium [155][156]. 
Chemokines induce inside-out activation via G-protein couple receptors, leading to 
the upshift in affinity of leukocyte integrins such as LFA-1 (αLβ2) and Mac-1 (αMβ2) 
[161][124][157]. These integrins mediate binding to ICAM-1 and ICAM-2, expressed 
constitutively on the vascular endothelial cells [124][157]. Consequently, leukocytes 
stop rolling, arrest and initiate transmigration [92][124][158]. 
 
Adhesion dynamics of P. falciparum-infected erythrocytes  
P. falciparum infected erythrocytes adhere to endothelial cells similarly as leukocytes. 
An iRBC tether to and roll on the endothelium, reduces its motion velocity and finally 
adheres [124]. Similar to the microvilli in leukocytes, infected erythrocytes express 
and elevate their ligands on their knobs, but instead of binding mainly to selectins, 
infected erythrocytes use a broader range of receptors found along different vascular 
beds [124]. iRBCs roll on ICAM-1, P-selectin and VCAM-1 [45], while CD36 and CSA 
provide stable stationary adherence [159]. Moreover, studies show that infected 
erythrocytes can firmly adhere to ICAM-1 [160] and that this receptor might also act 
synergistically with CD36 to promote firm adhesion [161]. Infected erythrocytes will 
not transmigrate but will, however, activate several signaling pathways in endothelial 
cells, leading to various responses such as actin recruitment and CD36 clustering 
[162], CD36 ecto-dephosphorylation [163] and α5β1 integrin recruitment [164]. These 
events result in an increased adhesion strength, which ensures lasting adherence 
under variable flow conditions.  
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Figure 4 | Schematic illustration of leukocytes and P. falciparum-infected 
erythrocytes dynamic and firm adhesion process (adapted from Helms et al., 
(2016) [125]). The different receptor-ligand pairs are shown. The adhesive structures 
correspond to microvilli in leukocytes which expose, concentrate and elevate the 
adhesion molecules L-selectin, PSGL-1 and integrins, and to knobs in iRBC with 
similarly expose PfEMP-1.  The cell adhesion for leukocytes involves selectin-
mediated rolling, chemokine-triggered activation and integrin-dependent arrest, while 
for iRBC rolling and firm adhesion is mediated by a broader range of receptors, and 
binding strengthening is followed by endothelial activation.  
 
 
1.8. Endothelial cells response to infected erythrocytes adherence 
Endothelial cell activation is a feature of severe malaria [96]. It potentiates 
sequestration and vascular obstruction through the upregulation of vascular 
endothelial receptors and by strengthening the adhesion interaction 
[96][165][162][163][164]. Furthermore, other signaling pathways involved in vascular 
dysfunction, vascular leak and apoptosis are initiated in endothelial cells upon 
infected erythrocytes binding [166][167]. 
 
Increased expression of adhesion receptors 
Upregulation of ICAM-1, VCAM-1 and E-selectin and their co-localization with 
parasitized erythrocytes sequestration have been observed in various organs, 
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including the brain, from malaria fatal cases [96][168]. The upregulation of these 
vascular receptors can be mediated in endothelial cells by binding of iRBCs in vitro 
[96][165]. Increase of ICAM-1 surface expression by binding of infected erythrocytes 
is linked to the nuclear translocation of nuclear factor kappa B (NF-ĸB) [169]. This is 
a fast response transcription factor present in the cytoplasm in an inactive form [170]. 
It is involved in immune and inflammatory responses and upon activation, induces 
the transcription of several genes encoding for cytokines, chemokines and cell 
adhesion molecules [170]. Its translocation to the nucleus, occurs rapidly, upon P. 
falciparum-infected erythrocytes binding to microvascular brain endothelial cells 
[169][171].  
 
Adhesion strengthening 
Initial attachment to CD36, leads to Scr-familly kinase-dependent dephosphorylation 
of the CD36 ectodomain (threonine 92 residue) via an ecto-alkaline phosphatase 
(AP) anchored to the endothelial plasma membrane [163][172]. This event might be 
critical for firm adhesion under flow conditions, since the removal of the negatively 
charged phosphate group from the CD36 ecto-domain, leads to greater interactions 
[162]. Furthermore, AP activity increases by IL-6, which is markedly elevated during 
malaria infection [173][172]. Moreover, studies showed correlations between IL-6 
levels and malaria severe outcome [173][174]. IL-6 is produced by a variety of cells 
including endothelial cells [175] and in vitro studies showed that iRBC binding 
induced endothelial cells to secrete large amounts of IL-6 [165]. IL-6 expression 
might as well be induced via NF-ĸB nuclear translocation [176][165][171]. 
 
Activation of the Src-familly kinases followed by CD36 engagement, also triggers 
rapid CD36 clustering and actin rearrangement via the adaptor protein P130CAS, 
increasing the adhesion binding strength of iRBCs to microvascular endothelial cells 
[162]. Moreover, α5β1 integrins, which do not support iRBC binding on their own, are 
recruited upon CD36 docking, further enhancing the magnitude of adhesion strength 
[164]. 
 
Loss of barrier integrity and vascular leak 
Endothelial cells constitute a vascular barrier, with selective permeability, between 
blood and underlying tissues. This function can be carried out by the connection of 
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adjacent endothelial cells via tight, gap and adherens junctions [177]. Modulation of 
endothelial permeability due to pulmonary or cerebral sequestration of iRBC during 
malaria infection might be implicated in the development of severe forms such us 
pulmonary oedema and CM [166]. Immunohistochemical analysis of CM postmortem 
tissues, show loss of tight junctional proteins such as zonula occludens 1 (ZO-1), 
occludin and vinculin, in areas where infected erythrocytes were sequestered 
[178][179][180]. Moreover, blood brain barrier resistance is reduce by 70%  upon 
contact with infected erythrocytes [181]. 
 
EPCR is expressed on endothelial cells and play a key role modulating blood 
coagulation, endothelial activation and barrier integrity. It binds and activates protein 
C, which once activated, prevents coagulation by inhibiting thrombin generation 
[182]. By reducing the level of thrombin, activated protein C strengthen the 
endothelial barrier integrity and prevents endothelial inflammation [182]. P. falciparum 
infected erythrocytes can bind to EPCR in brain, interfering with protein C binding 
and activation [63], thus exerting pro-coagulant and pro-inflammatory signaling by 
thrombin and leading to endothelial dysfunction [183]. 
 
Others 
Few studies have suggested that endothelial apoptosis in brain can be induced by 
infected erythrocytes biding, however relation to severity has not be found [166]. On 
the other hand, not all signaling induced by infected erythrocytes are detrimental. It 
has been reported that anti-apoptotic and other genes involved in endothelial 
protection are induced by parasite binding. Thus, ensuring parasite survival and 
transmission [166]. Therefore, a balance between endothelial activation and 
protection are critical factors in dictating the severity of malaria outcome.  
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Figure 5 | Summary figure showing the endothelial cell responses to infected 
erythrocytes biding (adapted from Cruz et al., (2012) [167]).  
 
 
Cytoadherence might also localize parasite-derived compounds, which induce 
directly or indirectly endothelial cell activation and damage. For instance, GPI can 
induce the production of TNF-α from macrophages [25][26][27][28], which in turn 
upregulates the expression of endothelial adhesion molecules such as ICAM-1 and 
VCAM-1 [184][185]. Moreover, GPI and hemozoin release, can also disrupt the 
endothelial barrier integrity and increase vascular permeability [186].  
 
Following infected erythrocytes rupture, other products such as hemoglobin and 
arginase are released into the plasma, which limit nitric oxide NO bioavailability [187]. 
Hemoglobin is a NO scavenger and arginase depletes L-arginine, the NO precursor 
[187][188]. NO is essential regulator of the microvascular blood flow, therefore, lower 
levels of NO produce loss of vasodilatory tone and might contribute to hypoperfusion 
[189]. Furthermore, the NO levels were found significantly reduced in severe malaria 
cases [190].  
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1.9. The impact of host genetic on red blood cells and protection 
against malaria 
In endemic areas, P. falciparum has exerted a high selective pressure on the human 
population over thousands of years of co-evolution. As consequence, several 
polymorphisms within the human genome have emerged as positive selection by 
conferring distinctive resistance to severe malarial disease. Consequently, mutations 
in the globin gene are the most common monogenic disorders in humans, affecting 
around 7% of the world´s population [191].  
 
The structure of the adult hemoglobin (HbAA) consist of a tetramer of two α and two 
β globin chains, each one attached to a heme prosthetic group which contains a 
ferrous iron (Fe+2) that can bind oxygen. This property allows the hemoglobin to 
transport oxygen in erythrocytes [192]. Hemoglobin disorders can be classified as 
structural hemoglobinopathies, in which the hemoglobin molecule is altered, and 
quantitative hemoglobin disorders, in which the globin structure is normal but its 
synthesis, α or β-globin chain, is reduced (α- and β-thalassemias) [192]. The 
structural hemoglobinopathies, sickle hemoglobin (HbS), hemoglobin E (HbE) and 
hemoglobin C (HbC) reach very high frequencies in several populations probably as 
result of natural selection by malaria [193]. 
 
Hemoglobin S 
Sickle hemoglobin results from a single amino acid substitution at position 6 of the β-
globin chain (β 6Glu→Val) [194]. The exchange of hydrophilic glutamic acid residue 
by a hydrophobic valine creates and hydrophobic “sticky patch” on the outer surface 
of the β-globin chain. When Hb becomes deoxygenated, the sticky patch can interact 
and bind to another deoxygenated HbS [195]. This binding causes the deoxy-Hb 
aggregation and the cell to acquire a rigid sickle shape. Vascular obstruction, 
ischemia and tissue death can develop as consequence of the rheological changes 
of these erythrocytes [10]. Furthermore, instability of sickle erythrocytes shortens its 
lifespan (17 days instead of 120 days) additionally causing hemolytic anemia [196]. 
Homozygotes (HbSS, sickle cell) can suffer from hemolytic anemia, tissue damage 
and pain, and usually die before adulthood. The heterozygotes (HbAS, sickle cell 
trait), however, do not present clinical symptoms and have a normal lifespan [196].   
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The HbS allele is widely distributed throughout West Africa, Middle East and parts of 
India, were some populations can reach up to 40% allele frequencies [197]. HbAS 
confer up to 91% protection from severe malaria and death, and  about 60% 
protection from clinical malaria [198][199]. Thus, HbS represents a classic case of 
balance polymorphism, in which the degree of protection experienced by the 
heterozygote balance the fitness cost of the homozygous form  [200]. 
 
The mechanism of protection by this hemoglobin remains unclear, however, normal 
parasite invasion and growth is observed for HbAS erythrocytes in vitro [201] and 
comparable parasitemias can be found in children with HbAA and HbAS erythrocytes 
[202]. Interestingly, the ability of parasitized HbSS and HbAS erythrocytes to bind to 
microvascular endothelial cells under static and flow conditions is reduced [203]. 
Furthermore, infected HbSA and HbSS erythrocytes show abnormal distribution and 
reduced levels of PfEMP-1 molecules on the infected erythrocytes surface, along with 
abnormal knob morphology and distribution [203]. Adhesion of infected HbS 
erythrocytes to uninfected erythrocytes (rosetting) is also reduced [203][204]. 
 
Hemoglobin E 
Hemoglobin E results from a single amino acid substitution at position 26 of the β-
globin chain (β 26Glu→Lys). This causes reduced synthesis rate of the β-E chain 
[193]. The HbE allele is distributed throughout East India and Southeast Asia, with 
very high frequency among some populations in Thailand, up to 70% [197][205]. 
Worldwide, HbE represents the second most frequent hemoglobinopathy after HbS. It 
confers protection against severe malaria outcome [206][197][205] by reducing the 
parasite susceptibility to erythrocyte invasion and thus, preventing the development 
of high parasite burdens [207].  
 
Hemoglobin C 
Hemoglobin C allele distributions is restricted to West Africa [197], were some 
populations can reach up to 21% allele frequencies [208]. This hemoglobin variant 
results from a single amino acid substitution at position 6 of the β-globin chain (β 
6Glu→Lys) [197]. This mutation might induce hemoglobin crystal formation and 
homozygotes might suffer from mild hemolytic anemia, while heterozygotes are 
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asymptomatic [209]. Hemoglobin C protects against severe malaria symptoms by 
~80% [210] and reduces the risk of clinical malaria by 29% and 93% for HbAC and 
HbCC, respectively [211]. However, it does not protect against uncomplicated 
malaria and parasitemias, which indicates that HbC does not interfere with parasite 
replication or growth in vivo [210]. In vitro studies also show no major effect in 
invasion and growth on HbAC or HbCC erythrocytes [212][213][202]. Overall, these 
in vivo and in vitro studies suggest that HbC might not protect against severe malaria 
by impeding the development of high parasitemias. 
 
Similar to infected HbS erythrocytes, the adhesion of infected HbAC and HbCC 
erythrocytes to microvascular endothelial cells is reduced, under static and flow 
conditions [203][214]. Moreover, infected HbC erythrocytes form less rosettes and 
are less prone to auto-agglutinate [214]. The reduced adhesive capabilities might 
arise from an abnormal and reduced PfEMP-1 surface display, together with, a lower 
knob density and abnormally large and widely separated knobs, present in infected 
HbCC and HbAC erythrocytes [214]. 
 
Aberrant knob formation and PfEMP-1 display on HbS and HbC infected 
erythrocytes 
PfEMP-1 is directed to the erythrocyte surface via a traffic system established by the 
parasite within the host cytoplasm (see section 1.6.). For this, the parasite remodels 
the erythrocyte membrane skeleton and generates long actin filaments that connects 
Maurer’s cleft  to the knobs at the plasma membrane, where cargo vesicles, carrying 
PfEMP-1, are transported to the knobs [121]. When compared to HbAA, the Maurer´s 
clefts in infected erythrocytes containing hemoglobin S and C, show altered 
morphology together with shorter actin filaments, which do not interconnect with the 
knobs (Figure 6) [120].  
 
HbS and HbC are unstable and tend to auto-oxidize. Consequently, elevated 
amounts of oxidized forms of hemoglobin, such as hemichromes and ferryl, 
accumulate within this cells [215][216]. Hemichromes can destabilize the membrane 
skeleton by decreasing the spectrin-protein 4.1-actin interaction [217] and ferryl 
hemoglobin can oxidize actin and interfere with actin filament dynamics [218]. Thus, 
high levels of oxidized forms of hemoglobin in HbS and HbC erythrocytes, might 
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interfere with parasite mediated actin reorganization [120]. As result of a distorted 
traffic system, infected HbS and HbC erythrocytes show reduced levels of PfEMP-1 
at their surface. Moreover, distorted actin remodeling might explain the abnormal 
PfEMP-1 display and aberrant knob morphology observed for infected HbS and HbC 
erythrocytes [121]. 
 
 
 
 
Figure 6 | Aberrant protein trafficking system observed in infected HbS and 
HbC erythrocytes (adapted from Cyrklaff et al., (2011) (2016) [120][219]). Cyo-
electron tomograms of uninfected HbAA erythrocyte (I) and infected HbAA (II), HbAS 
(III) and HbAC (IV) erythrocytes, showing the erythrocytes plasma membrane (dark 
blue), actin filaments (yellow), the knobs (red), the Maurer´s cleft and vesicles (light 
blue), scale bar 100 nm.  
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1.10.  Aims of the study 
In spite of reduced cytoadherence, substantial parasite densities have been 
observed in both malaria-infected HbAS and HbAC patients [210][199], with little or 
no effect on invasion and growth [203][214], indicating that parasites are able to 
invade and develop within HbS or HbC erythrocytes. These observations lead to the 
question: how does HbS and HbC protect against severe malaria without dramatically 
reducing the parasite density? We hypothesized that infected HbS and HbC 
erythrocytes can cytoadhere to the microvasculature strong enough to escape from 
splenic clearance mechanisms, but not enough to activate the endothelium and 
trigger life-threatening downstream inflammatory events.  
 
A better understanding of the cytoadherence properties of parasitized HbS and HbC 
erythrocytes and their effect on endothelial cell activation may explain the mechanism 
by which these hemoglobinopathies confer protection against severe malaria. The 
aim of this project is therefore, to investigate in a quantitative manner, the dynamic 
and firm adhesion of infected hemoglobinopathic erythrocytes, as well as the 
response of microvascular endothelial cells to this binding interaction. Understanding 
the mechanism underpinning protection by HbS and HbC against severe malaria will 
help to identify novel strategies for future clinical interventions. 
 
Specific aims: 
 Isolate and characterize a parasite population capable of cytoadhering to 
microvascular endothelial cells. 
 Study the cytoadhesive behavior of infected erythrocyte at differential 
intraerythrocytic developmental stages. 
 Characterize in quantitative terms the firm and dynamic adhesion behavior of 
infected wild type and hemoglobinopathic erythrocytes under physiological 
flow conditions.  
 Examine the effect of hemoglobin variants on infected erythrocytes binding 
strength to microvascular endothelial cells. 
 Investigate the effect of infected hemoglobinopathic erythrocytes binding on 
endothelial cell activation. 
MATERIALS AND METHODS 
 
 
24 
2. Materials and Methods 
2.1. Materials 
2.1.1. Equipment 
Equipment Model Company 
Analytical balance ABT 120-5DM Kern & Sohn, Balingen, 
Germany 
Atomic force microscope NanoWizard 3  JPK Instruments, Berlin, 
Germany 
Autoclave ABT 120-5DM 
2540 EL 
Kern & Sohn, Balingen, 
Germany 
Tuttnauer, Breda, The 
Netherlands 
Balance  Sartorius GmbH, Göttingen 
Centrifuge Biofuge fresco 
 
Biofuge pico 
 
Megafuge 1.0 R 
Megafuge 2.0 R 
Thermo Fisher Scientific, 
Dreieich, Germany 
Thermo Fisher Scientific, 
Dreieich, Germany 
Heraeus, Hanau, Germany 
Heraeus, Hanau, Germany 
Confocal microscope LSM510 Zeiss, Jena, Germany 
Electrophoresis power 
supply 
Power Pac 300 
Power Pac 200 
Bio-Rad, München, Germany 
Bio-Rad, München, Germany 
Flow cytometer FACSCalibur Becton and Dickinson, 
Heidelberg, Germany 
Syringe pump 55-2316 Harvard Apparatus, Holliston, 
MA 
Freezer -20ºC LGex 3410 MediLine Liebherr, Biberach, Germany 
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Freezer -80ºC HERAfreeze Thermo Fisher Scientific, 
Dreieich, Germany 
Fridge LKexv 3910 
MediLine 
Liebherr, Biberach, Germany 
Heating block NeoBlock Mono I NeoLab, Heidelberg, Germany 
High precision pump 55-2316 
AL-4000 
Harvard Apparatus, MA, USA 
World precision instruments, 
Florida,USA 
Ice machine  Ziegra, Isernhagen, Germany 
Incubator Heraeus Cytoperm2 
 
HeraCell 
Thermo Fisher Scientific, 
Dreieich, Germany 
Thermo Fisher Scientific, 
Dreieich, Germany 
Inverted microscope Zeiss Axio Observer 
Z1 
DM IL 
Carl Zeiss, Oberkochen, 
Germany 
Leica, Wetzlar, Germany 
Light optical microscope Axiolab Zeiss, Jena, Germany 
Liquid nitrogen tank MVE Cryosystem 
6000 
 
LS 6000 
RS Series 
Thermo Fisher Scientific, 
Dreieich, Germany 
Taylor-Wharton, Husum, 
Germany 
Taylor-Wharton, Husum, 
Germany 
Magnetic sorter VarioMACS Miltenyi Biotec, Bergisch 
Gladbach, Germany 
Magnetic stirrer RCT 
COMBIMAG RCH 
IKA, Staufen, Germany 
IKA, Staufen, Germany 
Micro osmometer Type 6 Löser Meßtechnik, Berlin, 
Germany 
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MiliQ water system Purist ultrapure Rephile, Germany 
Particle counter Z1 Beckman Coulter, Krefeld, 
Germany 
pH meter pH 7110 WTW, Weilheim, Germany 
Pipets P2, P10, P20, P1000 Gilson,  Limburg an der Lahn, 
Germany 
Pipetus Forty\Standard Hirschmann, Eberstadt, 
Germany 
Adaptors for silicon 
tubing 
Elbow connector 
Luer connector male 
Luer lock connector 
male 
Luer lock connector 
female 
Female luer lock 
coupler 
Ibidi, München, Germany 
Ibidi, München, Germany 
Ibidi, München, Germany 
 
Ibidi, München, Germany 
 
Ibidi, München, Germany 
Silicon tubing   1.6 mm 
 
Ibidi, München, Germany 
Scanning electron 
microscope 
Leo Gemini 1530 Carl Zeiss Oberkochen, 
Germany 
Shaker KS 501 digital IKA, Staufen, Germany 
Sonicator Sonoplus HD 2070 Bandelin, Berlin, Germany 
Spectrophotometer UVIKON 923 Kontron instruments, Munich, 
Germany 
Sputter coatter EM MED 020  Leica, Wetzlar, Germany 
Sterile work bench Herasafe 
 
SterilGard Class II 
Thermo Fisher Scientific, 
Dreieich, Germany 
The Baker company, Sanford, 
ME, USA 
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Thermocycler Labcycler Sensoquest, Göttingen, 
Germany 
UV chamber GS Gene linker Bio-Rad, München, Germany 
UV table TFX-35M Vilber Lourmat, Eberhardzell, 
Germany 
Vacuum Workstation PyroMark Q96 QIAGEN, Hilden, Germany 
Vortex Genie 2 Scientific Industries, Bohemia, 
NY, USA 
Waterbath MP Julabo, Seelbach, Germany 
 
2.1.2. Disposables 
Disposable Company 
µ-slide VI0.4 Treat Ibidi, München, Germany 
AFM cantilever with colloidal particule 2 
µm Ø CP-9P-SCONT-SiO-A 
NanoAndmore, Wetzlar, Germany 
AFM tipless nitride cantilever  MLCT-010 Brucker, CA, USA 
Aluminium foil Carl Roth, Karlsruhe, Germany 
Cell culture plate (6 well, 12 well and 24 
well) 
Greiner bio-one, Frickenhausen, 
Germany 
Cellulose swabs (Askina Brauncel) B Braun, Melsungen, Germany 
Centrifuge polypropylene (Cellstar) tubes 
(14 ml, 50 ml) 
Greiner bio-one, Frickenhausen, 
Germany 
Coverglass 15 mm Ø 
Marienfeld , Lauda-Königshofen, 
Germany 
Cryo.s,  polypropylene, with screw cap 
Greiner bio-one, Frickenhausen, 
Germany 
Cuvettes Acryl 10x10x48 mm SARSTEDT, Nümbrecht, Germany 
Filter systems 500 ml Corning, Kaiserslautern, Germany 
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Filters Millex GS (0,2μm)  Merck  Millipore, Darmstadt, Germany 
Glass bottom dishes 5 mm Ø 
WillCo Wells, Amsterdam, The 
Netherlands 
Gloves TouchNTuff  Ansell, München, Germany 
MACS CS column 
Miltenyi Biotec, Bergisch Gladbach, 
Germany 
Micro tube (1 ml, 2 ml) Sarstedt, Nümbrecht, Germany 
Micro tube (1 ml, braun) Carl Roth, Karlsruhe, Germany 
Microscope glass slides 75 x 25 x 1mm 
MarienFeld, Lauda-Königshofen, 
Germany 
Parafilm  Bemis, Londonderry, UK 
Petri dishes (60 mm Ø, 100 mm Ø, 145 
mm Ø)  
Greiner bio-one, Frickenhausen, 
Germany 
Pipette tipps  Corning, Kaiserslautern, Germany 
Plastic pipettes (1 ml; 2 ml; 5 ml; 10 ml; 
25 ml; 50 ml) 
Corning, Kaiserslautern, Germany 
Polystyren round.bottom tubes (5 ml) Corning, Kaiserslautern, Germany 
Precision wipes (11x21cm) Kimberly Clark, Mainz, Germany 
SEM conductive tabs 18 mm Ø Ted Pella, CA, USA 
SEM pin stub 18 mm Ø Ted Pella, CA, USA 
SEM storage box and holder for pin stubs Ted Pella, CA, USA 
Sterile filter tips ( 200 µl, 1000 µl) 
Denville scientific, Lambrecht/Pfalz, 
Germany 
Syringe Luer-lok (1 ml, 10 ml, 20 ml and 
60 ml) 
Becton and Dickinson, Madrid, Spain 
Thermowell tubes (0.2 ml tubes with 
dome cap)  
Corning, Kaiserslautern, Germany 
Transfer pipettes Sarstedt, Nümbrecht, Germany 
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Transwell permeable supports, 12mmØ, 
0.4 µm polycarbonate membrane, tissue 
treated 
Corning Incorporated, ME, USA 
2.1.3. Kits 
Kits Company 
Ambion DNA-free kit Invitrogen - Thermo Fisher Scientific, 
Vilnius, Lithuania 
Blood and cell culture DNA mini kit Qiagen, Düsseldorf, Germany 
Endothelial cell detachment kit Promocell, Heidelberg, Germany 
Endothelial cell growth medium (MV 2) 
Kit 
Promocell, Heidelberg, Germany 
Human IL-6 ELISA Max Deluxe Biolegend, London, UK 
SuperScript III First Strand Synthesis   Invitrogen-Thermo Fisher Scientific, 
Vilnius, Lithuania 
Taq DNA polymerase kit Qiagen, Düsseldorf, Germany 
Venor®GeM Classic mycoplasma 
detection kit for conventional PCR 
MB Minerva Biolabes, Berlin, Germany 
2.1.4. Chemicals 
All chemicals used within this study were purchased from one of the following 
companies: Boehringer Ingelheim, Carl Roth, GE Healthcare, Amersham, 
Honeywell, ICN Biomedicals, MP Biomedicals, Merk, Millipore, Roche, 
Calbiochem, Novagen, Sigma-Aldrich, Fluka, Thermo Fisher Scientific, Gibco, 
Invitrogen, and Molecular Probes. 
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2.1.5. Biological materials 
2.1.5.1. Antibodies  
Antibody Description Clone Clonality Isotype Company Use 
Alexa 
Fluor® 
488 anti-
rabbit IgG 
Goat anti-
rabbit 
- Polyclonal IgG 
Thermo-
Fisher 
IF 
Anti- 
CD54 
(ICAM-1) 
Mouse anti-
human 
15.2 Monoclonal IgG1 Serotec 
Inhibition 
assay 
Anti-
CD36 
Mouse anti-
human 
FA6-
152 
Monoclonal IgG1 Abcam 
Inhibition 
assay 
PE anti-
CD31 
(PECAM-
1) 
Mouse anti-
human 
WM59 Monoclonal IgG1 
Biolegend, 
London, 
UK 
Flow 
cytometry 
PE anti-
CD36 
Mouse anti-
human 
5-271 Monoclonal IgG2a 
Biolegend, 
London, 
UK 
Flow 
cytometry 
PE anti-
CD54 
(ICAM-1) 
Mouse anti-
human 
HCD5
4 
Monoclonal IgG1 
Biolegend, 
London, 
UK 
Flow 
cytometry 
PE IgG1 
isotype 
control 
Mouse anti-
human 
MOPC
-21 
Monoclonal IgG1 
Biolegend, 
London, 
UK 
Flow 
cytometry 
PE IgG2a 
isotype 
control 
Mouse anti-
human 
MOPC
-173 
Monoclonal IgG2a 
Biolegend, 
London, 
UK 
Flow 
cytometry 
Purified 
anti-NF-
Rabbit anti-
human 
Poly62
25 
Polyclonal IgG 
Biolegend, 
London, 
IF 
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ҡB P65 UK 
2.1.5.2. Dyes 
Dye Label Ex/Em (nm) Company Use 
Ethidium bromide 
Nucleic acid, 
dsDNA 
360/590 Roth 
DNA 
visualization 
SYBR® Green I 355/465 Sigma-Aldrich 
Flow adhesion 
assay, parasite 
labeling 
Hoechst 33342 361/497 ThermoFisher 
Cell imaging, 
IF 
2.1.5.3. Size markers 
GeneRuler 1 Kb plus DNA ladder (Ambion - Thermo Fisher Scientific, Dreieich, 
Germany). 
2.1.5.4. Cytokines 
Recombinant tumor necrosis factor alpha (TNF-α) from E. coli (Promocell, 
Heidelberg, Germany). 
2.1.5.5. Organismus and primary cells 
2.1.5.6. Oligonucleotides 
Organisms and cells Origin 
Human dermal microvascular endothelial 
cells (HDMEC) 
Single donor, Promocell, Heidelberg, 
Germany 
Plasmodium falciparum FCR3 strain Gambia [220]  
N° Sequence Company 
63, for gg act agt atg aaa ttc gca agt aaa aaa aat aat c Eurofins 
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2.1.6. Buffers and solutions 
P. falciparum culture 
Complete culture medium RMPI 1640 medium supplemented with 2 mM L-
glutamine, 25 mM HEPES, 100 µM hypoxanthine, 20 
µg/ml gentamicin and 10% (v/v) human serum. 
Freezing solution 6.2 M Glycerol, 140 mM Na-Lactat, 0.5 mM KCl, pH 
7.2 adjusted with 0.5 M of NaHCO3 at pH 9. 
Thawing solution I 12% (w/v) sodium chloride. 
Thawing solution II 1.8% (w/v) sodium chloride. 
Thawing solution III 0.9% (w/v) sodium chloride, 0.2% (w/v) glucose. 
Sorbitol lysis solution 
 
280 mM D-sorbitol, 5 mM HEPES, pH 7.4. 
(300 mOsm). Hit sterilized. 
MACS buffer PBS, 2mM EDTA, 0.5% (w/v) BSA. 
Gelatin solution 0.5% (w/v) gelatin (from porcine skin type A) was 
dissolved in RPMI 1640 supplemented with 2 mM L-
glutamine and 25 mM HEPES. 
RMPI incomplete RMPI 1640, 2 mM L-glutamine and 25 mM HEPES. 
Binding medium RMPI 1640, 2 mM L-glutamine, 25 mM HEPES, 
0.1% BSA (w/v) pH 7.2. 
 
NaOH and HCl were used to adjust the pH, solutions were filter sterilized (0.2 µm) 
and stored at 4°C. Otherwise indicated. 
 
Immunofluorescence methods (activation assays) 
FACS buffer PBS, 2% (v/v) FCS, 0.1% (w/v) sodium azide. 
FACS fixing solution 2% (v/v) formaldehyde in PBS. 
IF fixing solution 4% (v/v) paraformaldehyde in PBS. 
IF permeabilizing solution 0.5% (v/v) Triton X-100 in PBS. 
IF blocking solution 3% (w/v) BSA in PBS. 
73, rev gt tct ttt agc aaa aat tTt ttc aat tac aca tac Eurofins 
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TNF-α 10000 U/ml in PBS; 0.1% (w/v) BSA. Filter sterilized 
(0.2 µm). 
 
 
DNA/RNA 
TAE buffer 1X 40 mM Tris, 20 mM acetic acid and 1 mM EDTA 
(0.5 M pH 8.0). 
MOPS buffer 20X 0.4 mM MOPS, 40 mM sodium acetate, 5 mM 
EDTA (0.5 M pH 8.0). 
DNA loading buffer (6x) 60% glycerol, 60 mM EDTA / 2.5 mg/ml 
Bromophenol blue. 
RNA running buffer (20x) 400 mM MOPS, 40 mM C2H3NaO2, 5 mM of EDTA. 
 
NaOH and HCl were used to adjust the pH. 
For all solutions and buffers MilliQ water was used. 
 
2.1.7. Computer software and databases 
Program Company 
Mendeley Elsevier, London, UK 
LSM imaging software     Zeiss, Jena, Germany 
Cellquest Becton and Dickinson, Heidelberg, Germany 
JPK JPK Instruments, Berlin, Germany 
FIJI (v1.50a) National Institute of Health, Bethesda, MD 
SigmaPlot 13.0 Systat, CA, USA 
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2.2. Methods 
2.2.1. Ethical clearance  
This study was approved by the ethics committee of Heidelberg University, 
Mannheim University Hospital and the Biomolecular Research Center 
(CERBA/Labiogene). Blood samples were collected by venipuncture after obtaining 
written informed consent from the volunteers. 
 
2.2.2. Blood collection and genotyping  
Approximately 12 ml of citrated whole blood was collected. After centrifugation at 800 
x g for 10 min at RT, the plasma and buffy coat were discarded. The remaining 
erythrocytes were washed three times with three volumes of RPMI-1640 basal 
medium and stored until use at 4°C. Erythrocytes were used within two weeks after 
collection. Hemoglobin genotypes were determined by cellulose acetate 
electrophoresis as previously described [211], a routine test performed by the 
Kooperatives Speziallabor of the Heidelberg University Hospital. 
 
2.2.3. Cell culture methods 
2.2.3.1. Endothelial cell culture and handling  
2.2.3.1.1. Endothelial cell culture 
Human dermal microvascular endothelial cells were purchased from Promocell 
(Heidelberg, Germany). These are primary cells isolated from a juvenile donor 
foreskin. Cells were grown in low serum containing medium (endothelial cell growth 
medium MV 2) at 37°C with an atmosphere of 5% CO2. Neither antibiotics nor 
antimycotics were added. Cells between passage 4 and 7 were used for all assays. 
Cells were tested regularly for mycoplasma contamination using the mycoplasma 
detection kit (Venor®GeM classic, Invitrogen). 
 
For sub-culturing, the PromoCell detachment kit was used. Confluent cells (T25 flask) 
were washed with 2 ml Hepes BSS solution and incubated at RT with 2 ml trypsin-
EDTA until cells were detached. Since endothelial cell medium MV 2 contains low 
serum, 2 ml trypsin neutralizing solution was used. After centrifugation at 220 x g for 
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3 min, cell pellet was resuspended in MV 2 growth medium and placed into a new 
T25 culture flask and back into the incubator under regular cell culture conditions. 
 
2.2.3.1.2. Freezing and thawing of endothelial cells 
Cryopreservation was performed as recommended by the manufacturer. Confluent 
cells were detached as described previously (section 2.2.3.1.1.). After centrifugation 
cell were resuspended in 1 ml of serum-free freezing medium (Cryo-SFM) and freeze 
gradually (-1°C/min) to -80°C. Finally, cells were transferred into liquid nitrogen for 
long term storage. 
 
Thawing of cryopreserved cells was performed as recommended by the 
manufacturer. Firstly, 9 ml of endothelial cell growth medium (MV 2) was added to a 
T25 cell culture flask and then placed into the incubator (37°C, 5% CO2) for 30 min. 
After equilibration, cells were thawed for 2 min in the water bath at 37°C and 
transferred directly in to the T25 culture flask with the pre-warmed medium. Culture 
flask was placed into the incubator to let the cells attach. Medium was replaced after 
16-24 h. Cells were sub-cultured after reaching confluence (80-90%). 
 
2.2.3.2. Plasmodium falciparum in vitro culture and handling  
2.2.3.2.1. P. falciparum in vitro culture 
P. falciparum FRC3 strain was cultured as described by Trager and Jensen [221]. 
Briefly, parasites were cultured in type A+ erythrocytes suspended in complete culture 
medium containing A+ serum. Cells were grown at a hematocrit of 3.5% at 37°C 
under controlled atmospheric conditions (3% C02, 5% O2 and 92% N2). Hemoglobin 
variants infected erythrocytes were grown in complete culture medium containing AB 
serum, as the sugar group of the blood donor was unknown. 
 
2.2.3.2.2. Blood smear preparation and light microscopy 
Thin blood smears of the parasite culture were fixed in absolute methanol and 
stained with 10% (v/v) Giemsa solution for 20 min. After washing and air drying, 
smears were observed by light microscopy under oil immersion (100X) objective. 
Parasitemia was calculated as percentage from at least 1000 cells counted. 
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2.2.3.2.3. Cryopreservation of P. falciparum from in vitro cultures 
Parasite culture of approximately 3-5% parasitemia in ring-stage was used for 
cryopreservation, since their membranes are more robust and therefore less prone to 
lyse during the thawing procedure. After centrifuging the parasite culture 500 x g for 2 
min at RT, 1/3 cell pellet volume of freezing solution was added drop-wise, and the 
tube was let stand for 5 min at RT. Slowly, 4/3 cell pellet volume of freezing solution 
was then added, and the cells were carefully mixed, aliquoted into cryogenic-vials 
and stored at -80°C overnight. Cells were transferred to liquid nitrogen for long term 
storage. 
 
2.2.3.2.4. Thawing of P. falciparum cultures 
Cells were thawed for ~30 s in the water bath at 37°C, transferred into a 15 ml 
conical tube were 300 µl of thawing solution was added dropwise and the mixture 
was stand for 5 min at RT. Slowly 9 ml of thawing solution II was added, as well very 
slowly and cells were centrifuged for 2 min at 500 x g, RT. Finally, 7 ml of 
thawing solution III was added to the remaining pellet and suspension was 
centrifuged once again. Pellet was resuspended in complete culture medium and 
restored to normal culture conditions after adjusting the hematocrit to 3,5% with fresh 
packed blood. 
 
2.2.3.2.5. Synchronization of P. falciparum with isosmotic D-sorbitol 
During the late-intraerythrocytic development, approximately 16 h post-invasion P. 
falciparum increases the permeability of the red blood cell plasma membrane to a 
wide range of small solutes including D-sorbitol which have been shown to enter the 
red blood cell via a different pathway not operating in uninfected erythrocytes called 
the new permeation pathways [222]. As a result, in isosmotic solution of D-sorbitol, 
the infected erythrocytes at a late stage of development will swell and hemolyze and 
uninfected erythrocytes or early parasite ring stages will be not affected as they do 
not present NPP.  
 
To perform this synchronization, parasite cultures were collected by centrifugation for 
2 min 500 x g at RT and washed once with PBS. Twenty volumes (one volume = 
RBC pellet volume) of isosmotic sorbitol lysis solution were added to the culture 
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pellet and incubated at 37°C for 5 min. After an additional centrifugation, pellet was 
washed and resuspend in complete culture medium and restored to regular parasite 
culture conditions. Parasites were synchronized again after 10-12 h, keeping a tightly 
synchronized parasite population within a ± 4-6 h time window. Cultures were kept 
synchronized.  
 
2.2.3.2.6. Enrichment of knobby mature-stage P. falciparum-infected 
erythrocytes by gelatin flotation  
This method is used to enrich mature forms of infected erythrocytes however, does 
not generate pure parasite preparations. It is based on the sedimentation behavior of 
the iRBCs on gelatin solution [223] and it enriches only late-stage infected 
erythrocytes expressing knobs on the erythrocyte plasma membrane (+K, knobby 
parasites), since +K late stages sediment slower than uRBCs or ring-stage iRBCs.  
 
After centrifuging the parasite culture (3-5% parasitemia, 3.5 hematocrit) at 500 x g 
for 2 min at RT, cell culture pellet was suspended in 10 volumes (one volume = RBC 
pellet volume) of 37°C pre-warmed gelatin solution. Cell suspension was then 
incubated for 30-60 min at 37°C. Supernatant was carefully transferred to a new tube 
and centrifuged (500 x g, 2 min, RT). Cell pellet was washed twice with RPMI 
incomplete medium and restored to normal culture conditions adjusting hematocrit to 
3.5 % and parasitemia 0.5-1 % or used immediately for panning. 
 
2.2.3.2.7. Magnetic isolation of P. falciparum-infected erythrocyte late-
stages 
Ingestion of hemoglobin during the intraerythrocytic development, results in the 
accumulation of free heme, which is highly toxic to the parasite as it lacks heme 
oxygenases [224]. For instance, the parasite possesses a very efficient detoxification 
mechanism where heme is aggregated into an insoluble non-toxic crystals termed 
hemozoin (malarial pigment), which is accumulated in the parasite digestive vacuole 
[225]. During this process, the Fe+2 ions (diamagnetic) contained in the 
oxyhemoglobin are transformed in the hemozoin into Fe+3 ions (paramagnetic) [226]. 
Accumulation of hemozoin in the digestive vacuole is noticeable microscopically in 
the most metabolically active parasite stages such as trophozoites and schizonts and 
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this fact permits the purification of mature iRBC up to ≤ 98% parasitemia with high 
parasite viability [227]. 
 
To perform this method, the magnetic activated cell sorting (MACS) separation 
column was placed into the vario MACS magnetic support and equilibrated by adding 
pre-warmed MACS buffer for 20 min at RT. The suspended parasite culture (3-5% 
parasitemia, 3.5% hematocrit), was loaded into the magnetic column and led flowed 
through at low flow rate (1 drop/sec). The column was washed then with 
approximately 50 ml of pre-warmed MACS buffer. The effluent which contained the 
uninfected erythrocytes and ring-stage-infected erythrocytes was discarded. After 
washing, the column was then removed from the magnetic field and the late-stage 
erythrocytes were eluted by applying 10 ml MACS buffer into the column. After 
centrifugation (500 x g, 2 min, RT), purified iRBCs were washed twice with RPMI 
1640 medium. After purification iRBCs were used either for binding assays, 
endothelial cell activation assays, SEM, AFM or for hemoglobin variants infection.   
 
2.2.3.2.8. Hemoglobin variants infection 
Tightly synchronized parasites (time window of ± 6 h) at the trophozoite stage were 
magnetically enriched. iRBCs were suspended in P. falciparum culture medium 
containing AB serum after washing and added to fresh HbAS or HbAC blood to a 
parasitemia of 1-2% and 3.5% hematocrit. Thin blood smears were made to monitor 
parasite invasion and development. Hemoglobin AA erythrocytes were infected in 
parallel and used as control. 
 
2.2.3.2.9. Estimation of the parasite multiplication rate, development and 
multiple infectivity 
The parasite multiplication rate was determined for hemoglobin variants AS and AC 
erythrocytes, both as the parasitized erythrocyte multiplication rate (PEMR) and as 
the viable parasite multiplication rate (VPMR) as previously described [228]. Tightly 
synchronized parasite culture (± 6 h time window) at the schizont stage were 
magnetically purified, washed twice with complete RPMI medium and adjusted with 
fresh blood to a 0.05-1% parasitemia at 3.5% hematocrit and cultured under regular 
in vitro culture conditions. The number of newly invaded red blood cells was 
determined by light microscopy after preparing thin blood smears stained with 
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Giemsa of pre-invasion and 24 h post-invasion samples. The PEMR was calculated 
by dividing the final parasitemia at the ring stage by the starting parasitemia at the 
schizont stage (erythrocyte containing ≥ 2 parasites were counted as single infected 
erythrocyte), while for the VPMR estimation, the percentage of total ring-stage 
parasites present in all infected erythrocytes were divided by the starting parasitemia 
before schizogony. At least 1000 RBCs from each slide were counted. 
 
Parasite multiple infectivity (PMI), defined as an iRBC cell containing ⩾ 2 parasites, 
was estimated by counting the number of multiply invaded red blood cells in 300 
infected red blood cells. The percentage of single, double, triple and quadruple 
infections was quantified for infected HbAA and hemoglobinopathic erythrocytes. 
Furthermore, the parasite development was estimated by dividing the percentage of 
rings by the percentage of late-throphozoites after 24 hr. All assays were repeated a 
minimum of three times, from at least three different blood donors. 
 
2.2.3.2.10. Selection of P. falciparum FCR3 strain for cytoadhesion to human 
dermal microvascular endothelial cells 
The panning procedure was done as previously described by Claessens and Rowe 
[229]. Only cells between passage 4 and 7 were used, as during these stages the 
expression of surface receptors is constant [230]. After 48 h cells reached confluence 
and cells were activated with TNF-α (100 U/ml) for 24 h to induce ICAM-1 
expression. After that, panning was performed. For this, late stages at approximately 
5% parasitemia were selected for knobs by gelatin flotation. +Knob iRBCs were then 
collected from the gelatin supernatant and washed twice with RMPI-1640 basal 
media. The final pellet was suspended in 4 ml binding medium and added to the 
confluent endothelial cells (60-mm dish) previously washed with HBSS. Cells were 
co-cultured for 1 h at 37%. During the incubation, the parasites were suspended 
twice carefully by gently rocking the dish and rotating it clockwise and anti-clockwise. 
Once finished the incubation, the dish was washed ≤ 5 times with RPMI incomplete 
media by aspirating the medium and gentle rocking, until uninfected cells or non-
bound iRBCs were completely gone. Remaining adherent cells were placed back in 
the incubator overnight after adding 3 ml parasite culture medium and 40 µl of 
packed fresh blood. The following day, infected erythrocytes were harvested by 
washing them out of the plate vigorously with RPMI incomplete medium. After 
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centrifugation (800 x g, 2 min, RT) the cell pellet was suspended in complete culture 
medium and placed back to culture after adjusting hematocrit to 3.5 %. Panned 
parasites were termed here FCR3HDMEC. 
 
After every panning, the parasite binding capability to HDMEC was monitored by 
static adhesion assay (see section 2.2.4.1). Once a high binding population was 
obtained, adhesion and activation assays were performed. Infected erythrocytes 
were repeatedly selected for knobs by gelatin flotation and for binding to HDMEC 
(every 3-4 weeks). 
 
2.2.4. Binding assays 
2.2.4.1. Static adhesion assay (wash assay technique) 
2,5x105 HDMEC were seeded in 24 well plates pre-coated for 20 min at RT with 
fibronectin (10 mg/ml in PBS). HDMEC reached confluence after 48 h. Highly 
synchronized FRC3HDMEC iRBCs late-stages were purified by MACS. IRBC pellet was 
washed with RPMI incomplete medium and resuspended in binding medium. 
Purification yield was evaluated by Giemsa stained blood smear and the number of 
cells was determined using a particle counter. Confluent HDMEC were washed twice 
with HBSS and incubated with 500 µl of iRBCs suspension (5x106 iRBCs/ml) in 
binding buffer for 1 h at 37 °C. During the incubation, the parasites were suspended 
twice carefully by gently rocking the dish and rotating it clockwise and anti-clockwise. 
Cells were washed ≤ 5 times with RPMI incomplete medium by aspirating the 
medium and gentle rocking until non-bound iRBCs were completely gone. Remaining 
adherent cells were washed once with PBS and fixed with 2% (v/v) glutaraldehyde in 
PBS for 30 min at RT and stained with 10% (v/v) Giemsa for 30 min at RT. Adhered 
cells were observed under an inverted microscope at 10X magnification air objective. 
Images of at least 6 fields of view were taken and the number of adhered cells per 
area was calculated using an automated cell counter plugin from ImageJ (v2.7.3). 
Duplicates were done for each sample and uninfected erythrocytes were assessed in 
parallel as negative binding control. 
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2.2.4.2.  Flow chamber adhesion assay 
30 µl of 1.3x105 cells/ml were seeded in Ibidi µ-slide V0.4 pre-coated with fibronectin 
(10 µg/ml in PBS) and place back into the incubator to let the cells sit and adhere for 
30 min. Cells were then fed with 120 µl (reservoir volume). Cells were fed twice a day 
and they reached confluence within 48h. If needed, cells were incubated with TNF-α 
(100 U/ml) for 24h in HDMEC medium without hydrocortisone before the experiment 
to induce ICAM-1 expression. 
 
Tightly synchronized trophozoites were magnetically purified and parasitemia 
calculated by Giemsa stained thin blood smear. After washing them twice with RPMI 
incomplete medium, cells were resuspended in binding medium and incubated with 
0.4 µl/ml SYBR Green for 30 min at 37°C (in dark), for parasite labeling and 
therefore, automated cell tracking. After ≤ 5 washes, the cells number was 
determined using the particle counter and iRBCs were then resuspended in binding 
medium at a concentration of 1x106 iRBCs/ml. At this point, confluent HDMECs were 
washed with binding medium and parasite suspension at 37°C was flowed through 
the cell monolayer on the flow chamber at different flow rates to create shear stress 
ranging from 0.03 to 0.3 Pa. This range of shear stress is typically found in post-
capillary venules [231]. 5 ml of parasite suspension was flowed through the chamber 
(a total of 5x106 iRBCs) at each shear stress. Unbound cells were washed out by 
flowing binding medium alone for 5 min at the same wall shear stress. For each 
shear stress condition, number of adherent cells was quantified from at least 6 fields 
of view at the center of the channel, were flow is found to be homogenous. 
 
To study iRBCs motion behavior on HDMEC, videos at each of the previous shear 
stresses were recorded (time interval 0.033) using an inverted microscope (Zeiss 
Axio Observer, 40X objective, EGFP HC Filter set Ex: 456-490 nm Em: 500-540 nm). 
Mean translational velocities and fluorescence intensity profiles were obtained after 
video analysis using the TrackMate plugin from ImageJ (v2.7.3). Only cells that 
showed an end to end motion were used for analysis. 
 
The generation of a desired wall shear stress from a flow rate was obtained by 
following the formula: 
Τ = η ∙ 176.1 ∙ Φ 
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Were Τ indicates the wall shear stress (Pa); η corresponds to the viscosity of the 
medium which was 0.7 mPa s, Φ corresponds to the flow rate (ml/min) and 176.1 is a 
factor obtained from the dimensions of the channel (provided by the manufacturer). 
 
Table 1. Correspondent flow rate used to generate the different shear stresses in the µ-slide 
VI0.4 chamber. 
 
 
 
2.2.4.3. Tracking analysis of single infected erythrocytes  
The TrackMate plugin from ImageJ (v2.7.3) was used in order to track iRBCs motion 
on HDMEC. The DoG detector was used to detect small size particles. The estimated 
blob diameter was set to 7 µm and the threshold to 4. The Simple LAP tracker with a 
linking distance of 25 µm was selected to reduce the branched tracks. Translational 
velocity and fluorescence intensity amplitude profiles were obtained. These profiles 
served for classification of the iRBC motion as rolling/flipping or non-interacting cells 
and for further quantification of the cytoadhesive behavior.  
 
2.2.4.4. Quantification of infected erythrocytes cytoadhesive behavior 
Since the focus was maintained on top of the endothelial cells, the maximum points 
in the fluorescence amplitude data corresponded to the parasite approaching the 
focal plane whereas the minimum points corresponded to the parasite when leaving 
the focal plane. Amplitude difference (  ) was determined by estimating and 
averaging the maximum 〈    〉 and minimum 〈    〉 points on the fluorescence 
Τ (Pa) Φ (ml/min) 
0.03 0.24 
0.05 0.39 
0.075 0.59 
0.10 0.79 
0.15 1.18 
0.20 1.58 
0.25 1.97 
0.30 2.37 
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amplitude profile, by using the peak detection algorithm in python, performed by Dr. 
Anil Dasanna, Institute of Theoretical Physics, Heidelberg University: 
 
   〈    〉  〈    〉 
 
Knowing that the maximum points on the fluorescence amplitude profile represent the 
parasite in closest proximity to the substratum, a threshold (-0.05 a.u.) was applied to 
maximum amplitude values. All data points above the threshold were then summed 
and the contact time estimated (since each data point corresponds to 0.033 sec). 
Pearson correlation coefficient between fluorescence amplitude and translational 
velocity profile was used to determine the regularity of flipping as previously 
described [232]. Furthermore, the mean translational velocity were obtained for all 
trajectories. All calculations were done after normalizing all fluorescence amplitude 
profiles with the minimum intensity value, since the florescence intensity signal was 
not constant for all the samples.  
 
2.2.4.5. Adhesion using blocking antibodies 
Adhesion assay was performed as described in section 2.2.4.2., were HDMEC were 
pre-incubated with saturating concentrations of monoclonal antibodies (FA6-152 and 
15.2) against CD36 or/and ICAM-1 PfEMP1 binding sites (4 µg/ml in HDMEC culture 
media, for 1 h under regular culture conditions) before the experiment. No 
monoclonal antibody control was evaluated in parallel.  
 
2.2.4.6.  Flow-based adhesion assay / detachment assay 
Flow chambers (Ibidi µ-slide V 0.4) were coated with fibronectin (10 µg/ml in PBS) for 
30 min at RT. After washing the channels with PBS, 30 µl of 1.3x105 cells/ml were 
seeded per channel and cells were place back into the incubator to let them sit and 
adhere for 30 min. Reservoir volume were filled (120 µl) with medium. Cells were fed 
twice a day with HDMEC cell complete medium and they reached confluence within 
48 h. If needed, cells were incubated with TNF-α (100 U/ml) for 24h in HDMEC 
medium without hydrocortisone before the experiment to activate the endothelial 
cells. 
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Tightly synchronized infected erythrocytes at late stages were purified trough the 
magnetic column and iRBCs pellet was washed twice with incomplete RPMI-1640 
medium. For automated cell counting, iRBCs were labeled with 0.4 µl/ml SYBR 
Green for 30 min at 37°C in dark. After ≤ 5 washes with incomplete RPMI-1640 
medium, cells were counted and resuspended in binding medium at a concentration 
of 1x106 iRBCs/ml. A total of 5 ml of parasite suspension at 37°C was flowed through 
the HDMEC monolayer on the flow chamber, at a wall shear stress of 0.05 Pa. 
Unbound cells were washed out by flowing binding medium alone for 5 min. At least 
6 fields of view at the center of the channel were imaged and initially bound iRBCs 
were quantified. After this step, shear stress was increased stepwise up to 4 Pa. 
Each wall shear stress was applied for 5 min and initial shear stress of 0.05 Pa was 
applied while images were taken, that the flow conditions were always present. 
Infected hemoglobin variants and wild-type erythrocytes were run in parallel. Binding 
strength was estimated by calculating the critical shear stress at which the 50% of the 
initially bound iRBC population detached (τ50).  
 
2.2.5. Assessment of endothelial cell activation 
2.2.5.1. Co-culture of HDMEC and P. falciparum-infected erythrocytes 
Activation assay was done as described by Viebig et al. [165]. HDMEC were seeded 
in fibronectin pre-coated 12 well plates (10 mg/ml in PBS). After reaching confluence, 
endothelial cells were washed with HBSS and co-cultured with 5x106 iRBCs at the 
trophozoite stage (enriched by MACS) resuspended in 1 ml of HDMEC culture 
medium without hydrocortisone (hydrocortisone prevents activation and therefore 
was depleted during this assay) for 16 h under regular culture conditions. After the 
incubation period, supernatant was collected, centrifuged for 1 min at 10000 x g and 
4°C. The supernatant was frozen to -20°C until ELISA for IL-6 detection was 
performed (see section 2.2.6.1.). The remaining endothelial cells were used for flow 
cytometry in order to measure ICAM-1 endothelial cell surface levels after iRBCs 
exposure (see section 2.2.6.2.). 
 
Alternatively, HDMEC were seeded in Ibidi µ-slide V0.4 pre-coated with fibronectin (10 
µg/ml in PBS). After reaching confluence, endothelial cells were incubated as 
described previously, with 150 µl of parasite suspension (5x106, 2x107, 7x107 or 
1x108, iRBCs/ml) for 2 h under static normal culture conditions. When assessed in 
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flow conditions, infected erythrocytes (1x108 iRBCs in 5 ml) were flown through the 
confluent HDEMC seeded on the channel at a wall shear stress of 0.03 Pa (30 min) 
and incubated for another 90 min. After this period, endothelial cells were washed 3X 
with cold PBS and proceed to NF-ҡB immunolocalization (see section 2.2.6.3. and 
2.2.7.1.). For all activation assays, HDMEC in parallel were incubated with 
endothelial cell culture medium without hydrocortisone and uninfected erythrocytes 
as negative controls, and TNF-α (100 U/ml) as positive control for endothelial 
activation. 
 
2.2.6. Immunofluorescent methods 
2.2.6.1. Enzyme-linked immunosorbent assay for IL-6 quantification 
Enzyme-linked immunosorbent assay (ELISA) is used to detect and quantify specific 
antigen or antibody using an enzyme chemically linked to the antibody directed to the 
antigen/antibody of interest. The capture or sandwich ELISA is a modification of the 
classical ELISA used to detect secreted products such as cytokines. Instead of 
coating the plastic plate with antigen to detect antibodies, it is coated with antigen-
specific antibodies, which are then able to bind with high affinity to the specific 
antigen, thus concentrating it on the plate surface even if the antigen its present at 
very low concentrations in the suspension. A secondary antibody chemically linked to 
an enzyme, usually HRP, is directed against another epitope of the captured antigen, 
thus it can be detected by an enzyme color change reaction that can be read in 
multichannel spectrometer [233]. 
 
Capture ELISA was used to quantify IL-6 released from HDMEC after co-culture with 
infected erythrocytes (human IL-6 ELISA MAXTM Deluxe set) as recommended by 
manufacturer, after performing the activation assay (see section 2.2.5.). Duplicates 
from at least three independent experiments were evaluated. 
 
2.2.6.2. ICAM-1 cell surface levels measured by flow cytometry  
Flow cytometry allows to measure multiple physical parameters of a cell such as cell 
relative size, internal complexity and granularity and relative fluorescence intensity, 
while the cell flows in a fluid stream through a beam of light. These parameters are 
determined using an optical-to-electronic coupling system that records how the cell 
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scatters incident laser light and emits fluorescence. Side-scattered light is collected at 
approximately 90° to the laser beam and corresponds to the cell granularity or 
internal complexity and forward scatter light is collected at 0-10° to the laser beam 
and indicates the relative cells size. By using specific labeled antibodies to tag cell 
surface proteins, it is possible to identify individual cells and quantify the levels of 
protein expression on their surface. The scatter light and fluorescence signals are 
detected and amplified by the photomultiplier tube and the amount of signal detected 
is proportional to numbers of fluorochrome molecules on the cell [233]. 
 
To quantify the ICAM-1 levels on endothelial cells after exposure to FCR3HDMEC 
infected erythrocytes, endothelial cells were first washed with pre-warmed PBS and 
detached with trypsin-EDTA. After detachment, trypsin was inactivated using trypsin-
inhibitor (1:1 trypsin volume) and cells were centrifuged at 300 x g for 5 min at RT. 
Cell pellet was washed once with 400 µl FACS buffer and cells were counted. 2-
10x105 cells were used per staining. For this, cell pellet was resuspended in 50 µl 
FACS buffer with PE-labeled antibody at a 1:50 dilution and incubated for 30 min on 
ice in dark. Cells were washed with 100 µL FACS buffer and fixed with 100 µL of 2% 
(v/v) formaldehyde in PBS. Fluorescence intensity (Ex: 488 nm, Em: 575 nm) and 
forward scatter light was recorded. Post-analysis was performed using CellQuest 
software. Quantification of CD36 was also performed in order to corroborate stable 
levels expression on HDMEC in the different cell passages and donors. 
 
2.2.6.3. NF-ҡB immunolocalization 
Immunofluorescence (IF) microscopy make the use of a specific antibody to localize 
a target molecule with accuracy in single cells or in tissue sections. Indirect 
fluorescence makes the use of a secondary antibody labeled covalently with a 
fluorescent dye. The stained cells can be the examined under the microscope were 
exposed to a specific light wavelength to excite the fluorochrome. Which once excited 
emits light at a characteristic wave length that is collected through a selective filter. 
Different than a fluorescence microscope, confocal microscopy allows as to produce 
a very thin optical section of a cell or tissue. In this way the fluorescence emission 
itself can be restricted to the optical section [234]. 
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Immunolocalization of p65 NF-κB in HDMEC was evaluated by confocal microscopy 
after co-culturing them with FCR3HDMEC infected erythrocytes as previously described 
[169]. Endothelial cells were washed three times with ice cold PBS and fixed with 4% 
(v/v) paraformaldehyde in PBS for 15 min at RT. Cells were then rinse three times 
with cold PBS and permeabilized with 0.5% (v/v) triton X-100 in PBS for 10 min at 
RT. After washing, cells were blocked with 3% BSA in PBS for 30 min at RT. Cells 
were incubated with 1:200 rabbit polyclonal IgG anti-human NF-ҡB p65 subunit 
diluted in blocking solution overnight at 4°C. After washing three times with PBS, 
Alexa-488 conjugated goat anti-rabbit IgG was added to a dilution of 1:400 in 
blocking solution and incubated for 1h at RT in the dark. After washing, nuclei were 
counterstained with Hoechst (5 µM) for 10 min at RT. Cells were imaged immediately 
or kept in 0.02% (w/v) sodium azide in PBS for longer storage. Images were acquired 
by confocal microscopy and post-analyzed as described by Vora et al., 2010 [235]. 
 
2.2.7. Microscopy techniques 
2.2.7.1.  Confocal imaging acquisition and analysis 
Fluorescence imaging of P65-NF-ҡB translocation was performed using a Zeiss 
confocal microscope. The Hoechst (excitation: 351 nm, emission: 385-470 nm), 
Alexa-488 (excitation: 488 nm, emission: 505-550) and DIC images were acquired 
from at least 6 random fields of view (63X/ 1.2 NA W objective) for each sample. 
Images were recorded using a pin hole Ø of 1.71 airy units, a scan speed of 1.6 
µs/pixel and a frame averaging of 2. The PMT gain and offset were adjusted to obtain 
sub-saturating fluorescence intensity with an optimal signal-to-noise ratio. The 
percentage positive p65-NF-ҡB immunolabeled nuclei from the total number of nuclei 
observed by Hoechst staining (nuclear labeling index; NLI) was estimated as 
previously described [235] and expressed as mean ± SEM from at least three 
biological replicates. 
 
2.2.7.2.  Scanning electron microscopy  
The resolution power obtained from optical microscopes depend on the wavelength 
of light, which is limited then to 0.2 µm, when using green light illumination. Electron 
microscopes use instead of a light beam an electron beam, producing shorter 
wavelengths that allow resolving ~0.1 nm structures [117]. For this reason, scanning 
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electron microscopy (SEM) was performed to resolve and quantify the nano-scale 
knobs presented on the infected erythrocytes plasma membrane.  
 
Magnetic purified infected erythrocytes were fixed with 2% (v/v) paraformaldehyde 
and 2% (v/v) glutaraldehyde in PBS for 1h at RT and loaded onto coverslips 
previously coated with 0.01% poly-L-lysine (v/v in water) for 15 min. Cells were 
washed three times with PBS and dehydrated by ethanol series of 30%, 50%, 70%, 
90% and 3 x 100%, 10 min each; followed by immersion in 1:1 solution of 
hexamethyldisilazan:ethanol for 5 min and  hexamethyldisilazan 100% overnight. 
Dehydrated samples were sputter-coated with 10 nm gold/palladium (EM MED 020 
Leica, Germany) and viewed at 10000X magnification on a scanning electron 
microscope (Leo1530, Carl Zeiss, Germany). Quantification of knobs was done by 
manual counter using imageJ and the knob number was expressed per µm2. 
 
2.2.7.3.  Atomic force microscopy (AFM) 
Atomic force microscopy allows imaging with a high magnification and with very high 
resolution. It requires minimal and inexpensive sample preparation and can be used 
as well to image living cells. It can be used to resolve the topography of a specimen 
by scanning the sample in the x and y directions with the AFM cantilever, which will 
bend when encounter an uneven surface. The detected cantilever deflection is 
translated into a 3D topographic image [236]. In contrast to SEM, AFM provides 
quantitative information on the height [236]. On the other hand, AFM force 
spectroscopy permits the measurement of forces in the range of pico Newton. By 
approaching and retracting the AFM cantilever in the z-direction, a force-distance 
curve can be generated, which directly give information on the interacting forces 
between the cantilever and the substratum [236]. 
 
2.2.7.3.1. Sample preparation for knob imaging by scanning AFM 
Highly synchronized P. falciparum cultures were magnetically purified and washed 
twice with PBS. 4 µl from pellet were resuspended in 10% (v/v) Giemsa in PBS for 10 
min at 37°C. From this a thin blood smear was made and air dried. AFM imaging was 
performed by Katharina Quadt (Center for Infectious Diseases, Heidelberg University 
Hospital) as previously described [115]. 
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2.2.7.3.2.  AFM-Single cell force spectroscopy (AFM-SCFS) 
The quantification of the infected erythrocytes binding strength to HDMEC at the 
single cell level was performed as previously described by Davis et al., (2012) [162]. 
The Nanowizard III atomic force microscope was equipped with a CelHesion module 
(JPK Instruments, Berlin, Germany) and mounted on an inverted microscope stage. 
The set was enclosed in a chamber in order to keep the temperature and atmosphere 
constant at 37°C and 5% CO2. Measurements were performed using a relative 
contact mode with a relative set point of 0.15 nN, z-length of 50 µm, extend and 
retract speed of 1.5 µm/s, sample rate of 256 Hz and extend delayed that vary 
between 0 and 30 s.  
 
A triangular tip-less nitride cantilever with spring constant of 0.05 N/m was UV 
cleaned for 15 min and exposed to 4 mg/ml of dopamine hydrochloride in 10 mM Tris 
pH 8.5 for 1 h at room temperature and protected from light. Cantilever was washed 
with milliQ water and dried for 1 h at room temperature. In parallel, P. falciparum-
infected erythrocytes magnetically purified were washed and resuspended in HDMEC 
basal medium without supplements at 0.5% hematocrit. At the same time confluent 
endothelial cells grown in the center of a 15-mm petri dish pre-coated with fibronectin 
(10 µg/ml in PBS) were washed with HBSS, suspended in endothelial cell basal 
medium without supplements and mounted into the base of the inverted microscope. 
The atomic force microscope was set to force spectroscopy (contact mode) and 
previously calibrated onto an empty petri dish. Infected erythrocytes suspension was 
lead into the petri dish (5 µl) in an area without endothelial cell and cantilever was 
approach on top of a cell for 60 s in order to lead the red blood cell adhere to the 
functionalized cantilever before it was brought into contact with the endothelial 
monolayer. Force curves were analyzed using the JPK software to determine the 
maximum force of detachment and the number of rupture events.  
 
2.2.8.  Molecular biology methods 
2.2.8.1. P. falciparum RNA isolation for var gene transcriptional profiling 
Var gene transcription profiling of FCR3HDMEC was performed by q-PCR in order to 
determine the major transcript expressed on the population selected to bind on 
HDMEC. For this, tightly synchronized parasites at ring stage (10-16 h post-invasion) 
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at 5-10% parasitemia were used. The parasite culture was collected by centrifugation 
at 800 x g for 2 min at 4°C, supernatant was discarded, and cell pellet was lysed in 
4°C cold saponin lysis solution (0.1% (w/v) saponin in PBS) to get rid of uninfected 
erythrocytes. After mixing carefully and centrifuging at 2600 x g for 8 min at 4°C, 
remaining pellet was washed once with cold PBS and lysed with TRIzol (10 pellet 
volumes). Lysed cells were then kept at -80°C until RNA extraction. 
 
TRIzol lysates were thawed at 37°C, mixed thoroughly by vortex to dissolve clumps 
and divided into 1 ml aliquots. To the sample 0.2 TRIzol volumes of chloroform were 
added and after shaking vigorously for 15 s suspension was incubate at RT for 2 min 
and centrifuged 12000 x g for 30 min at 4C°. The aqueous phase containing the RNA 
was carefully removed and transferred to a new tube. 0.5 TRIzol volumes of 4°C cold 
isopropanol was added and solution was incubated for 10 min at RT to precipitate the 
RNA. Followed by a centrifugation at 12000 x g for 30 min at 4°C RNA pellet was 
washed with 1 TRIzol volume of ethanol 75%. Pellet was air dried at RT for 
approximately 10 min and resuspended in 20 µl of RNAase free water. RNA pellet 
was incubated for 10 min at 60°C to dissolve completely. RNA yield was determined 
by measuring the absorbance at 260 nm. Samples with an OD260/OD280 ratio close to 
2.0 were used for q-RT-PCR. RNA integrity was further assessed in agarose gel 
electrophoresis (0.7% agarose/ 20% formaldehyde in running buffer) for 1 h at 100 V. 
RNA was visualized with ethidium bromide. 
 
To proceed with the cDNA synthesis, contaminant genomic DNA (gDNA) was 
eliminated from the sample RNA by DNAse treatment using the TURBO DNA-freeTM 
kit (Ambion). cDNA was produce from RNA using the kit Superscript III First-Strand 
Synthesis SuperScript (invitrogen). To corroborate complete elimination of gDNA 
from the original sample, a PCR to detect PfCRT intron was performed as follow:  
 
PCR Master Mix For one reaction (µL) 
10 Reaction Buffer Tag -MgCl2 2,5  
dNTPs 2mM  2,5  
MgCl2 (50 Mm)  1,25  
Tag Polymerase (5U/µl) PFX 0,25  
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Primer 1 1 
Primer 2 1 
DNA Sample 1 
 
Program for thermocycler: 
1 Cycle 94°C for 4 min 
 94°C for 45 sec 
30 Cycles 54°C for 45 sec 
 68°C for 45 sec 
1 Cycle 68°C for 10 min 
Cool down to 4°C ∞ 
 
Samples were visualized in agarose gel electrophoresis (2% in TAE buffer) for 1 h 
100 V. P. falciparum gDNA was used as positive control. 
 
The real time qPCR was performed by Marilou Tétard and Benoit Gamain (Inserm, 
Paris, France). For this, a total of five micrograms of starting RNA were used to 
compare the full set of primers. The quantitative real-time PCR reactions were 
performed using the CFX96 thermocycler (BioRad) in 20 µl volume using Advanced 
Universal SYBR Green Supermix (BioRad) and specific primer pairs for each IT4 var 
gene [237] . Relative transcription was obtained after normalization with seryl-tRNA 
synthetase (housekeeping control gene) [PlasmoDB: PF07_0073] and converted to 
relative copy numbers. 
 
2.2.8.2. P. falciparum gDNA isolation 
P. falciparum culture at the trophozoite stage with a parasitemia of approximately 5% 
was collected by centrifugation at 800 g for 2 min at RT, washed with ice cold PBS 
and lysed in 0.1% (v/v) saponin in PBS. DNA was isolated using the tissue and blood 
DNA extraction kit as indicated by manufacturer. DNA integrity was evaluated by 
0.8% agarose gel electrophoresis with 3 µl ethidium bromide.  
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2.2.9. Spectrophotometric assays 
2.2.9.1.  Quantification of hemoglobin content by spectroscopy (new 
permeation pathways activation) 
Highly synchronized infected red blood cells were evaluated for hemolysis capability 
over the entire intraerythrocytic life cycle. In detail, every four hours a total of 1x107 
iRBC were washed in PBS and then suspended in 800 µl of isosmotic sorbitol lysis 
solution for 10 min at 37°C. After centrifugation at 500 x g for 2 min, 700 µl of the 
supernatant were collected and used to measure the absorbance at 540 nm in order 
to estimate the hemoglobin concentration. Hemolysis of uninfected erythrocytes was 
assessed in parallel as negative control. Duplicates of at least two independent 
samples were done. 
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3. Results 
3.1. Selection and characterization of a P. falciparum FCR3 binding 
population to HDMEC  
3.1.1. Selection of Plasmodium falciparum (FCR3) binding to HDMEC 
The predominant receptors for P. falciparum microvascular sequestration in field 
isolates are CD36 and ICAM-1 [238][239]. Both, CD36 and ICAM-1, are constitutively 
expressed on human dermal microvascular endothelial cells (HDMEC), at a reported 
density of 86 ± 14 x 106 and 6 ± 3 x 106 molecules per mm2, respectively [161]. 
Therefore, these cells were used within this study as model for substratum for P. 
falciparum cytoadherence. HDMEC are very flat primary cells isolated from human 
neonatal foreskin. HDMEC obtained from different donors, were evaluated for their 
levels of CD36 and ICAM-1 surface expression by flow cytometry (Figure 7A). The 
results showed variations in the CD36 and ICAM-1 density expressed at the cell 
surfaces and therefore in the cell population homogeneity regarding the receptor 
expression. For instance, cells isolated from donor one and three presented a 
subpopulation of cells lacking or expressing very low amounts of CD36 on their 
surfaces, while the other part of the population expressed high levels. These results 
showed the heterogeneity regarding CD36 surface expression in those endothelial 
cell isolations. Similar observation was made for ICAM-1 expression in the cells 
derived from donor three. On the other hand, the cell population obtained from donor 
two showed to be more homogeneous for both CD36 and ICAM-1 receptor 
expression and therefore was selected for all future assays.  
 
During malaria infection, systemic release of pro-inflammatory cytokines such as 
tumor necrosis factor alpha (TNF-α), increases [25][26][27][28]. This in turn, 
upregulates the expression of various endothelial adhesion molecules, such as 
ICAM-1. As expected [233], stimulation of HDMEC with TNF-α (100 U/ml) for 24 h 
induced a pronounced increase in ICAM-1 endothelial cell surface expression but did 
not markedly change the levels of CD36 expression (Figure 7B). After selection and 
characterization of HDMEC, a long-term P. falciparum culture was selected by 
panning over these microvascular endothelial cells. 
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Figure 7 | Surface expression of ICAM-1 and CD36 on HDMEC. (A) Expression 
levels of CD36 and ICAM-1 on the surface of HDMEC of different cell donors, 
measured by flow cytometry (phycoerythrin fluorescence, PE). (B) Geometric mean 
fluorescence of CD36 and ICAM-1 for resting and TNF-α activated endothelial cells 
(donor two, n = 2). 
 
Long-term in-vitro parasites populations usually show a very heterogeneous nature 
with respect to their binding properties [66]. Because of the absence of selective 
pressure, the parasite population can express many different var gene variants at any 
given time. Therefore, the P. Falciparum clone FCR3 (Gambia), was selected by 
panning for binding to HDMEC expressed ligands (Figure 8A). Initially, only few cells 
adhered to the endothelial monolayer, however, panning resulted in an approximately 
160-fold enrichment for parasites binding to the HDMEC already after the fourth 
round of selection (Figure 8A/B). The selcted population was termed FCR3HDMEC. 
These parasitized erythrocytes were capable of adhere to HDMEC under 
physiological flow conditions (0.05 Pa wall shear stress) as show in Figure 8C. The 
hemozoin crystals (malarial pigment) inside the parasite food vacuole can be 
appreciated in the phase contrast image as a black dot (Figure 8C, arrow), and its 
movement was used as indicator of parasite viability. Once selected, the binding 
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preference of P. falciparum FCR3HDMEC to CD36 and ICAM-1 on HDMEC was 
characterized. 
 
 
Figure 8 | Selection of P. falciparum FCR3 strain for binding to HDMEC. (A) 
Representative differential interference contrast (DIC) images (scale bar 100 µm, 
arrow points out the infected erythrocyte bound on the endothelial monolayer) and 
(B) the correspondent absolute number of P. falciparum parasitized erythrocytes 
cytoadhering under static conditions to confluent HDMEC after every round of 
selection. The mean ± SEM are shown, n = 2. (C) Representative phase contrast 
image (live cell imaging) of infected erythrocytes remaining adherent on HDMEC 
under flow conditions at a wall shear stress of 0.05 Pa, scale bar 20 µm. Arrow points 
to the hemozoin crystal present in the infected erythrocyte. 
 
3.1.2. Characterization of FCR3HDMEC receptor binding preference 
In order to characterize the binding preference of FCR3HDMEC infected erythrocytes, 
cytoadhesion on HDMEC was studied using saturating concentrations of FA6-152 
and 15.2 antibodies. The monoclonal antibodies 15.2 and FA6-152 have been shown 
to completely block the binding of infected erythrocytes to ICAM-1 [238] and CD36 
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[240], respectively. Under flow conditions, the antibodies FA6-152 and 15.2 blocked 
the adhesion of FCR3HDMEC infected erythrocytes to CD36 and ICAM-1 on HDMEC 
by approximately 93% and 17%, respectively (Figure 9). When applied in 
combination, the antibodies blocked the infected erythrocytes adhesion by ~99%. 
 
 
 
Figure 9 | Effect of blocking antibodies on FCR3HDMEC binding to HDMEC. 
Percentage of parasitized erythrocytes remaining adherent on HDMEC at wall shear 
stress of 0.05 Pa, after blocking CD36 and/or ICAM-1 parasite binding sites on the 
endothelial cells with specific monoclonal antibodies (MoAb). Values are expressed 
relative to the no MoAb binding control group. The mean ± SEM are shown (n = 3). 
Significant differences are indicated; One-way ANOVA for multiple comparisons. 
 
 
To further characterize the FCR3HDMEC population, the var gene transcription profile 
was studied in colaboration with Marilou Tétard (PhD student) and Dr. Benoît Gamain 
from the French National Institute of Health and Medical Research in Paris. The 
results showed that the major var gene transcripts expressed in the parasite 
population were IT4var13, IT4var25 and IT4var66 (Figure 10). These var genes 
belong to the subgroup UpsB and UpsC, which encode for PfEMP-1 variants 
predicted to bind to CD36 and ICAM-1 [241]. IT4var13 and IT4var25 have been 
characterized to confer binging to ICAM-1 and CD36 [242][243][244]. The percentage 
of var gene transcripts remained relatively constant within the parasite population 
over periodical selections, particularly the IT4var25 and IT4var66. Once selected and 
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characterized for its binding preference, the P. falciparum FCR3HDMEC growth and 
replication in wild-type and hemoglobinopathic erythrocytes was investigated. 
 
 
 
Figure 10 | Characterization of FCR3HDMEC var gene transcription. (A) 
Transcription profile for the var genes was assessed after repeated selection of P. 
falciparum (FCR3 strain) infected erythrocytes on HDMEC. Results were normalized 
to the housekeeping control gene seryl synthetase. Genes were organized based on 
the upstream sequence (Ups) group into UpsA (red), UpsA/B (yellow), UpsB (blue), 
UpsC (green), UpsE (white), and others (black). (B) Pie chart showing the 
percentage of each var gene transcript expressed in the parasite population from 
three RNA samples isolated from independent panning selections.  
 
 
3.1.3. Parasite multiplication rate, multiple infectivity and development  
The number of newly infected red blood cells starting from one schizont determines 
the parasite multiplication rate (PMR). The intrinsic ability of parasites to multiply at 
high densities has been correlated with disease severity [228]. The PMR was 
determined both as the parasitized erythrocyte multiplication rate (PEMR) and as the 
viable parasite multiplication rate (VPMR). PEMR considers multiple invaded cells as 
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one infected erythrocyte, while VPMR considers all viable merozoites that were able 
to invade new red blood cells, thus considering multiple infectivity. In vivo and during 
in vitro cultures, especially under static conditions, P. falciparum shows multiple 
infectivity [245], i.e. more than one parasite resides within the same erythrocyte. 
Microscopic examination of Giemsa-stained thin blood smears revealed multiple 
infected erythrocytes carrying a maximum of four parasites (Figure 11A, upper 
panel), which were capable of developing normally to later stages (Figure 11A, lower 
panel).  
 
The PEMR was estimated to be 6.6 ± 0.3, 6.4 ± 0.3 and 6.2 ± 0.4 for infected HbAA, 
HbAS and HbAC erythrocytes, respectively (Figure 11B). No significant difference 
between groups was found (between HbAA and HbAS p = 0.731, between HbAA and 
HbAC p = 0.783, One-way ANOVA). On the contrary, infected HbSS erythrocytes 
had significantly lower PEMR values (3.6 ± 0.8) when compare to wild-type control 
group (p < 0.001, One-way ANOVA). Compared to the PEMR, the VPMR values 
were higher for all the groups. They increased to 8.5 ± 0.7, 8 ± 0.6, 8.1 ± 0.8 and 4.7 
± 1 for HbAA, HbAS, HbAC and HbSS, respectively (Figure 11C). These results 
reflect the numerous multiple invaded erythrocytes found for the P. falciparum FCR3 
strain growing under static culture conditions. No significant difference for VPMR 
between HbAA, HbAS and HbAC was found (between HbAA and HbAS p = 0.856, 
between HbAA and HbAC p = 0.710, One-way ANOVA), but infected HbSS 
erythrocytes showed significantly lower VPMR values, when compared to the HbAA 
group (p < 0.01, One-way ANOVA). 
 
The biological reason for multiple invaded erythrocytes remains unclear, but it is has 
been correlated with severity, probably by increasing the amount of adhesins 
exported to the infected erythrocyte surface [245]. Furthermore, the amount of knobs 
positively correlates with the amount of intracellular parasites [245]. Therefore, when 
comparing infected wild-type and hemoglobinopathic erythrocytes in future adhesion 
assays, it is highly important to consider the levels of multiple invaded cells. The 
percentage of P. falciparum multiple invasions (parasite multiple infectivity, PMI) was 
found to be ~24% and did not vary significantly between groups (Figure 11D) (p = 
0.860, One-way ANOVA). Double invaded cells were the dominant form, 
representing ~80% of the multiple invaded erythrocytes, followed by triple (~16%) 
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and quadruple invasions (~4%) (Figure 11E). No significant differences between 
infected wild-type and hemoglobinopathic erythrocytes were found (2 parasites p = 
0.303; 3 parasites p = 0.457; 4 parasites p = 0.303, One-way ANOVA).  
 
Determining the parasite development in infected HbAA and hemoglobinopathic 
erythrocytes was also of relevance in our study since the iRBC adhesion increases 
as the parasite matures [116][118]. Parasites growing in HbAA, HbAS and HbAC 
erythrocytes developed normally from rings to late stages (between HbAA and HbAS 
p = 0.457; between HbAA and HbAC p = 0.361, One-way ANOVA comparing the ring 
to trophozoite ratios), but not when growing in HbSS erythrocytes (Figure 11F). For 
these cells, the number of parasites capable of developing through the end of the 
erythrocytic cycle significantly declined by 27% (p < 0.050, One-way ANOVA). Some 
of the HbSS erythrocytes showed sickling under normal in vitro culture conditions 
(Figure 11G; arrow a,b). Few parasites, however, were still able to grow inside these 
morphologically disturbed cells (Figure 11G; arrow b). Nevertheless, approximately 
13.6 ± 4% of the parasites growing in sickle erythrocytes arrested at late stages of 
maturation (Figure 11G; arrow c). These results were obtained microscopically by 
thin blood Giemsa smears from highly synchronized parasite cultures. For sickle cell 
hemoglobin, blood from only one donor was processed.  
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Figure 11 | Characterization of Plasmodium falciparum FCR3HDMEC growing in 
hemoglobinopathic erythrocytes. (A) Representative light microscopy images of 
intraerythrocytic P. falciparum infection containing ≤ 1 parasite per cell during the ring 
and trophozoite stage. Box plot showing the (B) parasitized erythrocyte multiplication 
rate (PEMR), (C) viable parasite multiplication rate (VPMR) and (D) the percentage of 
parasite multiple infectivity (PMI). Bar chart showing (E) the parasite multiple 
infectivity distribution and (G) the parasite development for infected HbAA, HbAS, 
HbAC and HbSS erythrocytes. The means ± SEM are shown for at least three 
independent biological replicates. Significant differences are indicated; One-way 
ANOVA. (G) Representative light microscopy images of uninfected sickle 
erythrocytes (HbSS) (arrow; a), P. falciparum-infected (arrow; b) and arrested 
parasite growth in HbSS erythrocytes (arrow; c), scale bar 5 µm. 
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3.2. Characterization of infected hemoglobinopathic erythrocytes 
adherence to HDMEC 
3.2.1. Adherence of FCR3HDMEC P. falciparum-infected hemoglobinopathic 
erythrocytes under static conditions 
The study of cell adhesion includes the process of cell attachment and cell 
detachment. It can be performed at a population or at single cell level. Adhesion 
studies at a cell population level can be further investigated via static or flow 
adhesion through the wash assay technique and flow chamber technique, 
respectively [246]. The attachment studies focus on the mechanism of adhesion to a 
specific substratum, while detachment studies give emphasis to the response of 
adherent cells to an applied force. The attachment capabilities of FCR3HDMEC infected 
erythrocytes was studied at a population level under static and flow conditions. The 
ability of infected hemoglobinopathic erythrocytes to adhere to microvascular 
endothelial cells was initially assessed under static conditions. The results obtained 
showed a marked reduction in the number of infected HbAS and HbAC erythrocytes 
adhering to HDMEC as compared to HbAA-iRBCs at the same developmental stage 
(Figure 12A/B). Cytoadhesion of infected HbAS and HbAC erythrocytes to HDMEC 
was reduced by ~61% and ~82%, respectively. As expected, uninfected erythrocytes, 
evaluated in parallel, did not adhere to the endothelial monolayer (Figure 12A, upper 
panel).  
 
 
Figure 12  | Comparative adherence of infected HbAA, HbAC and HbAS 
erythrocytes to HDMEC under static conditions. (A) DIC images of fixed samples 
showing the degree of static adherence of uninfeced (upper panel) and infected 
(lower panel) HbAA, HbAS and HbAC erythrocytes, scale bar 50 µm. (B) Percentage 
of binding for infected HbAA, HbAS and HbAC erythrocytes to confluent HDMEC 
under static conditions. Data was normalized to the HbAA binding control group run 
in parallel. The means ± SEM are shown for at least three independent biological 
replicates and blood from at least two different donors. Significant differences are 
indicated, One-way ANOVA.  
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3.2.2. Adherence of FCR3HDMEC P. falciparum-infected hemoglobinopathic 
erythrocytes under physiological flow conditions 
The flow chamber permitted to evaluate the range of wall shear stresses at which the 
infected erythrocytes capture events occurred. P. falciparum-iRBCs cytoadhere in 
vivo under low flow conditions within a range of shears forces encountered in post-
capillary venules and sinusoids. The effect of these shear forces on infected 
erythrocytes cytoadherence was studied in flow chamber experiments. iRBCs were 
flushed on confluent endothelial cells at different wall shear stresses ranging from 
0.03 Pa to 0.3 Pa, which are physiological relevant values [231]. The results showed 
that iRBCs adhere to HDMEC in a shear dependent manner (Figure 14B). This 
means that the number of adherent cells decreased as the wall shear stress 
increased, 0.03 Pa being the most favorable shear stress for iRBCs adhesion to 
HDMEC. Consistent with our previous observations, fewer infected 
hemoglobinopathic erythrocytes adhered to the endothelial monolayer, compared to 
HbAA-iRBCs, at all shear stresses evaluated (Figure 13A/B). Considering binding at 
all shear stresses the binding was reduced by approximately 36.7 ± 14%, 62.2 ± 6% 
and 64.2 ± 1% for HbAS, HbAC and HbSS-iRBCs, respectively (p < 0.001, One-way 
ANOVA). As expected, uninfected erythrocytes evaluated in parallel did not adhere to 
the endothelium (Figure 13A, upper panel).  
 
To estimate the binding strength of infected erythrocytes that adhered under flow 
conditions, detachment assays were performed. For this, infected erythrocytes were 
allowed to adhere to HDEMCs under flow conditions at a wall shear stress of 0.05 
Pa. Remaining adherent cells were then exposed to gradually increased wall shear 
stress steps up to 4 Pa. The number of cells remaining adherent were quantified and 
displayed as function of the wall shear stress (Figure 14A). Overall, only a small 
fraction of the initially bound population detached after applying low wall shear 
stresses and the rest of the population remained adherent. After applying shear 
stresses above 0.7 Pa higher number of infected erythrocytes started to detach. A 
fraction of the iRBCs remained adherent even after applying a wall shear stress of 4 
Pa. These results indicate that infected erythrocytes adhering under low flow 
conditions were able to resist higher shear forces before detaching. By fitting an 
exponential decay function to the number of infected erythrocytes remaining 
adherent as a function of the wall shear stress, the τ50 values were calculated. τ50 is 
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defined as the shear stress at which 50% of the initially bound cells detach and 
indicates the overall population binding strength [246]. When compared to a τ50 of 2.0 
± 0.4 for infected HbAA erythrocytes, similar τ50 values were observed for infected 
hemoglobinopathic erythrocytes, were infected HbAS, HbAC and HbSS τ50 values 
were estimated to be 1.7 ± 0.4, 1.5 ± 0.3 and 2.7 ± 1.6, respectively (p = 0.532, One-
way ANOVA). 
 
 
Figure 13 | Adherence of P. falciparum-infected erythrocytes under low 
physiological flow conditions. (A) Phase contrast images showing the degree of 
adherence for infected HbAA, HbAS and HbAC erythrocytes (lower panel) and 
control uninfected erythrocytes (upper panel), 0.05 Pa, scale bar 20 µm. (B) 
Percentage of adherent infected erythrocytes to confluent HDMEC under flow 
conditions ranging from 0.03 and 0.3 Pa. Data was normalized to the infected HbAA 
erythrocytes binding control group run in parallel. The means ± SEM are shown for at 
least three independent biological replicates and blood from at least two different 
donors. HbSS was evaluated only at 0.03 to 0.075 Pa and blood from only one 
donor. Statistical significance is indicated (One-way ANOVA).  
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Figure 14 | Detachment assay for P. falciparum-infected erythrocytes bound 
under physiological flow conditions. (A) A total of 5x106 infected erythrocytes 
were flushed over a confluent resting HDMEC at 0.05 Pa. The total number of 
adherent cells was quantified after washing unbound cells with the same shear 
stress. Wall shear stress was gradually increased up to 4 Pa. The number of cell 
remaining adherent after each shear stress applied was quantified and plotted as 
function of the wall shear stress. Mean ± SEM are shown for at least 3 independent 
replicates. (B) Adherent infected erythrocytes on resting and TNF-α activated 
HDMEC at 0.5 Pa. Mean ± SEM are shown for at least 3 biological replicates. 
Significant difference is shown (One-way ANOVA). (C) Remaining adherent iRBCs 
on TNF-α activated HDMEC. (D) Box plot showing the t50 obtained for infected 
hemoglobinopathic erythrocytes bound on resting and TNF-α activated HDMEC. The 
median, 25% and 75% quartile ranges and error bars are shown. No significant 
difference between groups was found (One-way ANOVA). For HbSS data from only 
two experimental replicates and one blood donor is shown. 
 
 
During infection with P. falciparum the plasma levels of TNF-α increase [27][185]. 
Consequently, the surface expression of endothelial cells receptors, such as ICAM-1, 
also increases. This event may have a positive effect on parasitized erythrocyte 
sequestration [184]. To assess the effect of endothelial activation by TNF-α on 
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infected erythrocytes sequestration, flow chamber assays were performed using 
TNF-α activated HDMEC as a substratum. HDMEC activation with TNF-α provoked 
an increased binding of infected erythrocytes. For instance, at 0.05 Pa, the number of 
iRBC binding to HDMEC increase by ~34%, ~26%, ~6% and ~12% for infected 
HbAA, HbAS, HbAC and HbSS erythrocytes, respectively (Figure 14B). Interestingly, 
stimulation of endothelial cells with TNF-α not only provoked an increased number of 
infected erythrocytes binding, but also caused a slight increase in the τ50 values for 
all groups (Figure 14C). The τ50 values for infected HbAA, HbAS, HbAC and HbSS 
were 3.5 ± 1.9, 2.8 ± 1.0, 3.8 ± 2.8 and 3.1 ± 1.7, respectively. Nevertheless, no 
significant differences were found when comparing the τ50 values obtained for TNF-α 
activated endothelium and the τ50 values obtained for resting endothelium (p = 0.166, 
One-way ANOVA) (Figure 14D). Also, no significant differences were found between 
the τ50 values obtained for infected HbAA, HbAS, HbAC and HbSS erythrocytes 
binding to TNF-α activated endothelium (p = 0.875, One-way ANOVA). 
 
Overall, the number of adherent cells was the major difference found between groups 
in both, resting and TNF-α activated endothelium. Nevertheless, the infected 
hemoglobinopathic erythrocytes capable of adhering under flow conditions adhered 
with comparable binding strengths to infected HbAA erythrocytes. This suggests the 
presence of a subpopulation of infected erythrocytes with similar binding capabilities 
as the HbAA group, identified as “strong binders”. The percentage of infected cells 
which did not adhere under flow conditions represents the subpopulation of weak 
binding infected erythrocytes. These weak binders showed a deficient firm 
adherence, probably as result of improper dynamic interaction on the endothelium.  
 
3.2.3. Quantification of FCR3HDMEC P. falciparum-infected erythrocytes 
cytoadhesive behavior on resting HDMEC 
The adhesion behavior of P. falciparum-infected erythrocytes under flow conditions 
resembles the cytoadherence of leukocytes, where the cells tether, roll and firmly 
adhere to the endothelium [124]. To study in quantitate terms the iRBCs dynamic 
adhesive behavior, the presence of the intracellular parasite, labeled with a nuclear 
staining dye, was used. SYBR green was selected among other dyes for its low anti-
plasmodial activity [247]. This feature makes SYBR green an optimal dye for tracking 
parasites with minimal or no interference with their viability [247]. Staining with SYBR 
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green showed low signal to noise ratio (Figure 15A) and had no effect on 
cytoadherence to HDEMC at 0.05 and 0.1 Pa (Figure 15B), as observed when 
labeled infected erythrocytes were compared to non-labeled ones (0.05 Pa, p = 0.372 
and 0.1 Pa p = 0.897, Student´s t-test). Fluorescent labeling allowed for the tracking 
of infected erythrocytes in an automated manner and extracting relevant information 
from the erythrocytes motion, derived from the fluorescence signal. 
 
 
 
Figure 15 | Effect of SYBR Green staining on cytoadherence of FCR3HDMEC to 
microvascular endothelial cells. (A) Representative phase contrast image of 
parasite nuclear staining after 1 h incubation with SYBR Green; scale bar 50 µm. (B) 
Absolute number of iRBCs adhering under flow conditions on confluent HDMEC after 
nuclear labeling with SYBR Green. Unlabeled iRBC were used as control for binding.  
Mean ± SEM are shown (n = 3). No significant difference was found between groups 
(Student´s t-test).  
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Fluorescent labeled infected erythrocytes were then assessed at different shear 
stresses using flow chambers (Figure 16A). By knowing the flow chambers 
dimensions and the medium viscosity, which was measured to be 0.7 mPa·s, the flow 
rate was calculated for each wall shear stress (Table 1, see section 2.2.4.2.). A 
precise syringe pump permitted the generation of specific flow rates to achieve a 
desired wall shear stress. A total of 5x106 infected erythrocytes superseded in 5 ml of 
medium were allowed to flow over the endothelial monolayer seeded in the flow 
chamber. This concentration of cells permitted to record binding interaction with 
minimal interferences from other cells, simplifying the tracking process. 
 
Inside the erythrocyte, the parasite is located at the periphery [20]. While the cell 
rotates by interacting with the endothelium and shear forces acting on its back, the 
fluorescence signal recorded results in a fluorescence amplitude (Figure 16B). As the 
focus is positioned on top of the endothelial monolayer, the maximum values 
recorded in the fluorescence amplitude correspond to the parasite in close proximity 
to the endothelium. Conversely, when the parasite finds itself away from the 
monolayer, the fluorescence intensity decreases to the lowest values recorded. By 
tracking the parasite nucleus, the iRBC translational velocity could also be obtained. 
Both, the fluorescence intensity and translational velocity profiles were used to 
describe and quantify the P. falciparum-infected erythrocytes motion behavior. In 
detail, from the fluorescence intensity and translational velocity profiles, four 
parameters were obtained: the mean translational velocity, the amplitude difference, 
the contact time towards the endothelium and the Pearson correlation coefficient 
between the fluorescence amplitude and the velocity profile. 
 
Initially, the interaction between trophozoite-iRBCs and HDMEC was evaluated at low 
physiological flow conditions, using shear forces that ranged from 0.03 to 0.2 Pa. 
Four different interactions between trophozoite-iRBCs and endothelial cells were 
observed: firm adhesion, dynamic adhesion, dynamic adhesion followed by firm 
adhesion and non-adhering cells (Figure 17). A non-adhering cell showed low 
intensity values, since it was not in close proximity to the membrane, and high mean 
velocities (Figure 17A). An adherent cell was observed as the fluorescence intensity 
remained constant over the time, as well its mean velocity, which remained close to 
zero (Figure 17B). A dynamically adherent cell showed regular oscillation in the 
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florescence intensity profile as consequence of the out-off center intracellular parasite 
location. This feature caused the parasite position towards the focal plane on the 
endothelium to change while the infected erythrocyte moved along the endothelial 
monolayer. At the same time, a low, but oscillatory velocity profile, which was anti-
correlative to the fluorescence amplitude, was observed (Figure 17C). The periodic 
oscillation in the velocity profile observed for dynamic adhesion resembled a flipping 
motion rather than a rolling motion. Some infected erythrocytes that dynamically 
adhered to the endothelium were capable of adhering firmly and remained adherent 
over the recording time, as seen in figure 17D. 
 
 
Figure 16 | Schematic of flow chamber experimental setup. (A) Using a precise 
syringe pump the infected erythrocytes were loaded at a desire wall shear stress into 
the flow chamber containing confluent endothelial cells. After positioning the focal 
plane above the endothelium, fluorescence from the labeled parasite nucleus was 
imaged and fast videos were recorded (300 frames / 9.9 sec). (B) During post-video 
analysis, the parasite nucleus of a single cell was tracked, and the correspondent 
fluorescence intensity amplitude and translational velocity were extracted. Using this 
information mean translational velocity, amplitude difference, contact time and 
Pearson correlation coefficient were calculated and used as measure for 
characterization of the infected erythrocyte cytoadhesive behavior. Courtesy of Dr. 
Britta Nyboer. 
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Figure 17 | Differential motion behavior of P. falciparum-infected erythrocytes 
under physiological flow conditions. Representative fluorescence amplitude and 
velocity profiles extracted from a (A) non-interacting, (B) firmly adhered, (C) dynamic 
adherent and (D) dynamic followed by firmly adhered infected erythrocytes flowing on 
confluent HDMEC at a wall shear stress of 0.03 Pa. a.u., arbitrary units.  
 
3.2.4. Differential motion behavior for P. falciparum-infected erythrocytes at 
trophozoite and schizont stage on resting HDMEC 
The erythrocyte shape [20], adhesiveness [248] and rigidity [249] highly influence the 
iRBC cytoadhesion behavior. Since these three parameters vary from early to late 
stages of the intraerythrocytic cycle, infected erythrocytes at the trophozoite and 
schizont stage were compared. After infected erythrocytes at the trophozoite stage 
(26 ± 6 hpi) adhered to HDMEC (Figure 18A, snapshot I) the hydrodynamic forces 
exerted on the iRBC back provoke the iRBC to peel off the endothelium (snapshot II). 
This reduction in the initial iRBC-HDMEC contact (snapshot III) provoked the flipping 
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of the cell over its other side (snapshot VI-V). In Figure 18C, representative 
fluorescence and velocity trajectories are showed for a trophozoite-iRBC. As 
described previously, the trophozoite trajectory revealed large fluorescence 
amplitude differences as well as periodical oscillations of the velocity profile, 
suggesting a flipping rather than a rolling motion. Furthermore, the velocity profile 
negatively correlated with the fluorescence amplitude (Figure 18C, indicated by the 
red circles). 
 
On the other hand, the known increase in sphericity and rigidity at the schizont stage 
(36 ± 6 hpi) provoked infected erythrocytes to roll rather than flip. The cell movement 
along the endothelium was smooth and did not show large cell displacements (Figure 
18B). Representative fluorescence and velocity trajectories are shown for an infected 
erythrocyte at the schizont stage (Figure 18D). For this trajectory, smaller amplitude 
differences and almost no oscillation in the velocity profile were observed. 
Furthermore, fluorescence and velocity amplitudes did not correlate. It was also 
noticed that the parasite was larger in the schizont stage than in the trophozoite 
stage, and that the parasite location changed from off-center to the middle of the 
erythrocyte. 
 
The correlation between fluorescence amplitude and velocity profiles was estimated 
by the Pearson correlation coefficient. Values close to -1 indicated negative 
correlation or anti-correlation while the values close to zero indicated no correlation. 
For the representative trophozoite trajectory (Figure 18C) the Pearson correlation 
coefficient was -0.690, indicating a strong anti-correlation and therefore a flipping 
behavior. On the contrary, for the schizont trajectory (Figure 18D) the Pearson 
correlation coefficient was calculated to be -0.0151, indicating no correlation between 
fluorescence amplitude and velocity profiles, and therefore suggesting a rolling 
behavior. In this way, Pearson correlation coefficient was then used as a key 
parameter for characterization and quantification of P. falciparum-infected 
erythrocytes cytoadhesive behavior. 
 
In Figure 19, flipping and rolling motion are shown as a series of phase contrast 
images over time. For the infected erythrocytes at the trophozoite stage, the 
erythrocyte discoid shape is visible as well as the intracellular parasite which 
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occupies approximately half of the erythrocyte space. The hemozoin crystals inside 
the food vacuole are visible as well (black dot). From these series of snap shots, the 
flipping, as described previously, can be appreciated. By following the hemozoin, the 
complete rotational cycles can also be observed. In these trajectories, the trophozoite 
completed three rotational cycles with variable durations. Furthermore, for 
trophozoites, it was noticeable that cells were sliding (large displacement without the 
cell rotating), this event is highlighted by the black square. On the other hand, a 
schizont infected cell showed a very homogeneous movement completing the 
rotational cycles with the same time duration. The almost spherical shape of the 
schizont infected erythrocyte could be noticed, which remained almost unchanged 
over the whole imaging recording. 
 
Figure 18 | Effect of the parasite developmental stage on the dynamic adhesion 
behavior. Snapshots obtained from experimental data (top view, phase contrast 
image) and computer simulations (side view, courtesy of Dr. Anil Dassana) illustrating 
an infected erythrocyte (A) flipping (trophozoite-stage) and (B) rolling (schizont-stage) 
over confluent HDMEC. Arrow indicates the direction of the flow; wall shear stress 
applied 0.05 Pa; scale bar 10 µm. The parasite can be identified in the phase 
contrast images by the hemozoin crystal, which is localized inside the parasites 
digestive vacuole. (C,D) Representative fluorescence and velocity amplitude profiles 
for infected erythrocytes at different developmental stage: (C) trophozoite stage (26 ± 
6 hpi) and (D) schizont stage (36 ± 6 hpi). Red circles indicate the anti-correlation 
between fluorescence and velocity amplitudes. Wall shear stress applied 0.03 Pa. 
a.u., arbitrary units 
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Figure 19 | Dynamic adhesion behavior observed for P. falciparum-infected 
erythrocytes at different developmental stages. Snapshots obtained from phase 
contrast videos recorded under low physiological flow conditions for trophozoite (26 ± 
6 hpi) and schizont (36 ± 6 hpi). X-direction arrow indicates the direction of the flow; 
y-direction arrow indicates the time; black square indicates a sliding process; 
complete rotational cycles are shown by brackets; scale bar 10 µm. 
 
RESULTS 
 
 
73 
3.2.5. Differential adhesion behavior for infected hemoglobinopathic 
erythrocytes on HDMEC 
After characterization of trophozoite and schizont-iRBCs dynamic adhesion, HbAA 
and HbAS-iRBCs were compared. In the flow chamber assays, the percentage of 
non-adhering cells recorded was very high (Figure 20A/B). For instance, at 0.03 Pa 
approximately ~55% of all tracked cells did not adhere to the endothelium. The 
percentage of non-adhering cells rapidly increased by higher shear forces, reaching 
almost 100% at 0.2 Pa for both infected HbAA and HbAS erythrocytes. On the other 
hand, the number of dynamic adhesion events (includes flipping and rolling events) 
decreased as the wall shear stress increased. No more dynamic adhesion events 
were recorded above 0.1 Pa (figure 20A/B). From the dynamic adhesion events 
recorded for HbAA-iRBCs at the different shear stresses, approximately a third of 
them, cytoadhered in the field of view (31 ± 3%). Non-cytoadherence could reflect 
some heterogeneity on the binding capabilities of the FCR3 population, endothelial 
monolayer heterogeneity, or that the adherence happened out of the field of view.  
 
The percentage of dynamic adhesion events for infected HbAS erythrocytes was 
comparable to the infected HbAA erythrocytes control group at all evaluated shear 
stresses (Figure 20C) (at 0.03 Pa p = 0.326, at 0.05 Pa p = 0.528, at 0.075 Pa p = 
0.403, at 0.10 Pa p = 0.825, at 0.15 Pa p = 1.0 and at 0.20 Pa p = 1.0, t-test). 
Importantly, out of the total number of dynamically adhering cells, the percentage of 
cells that remained firmly adherent was significantly lower for HbAS-iRBCs as 
compared to HbAA-iRBCs (p < 0.001, exponential decay fit, F-test). Only ~19 ± 3% of 
the recorded HbAS-iRBCs firmly adhered in the field of view at different shear 
stresses (Figure 20D). It could be noticed that after 0.1 Pa, no dynamic adhesion 
events were recorded, but few infected erythrocytes adhered abruptly in the field of 
view after tethering.  
 
For further quantification, only infected erythrocytes trajectories recorded at 0.03 and 
0.05 Pa were processed, since the number of dynamic adhesion events was 
statistically sufficient only at those shear stresses. 
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Figure 20 | Quantification of P. falciparum-infected erythrocytes dynamic and 
firm adhesion to HDMEC under low physiological flow conditions. Stacked bar 
charts representing relative proportions of various categories of motion behaviors 
observed for infected (A) HbAA and (B) HbAS erythrocytes flowing on confluent 
HDMEC at physiological shear stresses ranging from 0.03 to 0.2 Pa. (C) Percentage 
of dynamic adhesion events (n.s., Student´s t-test) and (D) flow firm adherence (p < 
0.001, F-test) of parasitized erythrocytes containing either HbAA (open circles) or 
HbAS (closed circles) to HDMEC. Values are expressed relative to the HbAA-iRBCs 
control group binding at a wall shear stress of 0.03 Pa. The mean ± SEM. are shown 
for at least four independent replicates.  
 
Representative trajectories of infected HbAA and HbAS erythrocytes revealed also 
differences on the dynamic adhesion behavior for both groups, at trophozoite and 
schizont stage (Figure 21). For HbAS-infected erythrocytes at the trophozoite stage, 
the fluorescence amplitude and velocity profile showed the same evident anti-
correlation as for HbAA-iRBCs trophozoites, but with larger fluorescence amplitude 
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difference. Additionally, the velocity shortly reached high values (showed by the 
arrows) which could indicate some degree of detachment of the iRBC from the 
substratum. At the schizont stage, infected HbAS erythrocytes also showed reduced 
amplitude differences and reduced velocities, however, it was not comparable with 
the schizont cells observed for the HbAA-iRBC group, which showed regular rolling. 
 
 
 
Figure 21 | Differential cytoadhesive behavior of P. falciparum-infected 
erythrocytes under low physiological flow conditions. Representative 
fluorescence and velocity amplitude profiles observed for infected HbAA and HbAS 
erythrocytes at different developmental stages flowing on confluent HDMEC at a wall 
shear stress of 0.03 Pa. (A) HbAA-IRBC (trophozoite), (B) HbAA-IRBC (schizont), (C) 
HbAS-IRBC (trophozoite) and (D) HbAS-IRBC (schizont). Arrows indicate jumps in 
the velocity values. a.u., arbitrary units. 
 
From at least 27 trajectories and four independent biological replicates, infected 
HbAA and HbAS erythrocytes at the trophozoite stage (26 ± 6 hpi) and at the 
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schizont stage (36 ± 6 hpi) were compared for their motion behavior (Figure 22 and 
23). Quantification of the iRBC cytoadhesive behavior was done for trajectories 
obtained at 0.03 and 0.05 Pa. At these wall shear stresses most of the rolling and 
flipping trajectories were observed and recorded. At 0.03 Pa (Figure 22), the resulted 
comparison showed that infected HbAS erythrocytes flipped and rolled at significantly 
higher velocities when compared to HbAA-iRBCs (trophozoites, p < 0.001 and 
schizonts p < 0.001, One-way ANOVA). When HbAA-iRBCs matured from 
trophozoites to schizonts, the velocity decreased significantly (p < 0.001, One-way 
ANOVA). This was not the case for HbAS-iRBCs, where the velocity between 
trophozoites and schizonts was shown to be comparable (p = 0.145, One-way 
ANOVA) (Figure 22A).  
 
The amplitude difference decreased significantly from trophozoites to schizonts, for 
both HbAA- and HbAS-iRBCs (HbAA-iRBCs p < 0.05 and HbAS-iRBCs p < 0.01, 
One-way ANOVA) (Figure 22B). However, compared to HbAA-iRBCs, the amplitude 
differences observed for the HbAS-iRBCs trajectories were significantly larger at both 
developmental stages (trophozoite p < 0.05 and schizont p < 0.001, One-way 
ANOVA). The larger amplitude differences observed for infected HbAS cells 
suggested that the parasite nucleus, represented by the fluorescent signal, reached 
larger distances away from the substratum when compared to HbAA control group. 
This observation could indicate a transient detaching of the iRBC from the 
substratum during the flipping or rolling cycle.  
 
Knowing that the maximum points on the fluorescence amplitude profile represent the 
parasite in closest proximity to the substratum, a threshold (-0.05 a.u.) was applied to 
maximum amplitude values. Since each data point corresponds to 0.033 sec, all data 
points above the applied threshold were summed up and the contact time was 
estimated (Figure 22C). The contact time increased significantly from trophozoite to 
the schizont stage for both infected HbAA and HbAS erythrocytes (HbAA p < 0.05; 
HbAS p < 0.01, One-way ANOVA). However, when compared to HbAA-iRBCs the 
contact time was significantly lower for HbAS-RBCs at both developmental stages 
(trophozoite p < 0.01 and schizont p < 0.05, One-way ANOVA).  
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Another parameter used for quantifying the cytoadhesive behavior was the Pearson 
correlation coefficient. This parameter is shown as function of the cumulative 
frequency (Figure 22D). The Pearson correlation coefficient values differed 
significantly for the groups at both developmental stages, as indicated by the F-test 
(between HbAA and HbAS at trophozoite stage p < 0.001; between HbAA and HbAS 
at schizonts stage p < 0.001). HbAS-infected erythrocytes trajectories were more 
anti-correlative with a median of -0.59 ± 0.03 compared to -0.44 ± 0.03 for HbAA-
iRBCs. This indicated a more prominent flipping for HbAS-iRBCs at the trophozoite 
stage, as well as an inability of HbAS-schizont infected cells to reproduce the smooth 
rolling observed for infected HbAA erythrocytes at the same developmental stage. 
 
At the higher wall shear stress of 0.05 Pa (Figure 23), similar behavior was observed 
for infected HbAS and HbAA cells. The mean translational velocities as well as the 
amplitude differences significantly increased for infected HbAS erythrocytes when 
compared to HbAA-iRBCs (velocity: trophozoites p < 0.05, schizonts p < 0.001; 
amplitude difference: trophozoites p < 0.05, schizonts p < 0.05, One-way ANOVA). 
The contact time was conversely significantly reduced for HbAS-iRBCs (significant 
for schizonts, p < 0.001). Moreover, a more pronounced anti-correlation was 
observed for HbAS-iRBCs, as indicated by the F-test (trophozoites p < 0.001, 
schizonts p < 0.001).  
Overall higher velocities as well as slightly larger amplitude differences were reported 
for all groups when compared to 0.03 Pa. Higher shear forces may have induced the 
cells to shortly detach from the endothelial monolayer, therefore not only increasing 
the translational velocity but also the amplitude difference. This was reflected as well 
in the contact time which showed lower values compared to 0.03 Pa. All parameters 
together indicated clear differences between infected HbAA and HbAS erythrocytes 
motion behavior on resting endothelium at low shear stress conditions. 
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Figure 22 | Quantification of P. falciparum-infected erythrocytes cytoadhesive 
behavior at 0.03 Pa. Box plot showing (A) the mean translational velocity, (B) 
fluorescence amplitude difference and (C) contact time for infected HbAA and HbAS 
erythrocytes at different developmental stages (trophozoite and schizont) with an 
applied shear stress of 0.03 Pa. The median, 25% and 75% quartile ranges and error 
bars are shown from at least four independent experiments and 27 trajectories. 
Statistical significance is shown (One-way ANOVA). (D) Pearson correlation 
coefficient between fluorescence amplitude and velocity profile is expressed as 
function of the cumulative frequency for trophozoites (p > 0.001; F-test) and 
schizonts (p > 0.001; F-test); n = 4 (27 trajectories).  
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Figure 23 | Quantification of P. falciparum-infected erythrocytes cytoadhesive 
behavior at 0.05 Pa. Box plot showing (A) the mean translational velocity, (B) 
fluorescence amplitude difference and (C) contact time for infected HbAA and HbAS 
erythrocytes at different developmental stages (trophozoite and schizont) with an 
applied shear stress of 0.05 Pa. The median, 25% and 75% quartile ranges and error 
bars are shown from at least four independent experiments and 27 trajectories. 
Statistical significance is shown (One-way ANOVA). (D) Pearson correlation 
coefficient between fluorescence amplitude and velocity profile is expressed as 
function of the cumulative frequency for trophozoites (p > 0.001; F-test) and 
schizonts (p > 0.001; F-test); n = 4 (27 trajectories).  
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The effect of increased endothelial ligands on infected erythrocytes cytoadherence 
behavior was evaluated for infected erythrocytes at the trophozoite stage on HDMEC 
stimulated with TNF-α for 24 h (Figure 24). As expected, when compared to HbAA-
iRBCs the mean translational velocity was significantly higher for HbAS-iRBCs (p < 
0.01, t-test). Similarly, larger fluorescence amplitudes were observed for HbAS-
iRBCs (p < 0.05, t-test). For HbAS-iRBCs, a lower mean contact time value was 
obtained, however, not statistically significant (p = 0.084, t-test). The Pearson 
correlation coefficient was shown again to be significantly lower for HbAS-iRBCs 
(more anti-correlative).  
 
The red and blue lines in the graphs of Figure 24, correspond to the mean values of 
translational velocity, amplitude difference, contact time and Pearson correlation 
coefficient obtained for infected HbAA and HbAS erythrocytes flipping on resting 
endothelium, respectively. When compared to resting endothelium, infected HbAA 
and HbAS erythrocytes move at lower velocities on TNF-α activated endothelial cells, 
however statistical significance was only found for HbAA-iRBCs (p < 0.01, HbAS p < 
0.204, One-way ANOVA) (Figure 24A). The contact time increased significantly for 
both HbAA- and HbAS-iRBCs (p < 0.001, One-way ANOVA) (Figure 24C). Moreover, 
the mean amplitude difference and the mean Person correlation coefficient obtained 
for HbAA- and HbAS-iRBCs flipping on TNF-α activated endothelium, remained 
comparable to the values obtained when resting endothelium was used as 
substratum (HbAA p = 0.582, HbAS p = 0.397 and HbAA p = 0.808, HbAS p = 0.809, 
respectively; One-way ANOVA). 
 
Altogether these results indicate that the trend between HbAA- and HbAS-iRBCs was 
consistent within the different substratum. Therefore, the differences in behavior 
observed for both groups might arise mainly from the erythrocytic adhesive and/or 
mechanical properties. The increase of endothelial cells ligand density, especially 
ICAM-1, which is known to largely increase upon TNF-α stimulation, provoked 
significant variations in the cytoadhesive behavior, especially in translational velocity 
and contact time. The other parameters, i.e. the amplitude difference and the 
Pearson correlation coefficient were not dramatically changed, suggesting that these 
two parameters might be more dependent on other erythrocyte properties such as 
cell shape and rigidity, rather than in the number of ligand-receptor interactions. 
RESULTS 
 
 
81 
 
Figure 24 | Quantification of P. falciparum-infected erythrocytes cytoadhesive 
behavior on TNF-α activated endothelium at 0.05 Pa. (A) Mean translational 
velocity, (B) fluorescence amplitude difference, (C) contact time and (D) Pearson 
correlation coefficient between fluorescence amplitude and velocity profile for 
infected HbAA (Red) and HbAS (blue) erythrocytes at the trophozoite stage with an 
applied shear stress of 0.05 Pa. The median, 25% and 75% quartile ranges and error 
bars are shown, as well the mean values (thick black line) from three independent 
experiments and 21 trajectories. Mean values found for infected HbAA and HbAS 
erythrocytes flipping on resting endothelium are represented by the red and blue 
lines, respectively. Statistical significance is indicated (Student´s t-test). 
 
Hemoglobin C erythrocytes showed a reduced static and flow adherence to HDMEC, 
and the characterization and quantification of the cytoadhesive behavior were 
originally part of the aims of the present study. However due to a limited sample 
access, the behavior quantification was not possible. Preliminary results showed 
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clear differences between trophozoite and schizont-stage infected HbAC erythrocytes 
(Figure 25). The typical flipping motion was observed for HbAC-iRBCs at the 
trophozoite stage (Figure 25A), characterized by large fluorescence amplitude and 
regular velocity oscillations, and by a strong anti-correlation (-0.669). Maturation to 
schizont-stage provoked reduced amplitude differences and fewer oscillations and 
variations in the velocity profile. However, similar to HbAS-iRBCs, schizonts HbAC-
iRBCs showed a stronger anti-correlation (-0.266) when compared to schizonts of 
HbAA-iRBCs (Figure 25B). Therefore, preventing the smooth rolling observed 
previously for HbAA-iRBCs. Further repetitions and proper quantification could further 
reveal important differences in the cytoadhesive behavior of P. falciparum growing in 
this hemoglobin variant. 
 
Figure 25 | Differential cytoadhesive behavior of P. falciparum-infected HbAC 
erythrocytes under low physiological flow conditions. Representative 
fluorescence and velocity amplitude profiles observed for infected HbAC erythrocytes 
at different developmental stages, (A) trophozoite and (B) schizont, flowing on 
confluent HDMEC at a shear stress of 0.05 Pa. Pearson correlation coefficient is 
shown for the selected trajectories.  
 
3.2.6. Delayed activation of new permeation pathways in infected 
hemoglobinopathic erythrocytes 
During the late-intraerythrocytic development P. falciparum increases the 
permeability of the red blood cell plasma membrane to a wide range of small solutes 
which have been shown to enter the red blood cell via a different pathway not 
operating in uninfected erythrocytes. This pathway is referred as new permeation 
pathways (NPP) and is permeable to anions as well as cationic and electroneutral 
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solutes including sugars like D-sorbitol [250]. As soon as the NPP are activated, the 
electrochemical Na+ and K+ gradients are gradually dissipated, subsequently, the cell 
starts to swell due to an influx of Na+ and accompanied water [251], increasing the 
infected erythrocyte volume by 60% [20]. This feature contributes to the spherical 
shape observed at the schizont stage-infected erythrocytes [20]. Rolling adhesion 
seems to be highly dependent on the cell sphericity, therefore differences in the 
rolling behavior observed for schizont-infected hemoglobinopathic erythrocytes 
suggested altered erythrocyte morphology at this stage. Since the NPP activation 
contributes to the spherical shape at the end of the erythrocyte cycle, the NPP 
activation was evaluated for infected HbAA, HbAS and HbAC erythrocytes. 
 
For this, highly synchronized FCR3HDMEC cultures on HbAA, HbAS and HbAC 
erythrocytes were studied over the whole intraerythrocytic developmental cycle (~48 
hours post invasion (hpi)) for their induction of NPP using iso-osmotic D-sorbitol 
solution (Figure 26 A). D-sorbitol is permeable to the NPP and lead to cell lysis by 
driving water with it into the cell. The released hemoglobin from lysed cells was 
quantified by spectroscopy at a wavelength of A540 nm. Thus, the amount on 
hemoglobin corresponded to the levels of NPP activation. NPP activation coincides 
with the transition from ring to trophozoite stage at ~20 hpi. For parasitized HbAA 
erythrocytes the measured hemoglobin from lysed cells starts rising after 20 hpi. 
These cells reached the half maximum NPP activation at 26 ± 2 hpi, consistent with 
previous reports [252]. According to the F-test NPP activation was found to be 
significantly different for infected HbAS (p > 0.001) and HbAC (p > 0.001) 
erythrocytes when compared to HbAA control group. No difference between 
parasitized HbAS and HbAC erythrocytes was found (p > 0.77). NPP induction was 
delayed by ~4 h in both infected HbAS and HbAC erythrocytes. In both cases, the 
50% maximum NPP activation was reached at 30 ± 2 h. Additionally, the NPP in 
hemoglobinopathic erythrocytes did not reach the maximum activation observed for 
infected wild type cells. The delay in NPP activation in these infected 
hemoglobinopathic erythrocytes might prevent the infected erythrocyte to become as 
spherical as HbAA-iRBCs at the end of the intraerythrocytic cycle. 
 
In parallel to the NPP assessment, parasite development was monitored 
microscopically every 4 hours by Giemsa-stained thin blood smears and no 
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difference in the intraerythrocytic parasite development was found between groups 
over the 48 h time course (Figure 26B).  
 
Figure 26 | New permeation pathways activation for parasitized HbAA, HbAC 
and HbAS erythrocytes. (A) Induction of NPP was assessed by spectroscopy by 
measuring the hemoglobin content at 540nm after exposing the infected erythrocytes 
to iso-osmotic D-sorbitol solution every 4 h during the whole intraerythrocytic cycle. 
The means ± SEM are shown for three independent biological replicates and blood 
from at least two different donors. The 50% NPP induction in infected HbAA 
erythrocytes is indicated by the dotted line. Statistic comparison between groups was 
performed using the F-test after fitting the data points to a three‐parameter Hill 
function. a.u., arbitrary units. (B) Bright field images of the Giemsa-stained blood 
smears showing the parasitic stage and morphology for infected HbAA, HbAS and 
HbAC erythrocytes at every time point (4 h) during the time course. Scale bar 10 µm. 
 
3.2.7. Knob characterization of hemoglobinopathic P. falciparum-infected 
erythrocytes  
When compared to HbAA-iRBCs, larger amplitude differences were observed for 
infected HbAS erythrocytes, together with higher translational velocities and reduced 
contact times. These features could emerge as consequence of reduced knob 
densities in infected hemoglobinopathic erythrocytes. Knobs density and morphology 
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were investigated by scanning electron microscopy (SEM) and atomic force 
microscopy (AFM). AFM experiments were performed by Katharina Quadt (PhD 
student, Center for Infectious Diseases, Heidelberg University Hospital). 
 
Scanning electron microscopy images permitted the quantification of knobs and the 
estimation of knob diameter from well preserved samples at the trophozoite stage. In 
Figure 27A, a representative SEM image is shown for an uninfected erythrocyte, 
lacking the electron dense protrusions, and infected HbAA, HbAS and HbAC 
erythrocytes displaying knobs on their surfaces. Fewer and slightly larger knobs were 
observed for the infected hemoglobinopathic erythrocytes. Compared to HbAA-iRBCs 
(Figure 27B), infected hemoglobinopathic erythrocytes showed significant lower knob 
densities on the surface of hemoglobinopathic erythrocytes (between HbAA and 
HbAS p < 0.01; between HbAA and HbAC p < 0.001, One-way ANOVA), but no 
difference was found between hemoglobin variants (between HbAS and HbAC p = 
0.702). Knob diameter (Figure 27C) was found to be significantly larger for infected 
HbAS and HbAC erythrocytes when compared to wild-type control group (between 
HbAA and HbAS p < 0.001; between HbAA and HbAC p < 0.001) but not when 
compared to each other (between HbAS and HbAC, p = 0.423).  
 
For the measurement of knob height, SEM is not the most appropriate technique. 
Therefore, knob density, diameter and height were measured by atomic force 
microscopy. These measurements were only performed for infected HbAA and HbAS 
erythrocytes at the trophozoite (26 ± 6 hpi) and schizont stage (36 ± 6 hpi) (Table 2). 
The results reveal discrepancies in the knob density, showing lower mean values 
when measured by AFM than when measured by SEM. For instance, the mean knob 
density for HbAA-iRBC quantified by SEM and AFM were 12.6 ± 1 knobs/µm2 and 
5.7 ± 0.4 knobs/µm2, respectively. While for HbAS-iRBC the mean knob density 
obtained by SEM and AFM was estimated to be 5.8 ± 1 knobs/µm2 and 3.3 ± 0.5 
knobs/µm2, respectively. Nevertheless, the difference in knob reduction between 
infected HbAA and HbAS erythrocytes at the trophozoite stage remained constant 
between AFM and SEM (about a factor of 2). The mean knob diameter values were 
comparable when measured by SEM and AFM.  
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Figure 27 | Knob characterization for hemoglobinopathic infected erythrocytes. 
(A) Representative scanning electron microscopy images of uninfected erythrocytes 
and Pf-infected HbAA, HbAS and HbAC erythrocytes at the trophozoite stage. Box 
plots showing the (B) knob density and (C) the knob diameter for infected HbAA, 
HbAS and HbAC erythrocytes (trophozoite-stage). The median, 25% and 75% 
quartile ranges and error bars are shown from at least 14 cells. Statistical differences 
are indicated; one-way ANOVA.  
 
The AFM data showed that the mean knob height significantly increased for HbAS-
iRBCs when compared to HbAA-iRBCs (p < 0.001, t-test).  Furthermore, the number 
of knobs increased from trophozoite to schizonts stage for both HbAA- and HbAS-
iRCBs, but it remained significantly lower for HbAS group when compared to HbAA-
iRBCs (p < 0.05, t-test). Knob diameter as well as knob height remained relatively 
constant from trophozoite to schizont and were significantly larger for HbAS-infected 
erythrocytes (p < 0.001, t-test) (Table 2). 
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The discrepancies in the knob density measured by SEM and AFM could be partly 
explained by the sample preparation. Infected erythrocytes are osmotically fragile 
cells and could have shrunk during the SEM preparation [117]. The erythrocyte 
diameter measured by SEM was about 5.5 µm while the erythrocytes diameter 
measured by AFM was about 6.5 µm. This could clarify the increased knob densities 
observed for infected erythrocytes when measured by SEM. Similar discrepancies in 
the knob densities measured by AFM and SEM in parallel have been previously 
observed [116].  
 
Table 2. Knob characterization of infected HbAA and HbAS erythrocytes at the 
trophozoite and schizont stage by AFM. Statistical significance was obtained by 
Student’s t-test. 
 
Trophozoites Schizonts 
HbAA HbAS P value HbAA HbAS P value 
Knob density (µm-2) 5.7±0.4 3.3±0.5 <0.001 7.6±0.8  5.8±0.6 <0.05 
Knob diameter (nm) 83±2.4 103±2.5 <0.001 89±2 101±3 <0.01 
Knob height (nm) 6.5±0.3 9.2±0.4 <0.001 9.4±0.6 11.3±0.6 <0.05 
 
 
In order to interpret all the data in a more meaningful way, principal component 
analysis (PCA) was performed (Figure 28). For the analysis, the Pearson correlation 
coefficient, translational velocity, amplitude difference, contact time and knob density 
were included as variables. Since cell rigidity is thought to play an important role in 
the iRBCs dynamic adhesion, membrane bending rigidity values previously 
measured for iRBC-HbAA and iRBCs-HbAS [253] were also included in the PCA 
analysis. The mean values reported for infected HbAA and HbAS erythrocytes 
bending modulus were 3.4±1.4 (10-19 J) and 5.9±1.2 (10-19 J), respectively, indicating 
the increase in membrane bending rigidity for HbAS-iRBCs [253].  
 
In the PCA, the two major components in which the data differed more were 
obtained. The PC1 showed the highest variation (84%, 86%) and the PC2 the 
second highest variation (8%, 10%). The score graph showed clear separation 
between infected HbAA and HbAS erythrocytes at both, trophozoite and schizont-
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stage. In the PCA, it is also visible that the infected HbAA erythrocyte population was 
dominated by high knob density, larger contact times, no correlative Pearson 
correlation coefficient, lower amplitude differences and lower bending modulus. While 
infected HbAS erythrocytes were dominated by high translational velocities, higher 
bending modulus, larger amplitude differences, lower knob densities, reduced contact 
times and anti-correlative Pearson correlation coefficient. 
Figure 28 | Principal component analysis. Features analyzed include knob density, 
Pearson correlation coefficient (PCC), mean translational velocity, bending modulus, 
contact time and amplitude difference. Data is showed in a score graph for infected 
HbAA and HbAS erythrocytes at the (A) trophozoite-stage and (B) schizont-stage. n 
= 4 (27 cells). Loadings are shown for every variable: knob density (red arrow), 
Pearson correlation coefficient (yellow arrow), mean translational velocity (blue 
arrow), bending moduli (green arrow), contact time (light blue arrow) and amplitude 
difference (pink arrow). 
 
Experimentally measured values of membrane bending modulus [253] and knob 
density from AFM were used by our collaborator Dr. Anil Dasanna (Prof. Ulrich 
Schwarz's group, Institute of Theoretical Physics, Heidelberg University) in 
mesoscopic computer simulations. The computer simulations studied the adhesion of 
iRBC under shear flow to a substratum that mimics HDMEC, by modeling deformable 
cell and explicit hydrodynamics which requires relevant parameters of the system 
such as bending modulus and knob density. From simulations a 2-factor 
decreased knob density and 2-factor increased bending modulus, resulted in 
increased velocity, increased amplitude difference, reduced contact time 
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and stronger anti-correlation [254]. This data indicated that lower knob density and 
increased bending modulus were responsible for altered cytoadhesive behavior that 
is observed for infected HbAS erythrocytes. 
 
Other important information, such as the adhesion footprints, was then extracted from 
the simulations. The footprints patterns resultant from the dynamic adhesion of 
infected HbAA and HbAS erythrocytes at the trophozoite and schizont stage were 
visualized (Figure 29). Every dot corresponds to one ligand-receptor formation. At the 
trophozoite stage, infected erythrocytes showed larger contact areas compared to the 
infected cell at schizont stage. This results as consequence of the spherical shape 
and overall cell stiffness. On the other hand, the infected HbAS erythrocyte showed, 
in this representative trajectory, an inconsistent adhesion pattern, with areas depleted 
of contact (Figure 29C). At the schizont stage, infected HbAS erythrocytes showed a 
more regular footprint, nevertheless, less contact points were obtained when 
compared to the infected HbAA erythrocyte trajectory (Figure 29D). The reduced 
contact area and time, together with a reduced iRBCs ability to firmly adhere might 
have a strong impact on the direct endothelial cell activation by HbAS-iRBCs. 
 
Figure 29 | Adhesion foot prints patterns for infected erythrocytes. 
Representative foot prints originated from infected HbAA (A,B) and HbAS (C,D) 
erythrocytes dynamically adhering on HDMEC-like substratum, at the trophozoite 
stage (A,C) and schizont stage (B,C). Data was obtained from mesoscopic 
simulations using the knob density obtained experimentally and the bending modulus 
[253]. Simulations were performed by Dr. Anil Dasanna, Institute of Theoretical 
Physics, Heidelberg University. 
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3.3. Endothelial cell activation by P. falciparum infected 
erythrocytes  
3.3.1. NF-ĸB nuclear translocation induced by infected erythrocytes binding  
It has previously been shown that direct interaction of P. falciparum infected 
erythrocytes caused activation of several signaling cascades in the microvascular 
endothelial cells [96][165][169]. NF-ĸB is a fast-acting transcription factor located in 
its inactive form inside the cell cytosol and upon infected erythrocytes binding, NF-ĸB 
is quickly translocated into the endothelial cells nucleus where it binds to consensus 
sequences of the DNA to initiate transcription of genes involved in immune response 
[170]. NF-ĸB is a dimer composed by several subunits, including p65 and p50. It is 
known that P. falciparum infected erythrocytes binding induce the fast nuclear 
translocation of p65 subunit in human brain microvascular endothelial cells 
[171][169].  
 
To assess activation of HDMEC by infected erythrocytes, immunofluorescence of 
p65-NF-ĸB subunit followed by confocal microscopy imaging was performed. For this, 
confluent HDMEC were co-cultured with different parasitized erythrocytes loads for 
various incubation times (Figure 30). The level of activation was quantitatively 
represented as the nuclear labeling index (NLI) or the percentage of cells with p65-
NF-ĸB positive labeled nuclei. NF-ĸB nuclear translocation in HDMEC upon infected 
erythrocytes binding was found to be concentration dependent, as the number of 
activated cells rose by increasing the infected erythrocytes load. However, an 
increase on the time of incubation had no major effect on activation. Interestingly, 
areas fully covered by infected erythrocytes showed fully activated endothelial cells 
(Figure 30B, arrows), further suggesting the importance of the number of adherent 
cell on endothelial cell activation. Uninfected erythrocytes (1.5×107 uRBC/well) and 
medium served as negative control and showed none or basal activation. TNF-α 
served as positive control and induced ~100% of the cells to be activated. It is 
appreciable that 2 h of incubation gave the lowest variation in the data. Therefore, 
this condition was used in future comparisons.  
 
 
RESULTS 
 
 
91 
 
Figure 30 | P. falciparum-infected erythrocytes induce nuclear translocation of 
NF-ĸB in a dose dependent manner. (A) Percentage of positive p65-NF-ĸB nuclear 
labeled cells (nulear labeling index, NLI) is shown after co-culturing confluent 
HDMEC with different parasitized erythrocytes loads for different incubation times 
under static conditions. HDMEC co-cultured with uninfected erythrocytes and 
medium alone served as negative control while TNF-α served as positive control (n = 
2). (B) Representative confocal microscopy image of p65-NF-ĸB obtained for 
HDEMC after co-culturing endothelial cells with infected HbAA erythrocytes adhering 
under static condition for 2 h (1x107 iRBCs). In the DIC the parasitized erythrocytes 
can be appreciated. In the Hoechst staining the nuclei are shown. 
 
3.3.2. Endothelial ICAM-1 surface expression and IL-6 secretion upon infected 
erythrocytes binding  
Once in the nucleus, NF-ĸB can bind to consensus sequences and initiate the 
transcription of several target genes including ICAM-1, VCAM-1 and IL-6 [255]. 
Therefore, NF-ĸB nuclear translocation is thought to induce a state of 
hyperadhesiveness, further worsening the degree of vascular obstruction, endothelial 
dysfunction and inflammation. Previous studies showed increased ICAM-1 
endothelial surface expression and IL-6 secretion upon infected erythrocytes binding 
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on human umbilical vein endothelial cells (HUVEC) [165]. To assess if this response 
occurs in HDMEC, flow cytometry was performed after co-culturing HDMEC with 
parasitized erythrocytes to quantify the levels of ICAM-1 cell surface expression. In 
parallel, IL-6 secreted levels were quantified using a specific capture ELISA. Our 
results clearly showed an increase of ICAM-1 surface expression on HDMEC (p < 
0.05, One-way ANOVA) and increased IL-6 levels (p < 0.05, One-way ANOVA) upon 
infected erythrocytes binding (Figure 31). To evaluate whether the observed 
activation was due to a binding of iRBCs to endothelial cell or due to parasite derived 
soluble factors, trans-well assays were performed. For this, HDMEC were cultured in 
the bottom of the chamber, while iRBCs were loaded into the top, separated by a 
porous membrane. Results clearly showed no activation in the trans-well assay, 
indicating that increased endothelial surface expression of ICAM-1 and IL-6 secretion 
was caused by direct contact between infected erythrocytes and the endothelium. 
TNF-α was used as positive control, and clearly caused an increase in both ICAM-1 
surface expression and IL-6 secretion. Opposite to that, co-culture of endothelial cells 
with uninfected erythrocytes or medium caused no changes on ICAM-1 surface 
expression or IL-6 secretion to the medium. 
Figure 31 | P. falciparum-infected erythrocytes directly activate HDMEC. The 
levels of ICAM-1 endothelial surface expression (A) and IL-6 secretion (B) were 
quantified by flow cytometry and ELISA, respectively, after co-culturing confluent 
endothelial cells with infected erythrocytes for 20 hr. Medium and TNF-α were used 
as negative and positive control, respectively. Trans-wells were used to prevent 
direct contact between endothelial cells and infected erythrocytes but allowed the 
exchange of soluble factors. Mean ± SEM are shown for three independent 
experiments. Significance is shown (One-way ANOVA), a.u., arbitrary units. 
RESULTS 
 
 
93 
Due to technical issues such as high requirement of cell material and extensive 
incubation times, ICAM-1 surface detection and IL-6 secretion quantification could 
not be performed under flow conditions. Therefore, only NF-ĸB nuclear translocation 
was used as marker for endothelial cells activation under flow conditions. Infected 
wild-type and HbAS erythrocytes were then compared on their ability to activate 
HDMEC under static and flow conditions. 
 
3.3.3. Reduced endothelial cell activation by infected HbAS erythrocytes 
Confluent HDMEC were co-cultured with different parasitized erythrocytes loads for 2 
h (Figure 32). In the confocal images (Figure 32A), it can be appreciated that without 
any stimulus, the p65-NF-ĸB signal inside the endothelial cells was distributed 
homogenously inside the cell. The number of nuclei can be visualized by the Hoechst 
nuclear staining (Figure 32B, lower panel). Stimulation with the pro-inflammatory 
cytokine, TNF-α, caused the translocation of p65-NF-ĸB to the nuclei of almost 100% 
of the cells (positive control). p65-NF-ĸB nuclear translocation was also observed 
when HDMEC were co-cultured with infected HbAA erythrocytes. The parasite nuclei 
staining shows the high number of infected erythrocytes adhering to the endothelial 
monolayer. In the case of infected HbAS erythrocytes, high number of adherent 
parasitized erythrocytes were observed. However, the percentage of endothelial cells 
showing activation was lower when compared to the achieved by infected HbAA 
erythrocytes.  
Quantitatively, the level of activation was represented as the nuclear labeling index or 
the percentage of cells with p65-NF-ĸB positive labeled nuclei. Parasitized 
erythrocytes bound under static conditions to HDMEC (Figure 32B) showed a clear 
increase in the percentage of activated cells as the infected erythrocyte load 
increased. Addition of 15x106 iRBC caused the full coverture of the endothelium. The 
same trend was observed for infected HbAS erythrocytes, however, the level of 
endothelial cell activation was significantly decreased as evaluated by the F-test (p < 
0.01), when compared to HbAA-iRBC applying the same parasitized erythrocyte load. 
Again, no activation was observed for the medium or uninfected red blood cells 
control. Stimulation with TNF-α caused activation of almost 100% of the endothelial 
cells. 
RESULTS 
 
 
94 
 
Figure 32 | Reduced endothelial cell activation by infected HbAS erythrocytes. 
(A) Representative confocal microscopy images of p65-NF-ĸB subunit obtained for 
HDEMC after co-culturing endothelial cells with infected HbAA or HbAS erythrocytes 
under static condition (1x107 iRBCs). Medium and TNF-α served as negative and 
positive controls, respectively. Total number of nuclei is shown by Hoescht 33342 
stain. Scale bar 20 µm. (B) Percentage of positive p65-NF-ĸB nuclear labeled cells 
(nulear labeling index, NLI) is shown after co-culturing confluent HDMEC with 
different parasitized erythrocytes loads under static conditions (p < 0.01, F-test). 
HDMEC co-cultured with uninfected erythrocytes served as additional negative 
control. (C) Percentage of positive p65-NF-ĸB nuclear labeled cells after co-culturing 
confluent HDMEC with infected erythrocytes (1x108) that remained adhered after 
flushing the parasite suspension at a wall shear stress of 0.03 Pa. Medium, 
uninfected erythrocytes and TNF-α served as negative and positive control, 
respectively. Mean ± SEM are shown for at least five biological replicates from at 
least two blood donors. Statistical significance is shown (one-way ANOVA).  
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Contrary to static conditions, where almost all parasitized erythrocytes were able to 
interact with the endothelium and bind, fewer cells bound to the endothelium under 
flow conditions. However, the activation of endothelial cells by HbAA-iRBCs was 
clearly marked under flow conditions (Figure 32C) (between medium and HbAA 
iRBCs p < 0.001, between HbAA uRBCs and HbAA iRBCs p < 0.001, One-way 
ANOVA), activating approximately 22 ± 4% of the endothelial cells. When compared 
to HbAA-iRBCs, the percentage of activated endothelial cells by HbAS-iRBCs, after 
adhering under flow conditions, was reduced by ~50%, activating only 11 ± 2% of the 
endothelial cells. 
 
3.4. Quantification of P. falciparum-infected erythrocytes binding 
strength at single cell level by atomic force microscopy-single 
cell force spectroscopy  
Atomic force microscopy single cell force spectroscopy (AFM-SCFS) can been used 
to quantify the binding strength of infected erythrocytes at a single cell level, applying 
controlled forces. Within this study, the AFM-SCFS technology was simply 
established for future use and comparison. Infected erythrocytes were successfully 
functionalized to a tip-less AFM cantilever using the dopamine hydrochloride polymer 
(Figure 33A). Functionalized iRBCs were brought into direct contact with the 
endothelial cell with a constant force of 150 pN, which mimics the force that infected 
erythrocytes experience in post-capillary venules when being pushed from the 
centerline of the flowing cells towards the endothelium [164]. 
 
Infected erythrocytes were brought into contact with the endothelial cell for different 
periods of time: 0s, 5s and 30s. The retract/extend curves were obtained (retract 
curve, Figure 33B) and analyzed. The maximum force of detachment as well the 
number of rupture events were calculated from the obtained force curves. These two 
parameters described the binding strength between the two cells. In accordance with 
previous studies [164], longer contact durations provoked larger binding strengths as 
seen by an increase in the maximum force and rupture events. The binding strength 
of P. falciparum-iRBCs increased from 144 ± 18 pN at 0 s contact time to 489 ± 39 
pN at 30 s contact time (Figure 33C). The number of rupture events also increased 
as well from 3.5 ± 0.6 at 0 s to 9.8 ± 1.3 at 30 s (Figure 33D). These results indicate 
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that initial contact permitted the formation of single or multiple bonds between iRBC-
HDMEC, and this binding strength increased with the duration of the contact in 
agreement with previous results [162]. When the infected erythrocytes were brought 
into contact with BSA coated surface, negligible forces of detachment were observed, 
with almost no rupture events, suggesting no strong binding interaction between 
infected erythrocytes and BSA, as expected.  
 
 
 
Figure 33 | Force measurements between P. falciparum-infected erythrocytes 
and HDEMCs at a single cell level. Phase contrast image of an infected erythrocyte 
mounted on the AFM tip less cantilever functionalized with dopamine hydrochloride, 
indicated by the arrow; scale bar 30 µm. (B) Representative force/retract curve 
obtained from the iRBC and HDMEC interaction at 0s contact time at a contact force 
of 150 pN. Maximum force of detachment is shown; rupture events are indicated by 
arrows. Bar charts showing the (C) maximum force of detachment and (D) number of 
rupture events for infected erythrocytes interacting for different times with HDMEC 
and with BSA for 5 sec as negative control. Mean ± SEM are shown from at least 7 
curves per treatment (n = 2). 
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The increase on iRBC binding strength to HDMEC by increased duration of contact 
have been reported [162]. The initial binding of infected erythrocytes causes on 
microvascular endothelial cells the rapid actin recruitment and CD36 clustering in the 
adherent sites, strengthening the binding between cells. The increase in adhesive 
strength over time would allow the iRBC to resist, after the initial attachment, the 
shear stress present in the microcirculation [162]. Thus, by using this methodology, 
the iRBC-EC binding strength as well as the endothelial cell activation (adhesion 
strengthening) could be quantified at a single cell level, including all different cells 
present in a population, without excluding the weak binders, like it happens for the 
flow adhesion assays. However, the disadvantage of AFM-SCFS is that is expensive 
and high time consuming/low throughput technique [246]. 
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4. Discussion 
Several studies support the hypothesis that sickle trait hemoglobin and hemoglobin C 
are naturally selected due to the protection they confer against severe malaria and 
malaria-related deaths, reaching high frequencies in several populations 
[256][257][258]. However, the mechanism by which these erythrocyte variants confer 
protection remains unclear. Recent studies have associated these hemoglobin 
variants with reduced cytoadhesion to microvascular endothelial cells under static 
and flow conditions [203][52][214]. However, these studies only considered firm 
adhesion and have ignored the fact that infected erythrocytes interact dynamically 
with the endothelium. Our results indeed reveal major differences in the adhesion 
dynamics between infected wild-type and hemoglobinopathic erythrocytes. 
Additionally, we observed that the cytoadhesion behavior varied depending on the 
stage of the intraerythrocytic parasite, with trophozoites flipping and schizonts rolling. 
We further noticed that despite an overall reduced firm adherence and irregular 
dynamic adherence, a fraction of infected hemoglobinopathic erythrocytes bound to 
the endothelium with comparable strengths as infected HbAA erythrocytes. 
Nevertheless, infected HbAS erythrocytes activated the microvascular endothelial 
cells in a reduced manner under static and flow conditions.  
 
4.1. Reduced cytoadherence of FCR3HDMEC infected 
hemoglobinopathic erythrocytes to HDMEC under flow 
conditions  
In order to survive, P. falciparum modifies its host erythrocyte extensively during the 
parasite intraerythrocytic development. This results in dramatic modifications of the 
infected erythrocyte´s morphological and rheological properties, which consequently 
leads to an increased membrane rigidity, reduced cell deformability and increased 
adhesiveness of infected erythrocytes to microvascular endothelial cell ligands 
[232][259]. Due to the overall decrease in cell deformability as well as changes in cell 
morphology, infected erythrocytes in vivo can no longer aggregate into the 
erythrocytes centerline as the blood enters low shear areas, such as the post-
capillary venules. This promotes the margination of the infected erythrocyte towards 
the vessel wall after being pushed away of the center line by aggregated erythrocytes 
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[150]. This is the initial step for P. falciparum-infected erythrocytes adhesion to the 
endothelial cells lining the vessels. As soon as the infected erythrocytes are captured 
from flow, they interact dynamically with the endothelium, reducing their motion 
velocity and finally adhering firmly to the substratum [124]. Previous studies have 
demonstrated that alteration in the adhesive and mechanical properties of P. 
falciparum-infected erythrocytes plays a critical role in their ability to cytoadhere [12]. 
 
In the physiological range of shear stresses as well as under static conditions, the 
firm adhesion of FCR3HDMEC infected hemoglobinopathic erythrocytes was highly 
affected. These results are supported by previous studies showing ~50% reduction  
for infected HbAS and HbAC to microvascular and about 80% for HbSS-iRBCs in 
binding to microvascular endothelial cells, when compared to HbAA-iRBCs in vitro 
[203]. In vivo the sequestration of infected HbAS erythrocytes is also reduced [260]. 
The reduction in microvascular sequestration might decrease parasite densities 
during an episode of malaria due to increased splenic clearance [260]. Infected 
HbSS erythrocytes showed the strongest reduction in the number of infected 
erythrocytes binding to microvascular endothelial cells, probably due to very low 
PfEMP-1 erythrocyte surface levels as well as larger and fewer knobs quantified in 
these cells [203]. Moreover, the multiplication rate and development of P. falciparum 
in HbSS was also altered. Reduced parasite invasion and growth in sickle 
erythrocytes have been reported under low oxygen conditions, which leads to 
erythrocyte sickling and parasite developmental arrest [245]. It seems that HbSS 
erythrocytes might further protect against severe malaria by preventing the 
development of high parasitemias due to a strong reduction of infected erythrocytes 
sequestration and interference with parasite intraerythrocytic growth. This idea is 
supported by reduced parasite densities reported in individuals homozygous for 
sickle hemoglobin compared to the HbAA control group [261][262]. Nevertheless, the 
protection conferred by HbSS is uncertain and difficult to evaluate in African 
populations due to the high mortality risk of HbSS and its derived complications such 
as sickle cell anemia [203]. 
 
By reducing microvascular sequestration, infected HbS and HbC erythrocytes can be 
trapped in the spleen where they will be recognized by the immune system and 
destroyed [263]. Infected hemoglobinopathic erythrocytes may have an increased 
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antigen presentation which leads to the fast development of acquired immune 
responses, including antibodies against PfEMP-1 [264]. In fact, individuals with HbAS 
and HbAC showed enhanced antibody responses against infected erythrocyte variant 
surface antigens including PfEMP-1 [265]. Additionally, a cohort study in Kenya 
showed that the protective effect of HbAS increased with age, implying a role of 
acquired immunity in the protection against severe malaria by hemoglobinopathies 
[266]. Antibodies against PfEMP-1 might further destabilize the cytoadhesive 
interactions, further reducing vascular obstruction. 
 
Our results further revealed that, under flow conditions infected wild-type and 
hemoglobinopathic erythrocytes adhered in a shear dependent manner to HDMEC. 
This suggested that the main receptor(s) to which the infected erythrocytes were 
binding on HDMEC were slip-type bonds. Slip bonds are non-covalent bonds that 
become weaker and break after reaching a critical shear force. In agreement with this 
observation, AFM measurements describe the CD36-iRBCs binding as a slip-type 
bond interaction [267][268][269]. Furthermore, CD36 was found to be the dominant 
adhesion receptor for FCR3HDMEC binding under flow conditions. This can explain the 
shear dependent behavior observed for iRBCs to HDMEC. On the other hand, ICAM-
1, the second dominant receptor for FCR3HDMEC, is known to form catch bonds 
interactions with infected erythrocytes [267]. This means that the lifetime of the 
adhesive bonds is force enhanced, leading to shear enhanced binding [270]. By 
forming catch bond interaction, ICAM-1 can mediate adherence at higher shear 
stresses, while slip-bond CD36 mediate binding at lower shear stresses [267][271]. 
This could help explain the observation of few infected erythrocytes binding at higher 
shears stresses (above 0.15 Pa). 
 
4.2. Differential cytoadhesion behavior for infected HbAS 
erythrocytes on HDMEC at trophozoite and schizont-stages 
Before firmly adhering, infected erythrocytes roll on the endothelium [124]. This initial 
interaction permits the cell in motion to slow down until it stops completely and 
remains adherent over the rest of the intraerythrocytic cycle. For the first time, we 
showed experimentally, differences in the cytoadhesion behavior between 
trophozoite- and schizont-stage infected erythrocytes. While trophozoites showed a 
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flipping behavior, schizonts rolled on the substratum. Flipping has been previously 
predicted by simulations to occur for non-spherical and less deformable erythrocytes, 
such as trophozoite-iRBCs [272]. For smooth rolling on the other hand, adhesive 
dynamic simulations predicted that, besides rigidity and sphericity, a homogeneous 
coverage of the infected erythrocyte surface with knobs is required and that the 
rolling becomes more stable as the knob density increased [232]. In agreement with 
this prediction, the knob density on the infected erythrocytes surface increased from 
trophozoite to schizont stage, allowing the cell to smoothly roll on the substratum.  
 
Both, HbAA and HbAS-iRBCs, were capable of flipping and rolling on HDMECs. 
However, HbAS-iRBCs showed pronounced differences in the adhesion behavior at 
both the trophozoite and schizont stages. The number of iRBCs that remained firmly 
adhered was largely reduced for HbAS erythrocytes, indicating that differences in the 
HbAS-erythrocyte properties such as adhesion, cell rigidity and cells shape might 
interfere with the proper dynamic and subsequently firm adhesion. Increased 
translational velocities and reduced contact times observed for HbAS-iRBCs may 
derive primarily from reduced knob densities. Reduced knob densities and larger and 
wider knobs were indeed observed for infected hemoglobinopathic erythrocytes, 
similarly to previous reports [203][214][219]. Reduced number and abnormal knob 
presentation has been associated with the instability of HbS and HbC and a tendency 
of these hemoglobin variants to spontaneously auto-oxidize, leading to a redox 
imbalance in the infected hemoglobinopathic erythrocytes. This in turn interferes with 
knob formation and PfEMP-1 display on the infected erythrocyte surface 
[120][219][121]. The values obtained in this study for HbAA- and HbAS-iRBCs knob 
densities varied from other published values [273][219]. Numerical discrepancies in 
the number of knobs can be due to the different PfEMP-1 variant expressed [116] 
and importantly due to the type of parasite in vitro cultivation method used within the 
studies [274].  
 
Decreased erythrocyte deformability play as well an important role in the dynamic cell 
adhesion [275] and differences in this property could affect the adhesion behavior of 
infected erythrocytes. Uninfected HbAS erythrocytes are stiffer than uninfected HbAA 
erythrocytes by a factor of ~2 [276]. Moreover, erythrocyte membrane bending rigidity 
increases in infected HbAS and HbAC erythrocytes by a factor of ~2 compared to 
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infected wild-type erythrocytes [253]. It has been speculated that the increased 
rigidity in HbAS erythrocytes might derive from changes in the affinity between the 
actin and spectrin filaments that comprise the erythrocyte membrane skeleton [276]. 
Sickle erythrocytes have an up to 5 fold increased      permeability [277]. The 
increased intracellular      can interact and modulate band 3-ankyrin-spectrin and 
spectrin-protein 4.1-actin complexes interactions, leading to greater cytoskeleton 
rigidity by [278][279]. Additionally, an increase of intracellular      concentrations 
leads to the activation of the      dependent    channel (Gardos channel). Gardos 
channels activation leads to a loss of   ,     ions and water [280], which results in 
red blood cell dehydration and cell shrinkage [281], further impairing cell deformability 
by increasing cytoplasmic viscosity and probably by promoting deoxy-hemoglobin to 
aggregate [282][283][284]. Aggregated hemoglobin fibers can  bind to spectrin via 
band 3 [285]. Therefore, the interaction between hemoglobin fibers attached to the 
membrane and hemoglobin fibers in the cytoplasm could contribute to the increased 
rigidity observed for HbS erythrocytes [276]. Additionally, increased membrane 
rigidity in HbAS erythrocytes may come from elevated lipid peroxidation as a 
consequence of oxidative stress in these cells [286], which is known to have a 
negative effect on membrane erythrocyte deformability [287]. 
 
Our results further suggested that cell shape influenced the dynamic adhesion 
behavior. The infected erythrocyte shape was described to be comparable for HbAA- 
and HbAS-iRBCs at the beginning of the intraerythrocytic cycle, with a reduced 
volumes of 0.63 and 0.58, respectively [20]. Reduced volume is defined as the ratio 
of a cell volume to the volume of a sphere with the same surface area; thus a reduce 
volume of 1 indicates a complete round object [20]. As the parasites mature, the 
reduced volume increased up to 0.99 and 0.76 for HbAA- and HbAS-iRBCs at the 
schizont stage [20]. This indicates an increase of the cell sphericity for both groups at 
the end of the intraerythrocytic cycle, however not to the same extent. The 
characteristic sphericity observed for HbAA-iRBCs schizonts comes from a 
combination of the large stiff intracellular parasite and the erythrocyte swelling due to 
NaCl- influx accompanied by water via the new permeation pathways [251]. Our 
results showed that NPP were delayed in HbAS-iRBCs, which might contribute to the 
non-spherical schizonts [288]. Moreover, intracellular      concentrations are 
elevated in HbS erythrocytes [277], consequently leading to activation of the      
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dependent Gardos channel. This event leads to the loss of   ,     ions and 
accompanied water, provoking the red blood cell to dehydrate and shrink, thus 
impeding the cells from becoming spherical [280]. By not reaching a round shape 
and presenting reduced knob densities, HbAS-iRBCs prevent the smooth rolling 
behavior observed for infected wild type erythrocytes at the schizont stage. 
 
Our experimental observations regarding the dynamic adhesion behavior for infected 
HbAS erythrocytes were similarly predicted by computational simulations using 
erythrocytes with decreased knob density and increased membrane bending rigidity 
[254]. These observations revealed the importance of knob density and cell rigidity in 
the iRBCs adhesion dynamics and predicted reduced contact areas and contact 
times for HbAS-iRBCs at both developmental stages [254]. This in turn might not only 
reduce the binding capabilities under flow conditions, but also decrease the 
probability of activating endothelial cells, since endothelial cell activation depends on 
the number of interactions and duration of the contact [289][166][290]. 
 
Moreover, the transition from trophozoite to schizont was accompanied by a reduced 
adhesive contact surface area of iRBCs to the substratum. Previous studies 
suggested that elasticity and shape at the trophozoites stage facilitates adhesion by 
enabling a larger contact area with the substratum, which leads to a greater binding 
strength required by P. falciparum-infected erythrocytes to resist shear stress 
encountered in the microvasculature [291]. On the contrary, more spherical and 
stiffer cells such as schizonts have reduced contact areas with the substratum, 
consequently leading to reduced binding strengths [291]. These assumptions are 
supported by simulations where larger contact areas were shown for trophozoites 
compared to schizonts, which may be critical since trophozoites are physiologically 
the parasitic stage that dynamically adhere and sequester within the deep 
microvasculature.  
 
4.3. Strong binding population of infected HbAS erythrocytes 
The binding strength of an infected erythrocyte to microvascular endothelial cells will 
determine the ability of these cells to resist shear stress encountered in the 
microvasculature and to remain adherent. A recent study, based on laser pulse 
detachment, compared the biding strength of infected HbAA and HbAS erythrocytes 
DISCUSSION 
 
 
104 
to CD36 or ICAM-1 (Fröhlich B., 2018, personal communications). The results 
showed reduced adhesion strengths for infected hemoglobinopathic erythrocytes to 
both receptors at a population level when cells were bound under static conditions. 
This effect was probably the consequence of reduced PfEMP-1 expression levels, 
altered PfEMP-1 and reduced knob densities display on the infected 
hemoglobinopathic erythrocyte surface. Under static conditions all infected 
erythrocytes sediment by gravity and adhere to the endothelium in a weak or strong 
manner, depending on the adhesive and mechanical properties of the infected 
erythrocytes. Therefore, this technique allows quantifying the overall binding strength 
of infected erythrocytes present in a population. 
 
Under flow conditions, fewer infected erythrocytes might adhere. Only those that 
present the optimal adhesive and mechanical properties will be able to firmly adhere. 
Therefore, infected erythrocytes that are able to remain adherent under flow 
conditions, might show stronger binding that those that were not capable of adhering. 
Our results showed that fewer infected hemoglobinopathic erythrocytes bound to 
microvascular endothelial cells under flow, but however they adhered with 
comparable strengths as infected wild-type erythrocytes. These results suggested the 
presence of a population of strong binding infected hemoglobinopathic erythrocytes 
and a population of weak binding infected erythrocytes. In agreement with our 
observations, earlier studies suggested the existence of different infected HbAS and 
HbAC erythrocyte populations based on knob density and PfEMP-1 surface 
expression levels [203][214]. Those studies revealed that a fraction of infected HbAS 
and HbAC showed similar knob densities which resembled those HbAA-iRBCs in 
terms of knob morphology and distribution. In contrast, the other remaining iRBCs 
fraction presented reduced amount of knobs with an abnormal morphology and 
distribution [203][214]. The differences between these subpopulations was attributed 
to the age of the hemoglobinopathic erythrocyte, since the knob density and 
morphology of older hemoglobinopathic cells were more affected [214]. Such strong 
binding subpopulations may contribute to chronic infection, since these parasitized 
erythrocytes are not cleared from the circulation by the spleen, unlike the non-
adhering cells (weak binders). This observation helps explain the development of 
substantial parasite densities in HbAS and HbAC individuals infected with P. 
falciparum. 
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Nevertheless, future comparative studies are required in order to provide a deep 
insight in to the main differences between these two distinct populations. It is thought 
however, that even though infected HbAS erythrocytes adhered under flow and 
bound strong enough to prevent detachment from the endothelium, these cells still 
presented altered adhesive and mechanical properties which might impede the 
proper interaction with endothelial cell ligands, thus leading to reduced endothelial 
cell activation. Indeed, endothelial cell activation was reduced under static and flow 
conditions for infected HbAS erythrocytes, despite the binding of several iRBCs to a 
major proportion of the endothelial cell layer. 
 
4.4. Reduced endothelial cell activation by infected HbAS 
erythrocytes 
Endothelial cell activation has been associated with disease severity as a direct 
consequence of P. falciparum binding. Binding of infected erythrocytes to HUVEC 
can increase the levels of ICAM-1 cell surface expression and IL-6 secretion [165]. 
The induced prolonged increased expression of ICAM-1 can promote cytoadhesion 
of following parasite generations, thus inducing a state of hyperadhesiveness [165]. 
Our data support these previous observations and showed that both ICAM-1 surface 
expression and IL-6 secretion in HDMEC is induced by infected erythrocyte binding. 
 
The activation of different signaling pathways in endothelial cells upon infected 
erythrocyte contact, seems to depend on the binding avidity of the PfEMP-1 to 
endothelial cell receptors [289][166] and has been shown to occur in a time and dose 
dependent manner [290][292]. It is thought that ICAM-1 binding induces ICAM-1 
surface expression through the NF-ĸB pathway. ICAM-1 ligation by leukocytes or 
linking antibodies induced the upregulation of ICAM-1 cell surface expression [292]. 
Interestingly, NF-ĸB signaling was shown to be induced by P. falciparum-iRBCs, 
where the NF-ĸB p65 subunit almost completely translocates into the nucleus shortly 
after direct interaction between infected erythrocyte and endothelial cells [290].  
 
Moreover, NF-ĸB p65  nuclear translocation as a consequence of parasite binding 
results in increased ICAM-1 surface expression [290], further suggesting that this 
signaling pathway might be involved in ICAM-1 expression. Similarly, IL-6 secreted 
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by endothelial cells after iRBC binding [165] might also be induced via NF-ĸB nuclear 
translocation [176][165][171]. 
 
Our results indeed showed an increase of ICAM-1 endothelial surface expression, IL-
6 secretion and NF-ĸB nuclear translocation upon binding of iRBCs. Under static and 
flow conditions infected HbAS erythrocytes activated HDMEC to a lesser extent 
unlike infected wild-type erythrocytes. By displaying reduced PfEMP-1 levels these 
infected hemoglobinopathic erythrocytes could weaken the binding interactions to 
endothelial receptors [202] leading to a reduced receptor engagement and reduced 
probability of fully activating the endothelial cells. Furthermore, morphologically 
abnormal knobs might not present PfEMP-1 molecules in the ideal orientations, 
required for optimal binding to different receptors [202]. A reduced contact area and 
contact time predicted for HbAS-iRBCs might also impede full interaction and 
engagement to host cytoadherence receptors.  
 
As previously suggested, the pathogenesis of severe malaria is likely to be a multi-
factorial process involving microvascular sequestration and endothelial activation 
[189]. Through reduced and abnormal presentation of PfEMP-1, infected HbAS 
erythrocytes not only decrease the vascular lumen obstruction by reducing adhesion 
under flow, but also mitigate the inflammatory response. By reducing the activation of 
microvascular endothelial cells and the subsequent expression of endothelial 
adhesion receptors such as ICAM-1, hemoglobinopathic erythrocytes might prevent 
the development of a hyperadhesiveness state. Furthermore, reduced activation 
could also decrease the production of pro-inflammatory cytokines, such as IL-6, 
which is known to increase the binding strength to CD36 by promoting its ecto-
domain dephosphorylation via AP activity on the endothelial cells [172]. However, 
other endothelial cell responses to the binding of infected erythrocytes should also 
further be investigated such as binding strengthening, endothelial dysfunction and 
loss of barrier integrity.  
 
Our results lead us to propose a model for protection against severe malaria whereby 
reduced adhesiveness and altered mechanical properties interfere with infected 
hemoglobinopathic erythrocytes host interactions. This leads to irregular dynamic 
adhesion and a subsequent reduction in firm adhesion, which prevents the binding 
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and obstruction of microvessels in vital organs, by high numbers of infected 
erythrocytes. A fraction of infected erythrocytes can however bind under flow 
conditions and remains adherent, thus promoting the development of substantial 
parasite densities. In comparison to wild-type erythrocytes, this infected HbAS 
erythrocyte fraction has different adhesion and mechanical properties which affects 
host-pathogen interactions and leads to reduced endothelial cell activation. This in 
turn mitigates the life-threatening inflammatory response exerted by infected wild-
type erythrocytes thereby avoiding the development of severe forms of the disease. 
 
Overall, impaired adhesiveness, increased cell rigidity and morphological differences 
contribute to strong differences in the dynamic adhesion behavior of HbAS-iRBCs. 
The attenuation of parasite-host interactions during the P. falciparum intraerythrocytic 
stage not only attenuates microvascular obstruction, but also diminishes the 
activation of microvascular endothelial cells. These events might collaborate to 
prevent the development of severe malaria symptoms. Our results provide a further 
understanding of the complex mechanism of protection against severe malaria by 
sickle trait hemoglobin. Similar results observed for infected HbC erythrocytes 
regarding adhesive and erythrocyte mechanical properties suggests a common 
mechanism of protection against severe malaria by HbS and HbC variants. However, 
further studies on HbAC and HbCC erythrocytes should be performed to confirm this 
idea. Understanding the relevant pathophysiological processes leading to severe 
malaria will encourage the development of new strategies for future clinical 
interventions. 
In summary, our data shows that differential dynamic behavior and firm adhesion of 
infected HbAS and HbAC erythrocytes results in reduced endothelial cell activation, 
supporting the model of HbAS and HbAC protecting against severe malaria by 
elucidating a milder inflammatory response and causing reduced microvascular 
obstruction.  
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5. Conclusions and Outlook 
The present work shows significant differences in both firm and dynamic adhesion of 
infected hemoglobinopathic erythrocytes and the subsequent attenuation of 
endothelial cell activation. Our results further suggested the existence of two 
populations of infected hemoglobinopathic erythrocytes based on the adhesive 
capabilities. The fraction of strong binding infected erythrocytes which were able to 
adhere to microvascular endothelial cells under flow conditions, may contribute to 
chronic infection and permit sickle cell trait and hemoglobin C individuals to develop 
substantial parasitemia during a P. falciparum malaria episode. On the other hand, 
the weak binding infected erythrocytes might benefit the host by largely contributing 
to the decreasing vascular obstruction and endothelial activation.  
 
The major challenge to study these two distinct iRBCs binding populations, is to 
separate them. Attempts to collect the strong binders by washing them off from the 
endothelial monolayer after initial binding were unsuccessful due to cell lysis and 
contamination of the cell pellet with cellular debris from both endothelial cells and 
infected erythrocytes. Therefore, a methodology that allows separating infected 
erythrocytes according to their binding capabilities is needed. Following previous 
publications [293], a microfluidic cell-sorting chamber is currently being developed in 
our group and will be used to separate the heterogeneous population of infected 
hemoglobinopathic erythrocytes, according to their binding capabilities. In this device, 
the adhesion receptors such as ICAM-1 or CD36, will be imprinted on a glass surface 
by micro-contact printing, creating an adhesion receptor pattern of periodic stripes 
inclined at specific angles intercalated with BSA-passivated non-adhesive zones. 
Infected erythrocytes might be able to roll on and follow the direction of receptor 
stripes, resulting in the adherent cell separation from the non-adherent group. 
Previous simulations have predicted that infected erythrocytes with high PfEMP-1 
levels will have larger rolling displacement towards the upper channel, whereas, cells 
with low levels of PfEMP-1 will roll poorly, causing them to stay in the lower part of 
the channel [294]. After separation, infected erythrocyte populations can be 
characterized according to knob density, distribution and morphology, cell shape and 
mechanical properties. Moreover, the binding capabilities, binding strength and 
endothelial cell activation of these iRBCs populations can be investigated using 
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established techniques including AFM-SCFS to study iRBCs binding strength and 
adhesion strengthening at a single cell level. 
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